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CHAPTER I 
 
 
INTRODUCTION 
        Most animals on this planet rely on different functional systems to survive such as 
respiratory system, digestive system, nervous system, circulatory system, etc. To fight against 
environmental pathogens, they all possess immune systems. The defense system is divided into 
two major branches – innate or natural immunity and adaptive or acquired immunity. Adaptive 
immunity is slow and, during this process, the host synthesizes antibodies which specifically 
recognize, kill and memorize pathogens. In contrast, innate immunity is fast but can kill a broad 
spectrum of pathogens. Both defense strategies are adopted by vertebrates while in most 
invertebrates only innate immunity is found. As one of the most successful classes in the animal 
kingdom, arthropods including all insects occupy almost all environmental niches on the earth. 
Their evolutionary success is, to some extent, attributed to innate immunity. 
        The first line of defense in insects is a physical barrier of cuticle lining the body surface, gut 
and trachea. If microorganisms surpass this barrier, they encounter pattern recognition proteins 
that recognize microbial surface moieties and relay danger signal to initialize the host immune 
process. Two types of defense are usually involved in insect immunity: cellular and humoral 
responses (Tzou et al. 2002). In the former, different hemocytes participate in phagocytosis, 
nodulation, and encapsulation to engulf, immobilize, and kill invading pathogens. Humoral 
defenses are mediated by plasma factors (including enzymes and inhibitors) that form large 
protein complexes during hemolymph clotting and melanization. The enzyme system also 
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generates cytokines to induce the production of antimicrobial peptides (AMPs) that kill secondary 
invaders. There is no distinct boundary between the two kinds of defense responses, since many 
humoral factors affect hemocyte function, hemocytes are an important source of plasma 
molecules, and cellular and humoral defense often work together to eliminate pathogens in 
processes such as melanotic encapsulation (Elrod-Erickson et al. 2000). 
        Insect immunity studies deal with mechanisms by which insects kill viruses, bacteria, fungi 
and parasites. The research focuses on the discovery of immunity-related proteins, their 
interactions with pathogens and among themselves. Such studies have a potential in medical 
applications to prevent vector-borne diseases as well as in agricultural applications to control 
pests and protect beneficial insects. The traditional way to study insect immunity is to study 
immunity-related proteins and their genes individually. Previous studies have discovered some 
system components and illustrated their functions in immune pathways. However, many 
immunity-related proteins are not yet identified and roles of some known proteins are 
controversial. The lack of knowledge on these proteins has hampered our understanding of the 
entire physiological process. With the development of biotechnology, life science has stepped 
into the ‘omics’ era in which scientists treat a complex life system as a whole and simultaneously 
study large number of transcripts (transcriptomics) and proteins (proteomics). My research is 
mainly focused on the transcriptomic and proteomic studies of immunity-related genes and 
proteins in a biochemical model insect, Manduca sexta, to better elucidate the immune process. 
        According to the central dogma, genes are transcribed to mRNAs and then translated to 
proteins. Thus, mRNAs become the bridge between genetic materials - genes and the major 
functioning components of life system - proteins. Organisms can regulate the life activity via the 
regulation of mRNA abundances. Compared with proteins, mRNAs are more stable and easy to 
sequence. As a result, transcriptomic studies are commonly conducted in life sciences. Traditional 
Sanger sequencing used to be the main sequencing technology in such transcriptomic studies. 
3 
 
Recently the next generation sequencing (NGS) technology is adopted by more and more people 
because of their high throughput and constantly decreasing cost. Among the NGS technologies, 
454 sequencing or pyrosequencing technology has been widely utilized in transcriptomic and 
genomic studies, since it yields longer reads (Morozova et al. 2009). 
        In a living organism, proteins function in various ways such as enzymes, structural proteins, 
transporters, signaling proteins, motor proteins, storage proteins, and defense proteins. They are 
diverse in sizes, sequences, secondary structures, and post translational modifications. Protein 
synthesis and sequencing are usually expensive as compared with DNAs. Some native proteins 
are unstable under in vitro condition, making it difficult to purify them and study their functions. 
Chemical properties of proteins render the research on proteins much more difficult than that of 
nucleotides. However, since they directly mediate and regulate life activities, protein research is 
central to understanding both cells and organisms. In proteomic studies, mass spectrometry (MS) 
is often utilized for protein identifications. Many MS-based quantitative methods are developed 
and used in proteomic studies. Of these, spectral counting has been widely used because it is 
easier to handle and more cost-effective (Lundgren et al. 2010).  
        My research has four objectives: 1) profiling of transcripts from hemocytes and fat body of 
both naïve and immune-challenged M. sexta larvae using pyrosequencing technology; 2) 
quantitatively analyze differentially expressed genes related to immunity and tissue specificity; 3) 
identify plasma proteins and peptides from naïve and immune-challenged M. sexta larvae using 
mass spectrometry; 4) semi-quantitatively analyze protein and peptide expression level changes 
before and after the challenge. 
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CHAPTER II 
 
 
LITERATURE REVIEW 
 
Insect immunity 
        The first line of defense in insect immunity is cuticle, a physiochemical barrier lining 
integument, gut, and trachea, which blocks most pathogens and prevents host from infection 
(Tzou et al. 2000). The cuticle is largely composed of proteins, lipids, and long N-acetyl-
glucosamine fibrils known as chitin made by the basal epidermal cells (Feldhaar and Gross 2008). 
Since the foods insects ingest contain bacteria, immunity in their digestive tract is important for 
them to keep healthy. The foregut and hindgut are to some extent protected by a thin layer of 
cuticle. In the midgut, certain specialized cells produce a peritrophic membrane consisting of a 
network of chitin microfibils associating with the matrix of carbohydrates and proteins. The 
peritrophic membrane is permeable to digestive enzymes and nutrients but prevent most gut 
microbes from entry.  
        Once the physical barrier is breached, humoral and cellular immune responses are triggered 
to eliminate the invading pathogens (Jiravanichpaisal et al. 2006). Cellular responses involve 
different types of hemocytes in phagocytosis, nodulation and encapsulation (Lavine and Strand 
2002). Plasmotocytes engulf pathogens via phagocytosis. Nodulation refers to the process of 
multicellular aggregation to entrap large amounts of bacteria in an extracellular material which is 
often followed by melanization. When pathogenic invaders, such as nematodes and parasitoid
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wasp eggs, are too large to be engulfed, they are often entrapped by aggregated hemocytes that 
attach to them in a process known as encapsulation. Cellular responses are carried out by different 
types of hemocytes, whereas humoral responses are implemented by complex proteins (including 
enzymes and inhibitors) in body fluids. The latter include the production of AMPs and reactive 
intermediates of oxygen or nitrogen (Jiravanichpaisal et al. 2006). Both responses start with 
recognition of pathogens by pattern recognition proteins (PRRs) that bind polysaccharides on the 
surface of microbes.  
        Pathogen recognition is an essential step in immunity to detect dangerous non-self. PRRs 
recognize pathogen-associated molecular patterns (PAMPs) of different pathogens such as β-1, 3-
glucan of fungi, lipopolysaccharide (LPS) of Gram-negative bacteria, lipoteichoic acid (LTA) of 
Gram-positive bacteria, and peptidoglycans of both types of bacteria. β-1, 3-glucan recognition 
proteins (βGRPs), Gram-negative bacteria binding proteins (GNBPs), peptidoglycan recognition 
proteins (PGRPs), hemolin, and C-type lectins are the most common PRRs which specifically 
bind to different PAMPs. Many of them are strongly induced after microbial infection (Janeway 
and Medzhitov 2002). 
        After pathogens are recognized, the pathogen-PRR complexes lead to activation of 
hemolymph proteases (HPs) in insect plasma (Ragan et al. 2009). The complicated HP cascade 
plays a critical role in extracellular signal transduction by activating the Toll pathway and pro-
phenoloxidase (PPO). Phenoloxidase (PO) is a key enzyme in melanization. Besides HPs, 
extracellular signaling often involves another family of proteins called serine protease 
homologues (SPHs) which have a domain similar in sequence to HPs. Their activate-site residues, 
such as -Ser are substituted by inactive residues, such as Gly. Functions of SPHs are not well 
characterized; some SPHs seem to interact with clip-domain SPs and their substrates to regulate 
the signaling pathway. Serine proteases are regulated not only by SPHs, but also by their 
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inhibitors called serpins (serine protease inhibitors). Serpins form inactive covalent complexes 
with their target proteases, and that reduces damage caused by overreaction of immune responses. 
        Currently, three immunity-related signaling pathways have been studied in the model insect 
Drosophila melanogaster. The Toll pathway is activated by Gram-positive bacterial and fungal 
infection (Leclerc and Reichhart 2004). Through the serine protease cascade, spatzle precursor is 
cleaved and the activated spatzle subsequently binds Toll. Toll is a transmembrane receptor and 
lead to the activation of a series of intracellular signaling molecules. Among them, transcription 
factors Dorsal and DIF (Dorsal-related immune factor) translocate to the nucleus to induce the 
expression of antimicrobial genes (Pinheiro and Ellar 2006). In the Imd pathway, the invasion of 
Gram-negative bacteria and certain gram positive bacteria are recognized by PGRPs which form 
a complex with Imd, DREDD, and dFADD (Hu and Yang 2000; Naitza et al. 2002). Then, 
through the Imd pathway, Relish translocates into the nucleus to stimulate expression of other 
antimicrobial genes (Stoven et al. 2003). The Imd pathway also regulate genes involved in wound 
repair and stress response (Silverman et al. 2003). The Hop pathway is the least characterized 
pathway that modulates and links humoral and cellular responses (Agaisse et al. 2003). 
 
Insect antimicrobial peptides 
        Antimicrobial peptides (AMPs) are effector proteins in immune processes and directly kill a 
spectrum of pathogens. They widely exist in various organisms ranging from prokaryotes to 
plants, arthropods and vertebrates (Bulet et al. 2004). In insects, hundreds of different AMPs have 
been reported and these AMPs share some common features. They usually have a low molecule 
weight (less than 10 kDa), carry positive net charge under physiological conditions, and are 
mostly hydrophobic (Reddy et al. 2004). These peptides are usually absent or present at low 
concentrations in naïve insects. However, after the insects are infected by microorganisms, 
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association of host recognition molecules with pathogens triggers the Toll and Imd pathways 
which results in large increases in AMP gene expression. Fat body, a tissue analogous to human 
liver and adipose, is a major source of plasma AMPs that kill the invading pathogens.  
        AMPs are categorized into several groups: alpha-helical peptides, disulfide-stabilized 
peptides, proline-rich peptides, glycine-rich peptides, and others (Meister et al. 1997). In M. 
sexta, at least five AMPs have been identified including attacin, cecropin, moricin, gloverin, and 
lebocin (Rayaprolu et al. 2010a). Attacin was first isolated from Hyalophora cecropia and it 
increases permeability of the outer membrane of Gram-negative bacteria and controls, at the 
transcription level, synthesis of outer membrane proteins associated with bacterial growth 
(Hultmark et al. 1983). Cecropin, first isolated from H. cecropia, is active against both Gram-
positive and Gram-negative bacteria. It penetrates the plasma membrane of pathogens, disturbs 
the electrochemical gradient, and kills the bacteria (Durell et al. 1992). Moricin was first isolated 
from Bombyx mori, and it is highly active against Gram-positive and Gram-negative bacteria but 
weakly active against certain yeasts (Hara and Yamakawa 1995). It affects permeability of 
bacterial cytoplasmic membrane. Like attacin, gloverin is another Gly-rich AMP against Gram-
negative bacteria which interacts with lipopolysaccharide (LPS) in the bacterial outer membrane 
to inhibit the synthesis of outer membrane proteins (Axen et al. 1997). Lebocin, a Pro-rich AMP, 
first isolated from Bombyx mori acts on bacterial membranes and glycosylation seems vital for its 
antibacterial activity. It shows weak antibacterial activity under physiological conditions and may 
function in synergism with cecropin D (Rayaprolu et al. 2010b). 
 
Next-generation sequencing 
        In the past thirty years, automated Sanger sequencing has been widely used in biological 
sciences (Sanger et al. 1977). Using this “first-generation” method, scientists have made many 
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momentous achievements, like the completion of human genome project (International Human 
Genome Sequencing 2004). About seven years ago, a novel sequencing technology was 
introduced. Compared with the conventional sequencing technology, this next-generation 
sequencing (NGS) technology produces an enormous volume of data in a cost effective way. 
Since its arrival in the marketplace, NGS has revolutionized the way we perform scientific 
research in life science.      
        Currently there are several commercially available NGS technologies including Roche/454, 
Illumina/Solexa, and Applied Biosystems SOLiD. These technologies use different sequencing 
chemicals and methods but their procedures are similar which include template preparation, 
sequencing and imaging, and assembly or genome alignment (Metzker 2010). Compared with the 
Sanger sequencing, NGS does not require the in vivo cloning step and it allows a large number of 
DNA fragments to be sequenced simultaneously in one plate, which greatly enhanced efficiency. 
The first NGS was introduced by Roche/454, known as “pyrosequencing technology” (Margulies 
et al. 2005). It utilizes emulsion PCR to amplify template DNA sequences. Amplified DNAs are 
then loaded on a plate containing millions of tiny wells. Pyrosequencing reactions are 
simultaneously carried out in each well. Compared with the other NGS, pyrosequencing provides 
much longer reads and the run time is relatively short (Mardis 2008; Morozova et al. 2009; 
Metzker 2010). However, the reagent cost and error rates for homopolymer repeats are relatively 
high. In 2006 Illumina/Solexa was introduced which is now the most widely used NGS platform. 
It amplifies the template DNA using bridge PCR and generates much more data per run at a 
relatively low cost. However, it renders low multiplexing capability of samples (Metzker 2010). 
The Applied Biosystems (ABS) SOLiD, released in October of 2007, stands for “Sequencing by 
Oligonucleotide Ligation and Detection”. Like pyrosequencing, ABS SOLiD uses emulsion PCR 
to amplify template DNA. But the sequencing method is based on ligation with dye-labeled 
oligonucleotides. This method yields a lower sequencing rate but requires longer sequencing time. 
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Besides the three popular NGS methods, some single-molecule sequencing approaches that do 
not require template DNA amplification have been developed. These “third-generation 
technologies” have the potential to reduce sequencing cost more steeply than NGS (Morozova et 
al. 2009). 
        The advent of NGS has stimulated researches in variant areas including resequencing 
targeted regions of interest or whole genome, de novo genome sequencing, transcriptomic study 
(RNA-Seq), and metagenomics studies. NGS has greatly advanced life science research and 
posed fierce bioinformatics challenges. 
 
Transcriptomic study 
        The transcriptome is the complete set of messenger RNA (mRNA) and noncoding RNA 
transcripts in an organism, tissue or even cell. Being the dynamic link between genome and 
proteome, transcriptome has drawn great interest from scientists conducting research in different 
areas of biological science. The earliest attempts to study cellular transcriptome included 
inspections of total cellular RNA from different tissues, or under different physiological state for 
the presence and quantity of transcripts of interest (Morozova et al. 2009). The first candidate 
gene-based studies utilized the Northern blot analysis method, a low-throughput technology that 
requires the use of radioactivity and a large amount of RNA samples (Alwine et al. 1977). 
Because of its own limitation, the Northern blot method failed to detect the rare transcripts or 
those with unknown sequences. With the development of the quantitative real time polymerase 
chain reaction (qRT-PCR) method (Becker-Andre and Hahlbrock 1989), the experimental 
throughput was increased while the required quantity of input RNA was reduced. However, even 
after decades, the throughput of such approaches does not exceed the order of hundreds of known 
transcripts at a time which could not satisfy the large scale transcriptomic studies (VanGuilder et 
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al. 2008). In the mid-1990s, the advent of microarray technology replaced the single-gene 
approaches by allowing simultaneous characterization of expression levels of thousands of known 
transcripts (Schena et al. 1995). The microarray method is based on the hybridization of labeled 
cDNA samples to immobilized high-density DNA probes in a collection of microscopic wells on 
a plate. Each DNA probe in a well represents a specific DNA sequence which is usually a unique 
gene. The signals after hybridization will be monitored and used to measure differential 
expression levels for large numbers of genes. Because of its high throughput, microarray 
technology has been a dominating method in transcriptomic studies ever since it was invented 
(Pozhitkov et al. 2007). However, even after years of improvement, microarray technology still 
has several limitations including its reliance on the existing knowledge of genome sequence for 
the probe preparation, high background noise owing to cross-hybridization, and a limited 
detection dynamic range due to the background noise and saturation of signals.    
        Compared with microarray technology, sequencing-based approaches have the main 
advantage of the independence of the genome sequence since these methods could directly 
determine the cDNA sequences. In the initial sequencing-based transcriptomic studies people 
were using Sanger methods to sequence cDNA or EST (expressed sequence tag) libraries 
(Boguski et al. 1994; Gerhard et al. 2004). But this method is relatively expensive, low 
throughput and does not provide quantitative information. Then tag-based methods were 
developed to overcome these limitations, including serial analysis of gene expression (Velculescu 
et al. 1995), cap analysis of gene expression (Kodzius et al. 2006), and massively parallel 
signature sequencing (Brenner et al. 2000). These methods solved the problem of low throughput 
and achieved precise quantitative analysis. However, they are still based on the Sanger method 
which is expensive and requires a laborious cloning procedure.  
        Recently the development of massively parallel sequencing technology has revolutionized 
the way people work on biological science. It has provided a new method for mapping and 
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quantifying transcriptomes called RNA-Seq (RNA sequencing) (Wang et al. 2009). This method 
has obvious advantage over the existing methods and it has been applied in different organisms 
including human and other animals, plants, and bacteria using Illumina/Solexa, Roche/454, and 
Applied Biosystems SOLiD sequencing technologies. In general, a set of transcripts is converted 
to a library of cDNA fragments with adaptors attached to one or both ends. These cDNA 
molecules, with or without amplification are then sequenced in a high throughput manner for 
short read sequences. The resulting enormous amount of read sequences are either aligned to the 
reference genome if it is available or de novo assembled if the genome has not been sequenced. 
Compared with the previous transcriptomic study approaches, RNA-Seq has the following 
advantages which make it currently the most powerful transcriptomic study method. RNA-Seq 
can simultaneously provide information about tens of thousands of transcripts with their 
sequences and expression levels in a cost-effective way. Unlike microarray, RNA-Seq does not 
rely on the genome sequence which makes it an ideal tool for transcriptomic studies on non-
model organisms. Moreover, since the quantitative analysis for RNA-Seq is based on the numbers 
of mapped reads, the background noise is very low compared to the microarray method which 
relies on the fluorescent signal after hybridization. In addition, RNA-Seq has a much larger 
dynamic range of expression levels over which transcripts can be detected. In conclusion, this 
method offers single-base resolution for annotation and “digital” expression levels for 
quantitative analysis while the cost is much lower than the conventional methods. Currently, the 
major challenges for RNA-Seq are the cDNA library construction and the development of 
bioinformatics tools. 
 
Mass spectrometry 
        Mass spectrometry (MS) is a well-known analytical tool for measuring mass-to-charge ratios 
of small charged particles. It has been widely used in both academia and industry for various 
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purposes such as drug discovery, diagnostics, and bio-analyses (Feng et al. 2008). Mass 
spectrometers are mainly composed of three parts including ionization source, mass analyzer and 
detector. Ionization source is the part where target materials are ionized. In the early stage of MS, 
there were few ionization methods which largely relied on the electron impact. For these methods, 
covalent bonds in the molecules could be easily broken. Thus the application of MS was limited 
and it was seldom used for biological samples analysis. Then “soft” ionization methods started to 
emerge including matrix assisted laser desorption/ionization (MALDI) (Karas and Hillenkamp 
1988) and electrospray ionization (ESI) (Fenn et al. 1989). In MALDI, the target molecules are 
co-crystallized with a protective matrix. A pulse of laser light is used to force molecules into gas 
phase and ionized them. Another commonly used ionization method, ESI is considered as the 
“softest” of all the ionization methods. Even non-covalent bond such as interactions between 
proteins could be preserved using this method. In addition, since sample molecules are introduced 
in solution, ESI can be coupled with liquid chromatography and capillary electrophoresis for 
enhanced mass analysis. After the ionization process, molecules are separated and analyzed in 
mass analyzers according to their mass-to-charge ratios. Most commonly used mass analyzers 
include quadrupole, quadrupole ion trap (QIT), linear ion trap (LIT), time of flight (TOF), Fourier 
transform ion cyclotron resonance (FTICR) and Orbitrap. TOF is the most straight forward 
method which uses an electric field to accelerate ionized molecules and measures the time for 
them to reach the detector. MALDI-TOF has been widely utilized for protein identification using 
the peptide mass fingerprint method (Pappin et al. 1993). Orbitrap is a recently developed mass 
analyzer and it takes the advantage of high resolving power of each detected peak and superb 
accuracy (Hu et al. 2005).  
        Tandem MS or MS/MS has been extensively used in different proteomic studies such as 
protein identification, peptide sequencing, and characterization of post-translational modification. 
Generally tandem MS contains two mass analyzers which are separated by a collision cell. 
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Selected molecules with certain mass-to-charge ratios from the first mass analyzer will be 
fragmented in the collision cell and these fragments will be further analyzed in the second mass 
analyzer. The sequential analysis of the ionized molecules and their fragments can be achieved 
either by two mass analyzers in a row (in space) or by analysis in one mass analyzer at different 
times (in time) (Hernandez et al. 2006). 
 
Proteomic and peptidomic study 
        The proteome is the full set of proteins comprising the structural, metabolic, and regulatory 
machinery of a cell, tissue, or organism. With the advancement of biological technologies, 
proteomic studies have drawn more and more people’s attention because of the important and 
direct roles proteins play in a living organism. Currently most proteomic studies are based on 
protein identification of biological samples, differential expression of proteomes under different 
conditions or in different tissues, and protein-protein interactions. Different methods have been 
developed for proteomic studies including mass spectrometry based methods, protein microarray, 
two-hybrid screening of libraries for protein-protein interaction, and high-throughput protein 
expression and structural characterization.  
        MS-based methods are most extensively used in variant proteomic studies such as protein 
identification, protein modification, differential protein expression, and protein-protein 
interaction. Pre-fractionation is an optional step in MS and it plays an essential role in most 
proteomic studies such as protein identification where target proteins are in complex mixtures. 
Two-dimensional (2D) gel electrophoresis is a commonly used pre-fractionation method because 
it is highly compatible with peptide mass fingerprinting and differential expression could be 
directly observed on the gel (Rabilloud 2002). However, this method is labor intensive, low-
throughput, and the reproducibility is not ideal. On the other hand, liquid chromatography (LC) 
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turns out to be an efficient tool to separate proteins in a complex mixture. It has been widely used 
in proteomic studies especially after the advent of ESI since ESI allows the direct ionization of 
liquid. LC coupled with MS, or LC-MS, is one of the most popular configurations for protein 
identification and peptide sequencing (Feng et al. 2008). Multidimensional protein identification 
technology (MudPIT) was introduced in 2000 in which multidimensional LC was coupled in-line 
with ESI-MS/MS for high-throughput protein identification (Wolters et al. 2001). Soon after that 
several off-line pre-fractionation methods were developed and applied in proteomic studies. 
        Peptides are small polymers of amino acids or low molecular weight proteins. The 
peptidome is the whole set of peptides in a cell, tissue or organism. Peptidomic approaches are 
most applied in neuroscience research and biomarker discovery. There are also some peptidomic 
studies on AMPs, which are important effectors of immune responses (Brown et al. 2009). 
Compared with proteomic studies, peptidomic samples are often prepared using specific methods 
since peptides are too small for analysis on 2D gels and too large for de novo sequencing 
(Baggerman et al. 2004). Since large abundant proteins sometimes can mask the signals of 
peptides, different methods, such as heating (Ziganshin et al. 2011) or organic solvent 
precipitation (Merrell et al. 2004) were used to get rid of large proteins while retaining small 
peptides for peptidomic studies. 
  
Quantitative proteomic study 
        Early proteomic studies were merely lists of proteins identified in the given biological 
samples. As the development of proteomics methods, protein quantitation has become an 
important aspect of proteomic studies. At an earlier stage of quantitative analysis, 2D gels were 
used to visualize the differences between protein samples from different physiological conditions 
or tissues. Although it is possible to visualize more than 1000 proteins on single 2D gels, protein 
separation and differential analysis are not coupled with identification of proteins in the spots of 
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interest (Schulze and Usadel 2010). Thus, it requires an additional step of MS-based 
identification of target proteins. In addition, accurate reproducibility has always been a problem 
for this 2D-gel based quantitative analysis. The advent of difference gel electrophoresis (DiGE) 
technology (Unlu et al. 1997) which allows the separation of proteins from two different samples 
on one single gel has significantly improved the quantitative accuracy of 2D gels. However, the 
reagent is relatively expensive and this method also requires the additional step of protein 
identification using MS. 
        Many MS-based quantitative proteomic methods have been developed which are divided 
into two groups: absolute and relative quantitative analysis methods (Lau et al. 2007). Absolute 
quantitative analysis (e.g., AQUA, QconCAT, and SISCAPA) tries to measure the absolute 
protein level using internal standards with known concentrations. Relative quantitative proteomic 
methods measure relative abundance ratios between two or more samples under different 
physiological conditions. Two types of methods are adopted for such analyses, including stable 
isotope labeling and label-free methods. For the labeling methods, samples after different 
treatment or from tissues are labeled with different isotopes and mixed before the 
chromatographic and MS analysis. Since the incorporated isotope could only change the mass of 
proteins in the labeled samples, proteins from different samples could be distinguished in the 
mass spectra. Isotopes could be incorporated metabolically into all proteins in vivo or a chemical 
reagent could be used to label the proteins in vitro (Schulze and Usadel 2010). Stable isotope 
labeling with amino acids in cell culture (SILAC) is a popular in vivo labeling method where cells 
are cultured in a medium containing a heavy amino acid, and compared to one containing 
standard light variant (Ong et al. 2002). The in vitro methods include isotope coded affinity tag 
(ICAT) (Gygi et al. 1999) and multiplexed isobaric tagging technology (iTRAQ) (Ross et al. 
2004) where a modifying group is added to a certain amino acid side group (ICAT) or free 
amines (iTRAQ). While stable isotope labeling approaches enable more sensitive detection of 
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differential expression than label free methods, they also have certain limitations. The expense of 
stable isotope and expertise required for the labeling methods largely limit their widespread use. 
In addition, comparison between more than two samples simultaneously using labeling methods 
is hampered by the technical limit. Thus label-free methods have gained much popularity in 
recent years due to their relative ease of use and general applicability to a wide range of 
proteomic studies.  
        Currently there are two fundamentally different label-free methods widely used in proteomic 
studies: ion intensity and spectral counting methods (Lundgren et al. 2010). The first approach is 
based on the measurement of ion intensity of peptides associate with a given protein. To improve 
the accuracy of quantitation using ion signal intensity methods, it is necessary to run multiple 
sampling of chromatographic peak by survey mass spectra at the expense of MS/MS experiments. 
Fewer MS/MS experiments could decrease the chance of peptide identification which potentially 
decreases the number of identified proteins. Thus optimizing the instrument settings for protein 
abundance estimation using ion signal intensity method can result in the reduction of total number 
of identified proteins. On the other hand, the spectral count method uses the total number of 
fragmentation spectra that map to peptides of a certain protein for quantitative analysis. The 
rationale behind this method is that more abundant proteins or peptides are more frequently 
detected than the low abundant proteins or peptides. Since this method relies on the number of 
MS/MS spectra mapped to peptides, the optimization for this method also favors optimization for 
total protein identification (Bantscheff et al. 2007). Based on these advantages, the spectral 
counting method has been used in a wide range of diverse comparative proteomic studies. 
However, this method showed its low accuracy especially for low abundant proteins. According 
to previous reports, mean spectral counts of less than five are supposed to be unreliable when 
working with a small number of replicates (Old et al. 2005). Thus, the spectral counting method 
is still considered to be a semi-quantitative approach. 
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CHAPTER III 
 
 
MATERIALS AND METHODS 
 
Insect rearing, bacterial injection, RNA isolation, and library construction 
        M. sexta eggs, purchased from Carolina Biological Supply, were hatched and reared on an 
artificial diet as described by Dunn and Drake (1983). Each of day 2, 5th instar larvae (60) was 
injected with a mixture of Escherichia coli ( 2×107 cells), Micrococcus luteus (20 mg) (Sigma-
Aldrich), and curdlan (20 mg, insoluble β-1,3-glucan from Alcaligenes faecalis) (Sigma-Aldrich) 
in 30 μl H2O. Total RNA samples were extracted from induced hemocytes (IH) and fat body (IF) 
24 h later using TRIZOL Reagent (Life Technologies Inc.). Control hemocyte (CH) and fat body 
(CF) RNA was prepared from day 3, 5th instar naïve larvae (60). PolyA+ RNA was separately 
purified from the total RNA samples (1.0 mg each) by binding to oligo(dT) cellulose twice in the 
Poly(A) Purist™ Kit (Ambion). First strand cDNA was synthesized using mRNA (5.0 mg), 
random dodecanucleotides (100 pmol), and SuperScript™ III reverse transcriptase (1000 U, Life 
Technologies Inc.). RNase H treatment, second strand synthesis, and gap joining were performed 
according to the published protocol (Zou et al. 2008). After shearing via nebulization, the four 
samples were end-repaired (Roe 2004) and ligated to double-stranded adaptor A and biotinylated 
adaptor B (Margulies et al. 2005).  
 
PCR amplification, pyrosequencing, and sequence assembly
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        The cDNA with adaptor B attached on one or both ends was isolated using streptavidin-
coated magnetic beads, end repaired, and quantified on an Agilent 2100 Bioanalyzer (Agilent 
Technologies). Diluted DNA molecules, individually captured by beads, were amplified using 
emulsion PCR with the two primers complementary parts of A and B adaptors (Margulies et al. 
2005). After removal of the second strand and empty beads, the sequencing primer identical to 
another part of A adaptor was used for sequencing. Two full plates were run with one-half plate 
for each library on a 454 GSFLX pyrosequencer (Roche Applied Science) using long-read 
GSFLX Titanium chemistry. Reads were assembled separately for each library (CF, CH, IF, IH) 
and collectively (CIFH) using Newbler Assembler (Roche Applied Science) into five datasets: 
CF, CH, IF, IH, and CIFH (Fig. 1). To improve coverage and quality of the sequence sets, data 
from our previous run on a 454 GS20 (Zou et al. 2008) were assembled into two datasets (06 for 
the 2006 data and 06CIFH for the 2006 and 2009 data) using the updated Newbler software. The 
resulting contigs and singletons from the seven datasets were compared against the NCBI nr/nt 
and KEGG databases using BLASTN, BLASTP, and BLASTX with a maximum E-value of 
      . For the combined library CIHF, numbers of CH, CF, IH, and IF reads assembled into 
each contig were extracted from the standard Newbler Assembler output and tabulated using 
Microsoft Excel. 
 
Read normalization and ratio calculation 
        Based on frequencies of several commonly used standards in each of the four libraries (e.g., 
number of rpS3 reads in CH/number of total reads in CH), a set of six ribosomal protein genes 
were selected as internal standards, which had high total read numbers and low coefficients of 
variation (i.e., SD/mean) in their frequencies. The sums of their read numbers for specific 
libraries, or library normalization factors (LNFs), which already reflected the differences in 
library sizes, were directly used to calibrate other read numbers in the corresponding libraries. For 
a specific contig in CIFH, its relative abundance (RA) in libraries X and Y is defined as: RAx/y = 
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(actual read # in library X/LNFx)/(actual read # in library Y/LNFy). In case read # in library Y is 
zero, adjusted read number (ARN), instead of RA, is calculated as: ARNx = actual read # in 
library X × LNFy/LNFx. Some of the contigs in CIFH, whose RAs or ARNs are above certain 
thresholds, are categorized into UP, DN, HC, and FB: UP for up-regulated genes (RAIF/CF > 5, 
RAIH/CH > 8, ARNIF > 10 when RNCF = 0, or ARNIH > 10 when RNCH = 0), DN for down-
regulated genes (RACF/IF > 10, RACH/IH > 10, ARNCF > 20 when RNIF = 0, or  ARNCH > 20 when  
RNIH = 0), HC and FB for genes preferentially expressed in hemocytes (RAIH/IF> 40, RACH/CF > 
40, ARNIH > 80 when RNIF = 0, or ARNCH > 80 when RNCF = 0) and fat body (RAIF/IH > 100, 
RACF/CH > 100, ARNIF > 200 when RNIH = 0, or ARNCF > 200 when RNCH = 0), respectively.  
 
Sequence extension, database search, and domain prediction  
        CIFH contigs in UP, DN, HC, and FB categories were used as queries to search local 
databases of 06CIFH_contigs/singletons, UK_gut - contigs by BLASTN (http://darwin.biochem. 
okstate.edu/blast/blast.html). The M. sexta midgut ESTs (i.e., UK_gut_contigs) (Pauchet et al. 
2010) were kindly provided by Dr. Yannick Pauchet at University of Exeter, UK. The search 
results were used to extend the CIFH contigs or, in some cases, fill a gap between two contig 
sequences. The extended sequences were searched against NCBI using BLASTX as described 
above. For UP CIFH contigs lacking BLAST hits, a set of more stringent conditions was applied 
to select sequences for further analysis: a) RAIF/CF > 15, RAIH/CH > 15, ARNIF > 30 when RNCF = 
0, or ARNIH > 30 when RNCH = 0, b) total read number > 70, and c) GC content ≥ 35% (i.e., 
coding region-including). Open reading frames in a chosen contig were examined for leader 
peptide using SignalP 4.0 (http://www.cbs.dtu.dk/services/SignalP/), which is commonly found in 
proteins highly induced upon immune challenge (Jiang 2008). The polypeptide sequences were 
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then analyzed to detect conserved domain structures by SMART (http://smart.embl-
heidelberg.de/smart/set_mode.cgi). 
 
Insect rearing, pathogen injection, and plasma collection 
        M. sexta eggs, obtained from Dr. Michael Kanost’s lab at Kansas State University, were 
hatched and reared on an artificial diet as described by Dunn and Drake (1983). Each of day 2, 
5th instar larvae was injected with a mixture of Escherichia coli (        cells), Micrococcus 
luteus (13 mg) (Sigma-Aldrich), and curdlan (13 mg, insoluble β-1,3-glucan from Alcaligenes 
faecalis) (Sigma-Aldrich) in 20 μl H2O. As a negative control, larvae at the same stage were 
injected with 20 μl of sterile phosphate buffer saline. At 24 h after injection, prolegs of the insects 
were cut and hemolymph was collected to clean tubes containing phenylthiourea (PTU) and 
paraaminobenzamidine to the final concentrations of 0.01% and 1mM, respectively. The tubes 
were centrifuged at 4000g for 5 min at 4°C to precipitate hemocytes, the supernatants transferred 
to clean tubes, and equal amount of plasma samples were pooled from three individual insects as 
one sample. Three biological replicates of both immunized and negative control were prepared. 
Forty microliters of pooled plasma samples (3 control and 3 induced) was pipetted to a clean tube 
mixed with 8 μl of 6 × SDS sample buffer (7.0 ml 0.5M Tris-HCl, 3.0 ml glycerol, 1.0 g SDS, 
50mM TECP, 3mg bromphenol blue), respectively. The rest of plasma samples were aliquoted 
(100 μl/tube) and stored at -80°C. 
 
Preparation of plasma samples for peptidomic analysis 
        The control and induced plasma samples were thawed on ice and mixed with equal amount 
of chilled acetonitrile by vortexing. After incubation on ice for 2h, the suspensions were 
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centrifuged at 10000g for 10 min at 4°C. The supernatants (150 μl, control and induced, each 
with three biological replicates) were moved to new tubes, dried, and redissolved in 8 M urea in 
100 mM Tris-HCl pH-8.5 at room temperature. Protein concentrations of the samples were 
quantified using BCA assay (Bio-Rad). After mixing with 5 mM TCEP at room temperature for 
20 min, 1/20-volume of 200 mM iodoacetamide was added to each tube and alkylation was 
allowed to proceed for 15 min in the dark at room temperature.  The sample was then diluted with 
four volumes of 100 mM ammonium bicarbonate and digested with 8 µg/ml trypsin for 4 h at 37 
°C.  Digested samples were acidified with 5% formic acid prior to mass spectrometry analysis.  
 
Preparation of plasma proteins for proteomic analysis 
        The protein samples (three control and three induced) in 1 × SDS loading buffer were 
thawed and heated for 5 min at 95°C. Based on their protein concentrations, 60 μg of each sample 
was loaded into each well of a 4-15% linear gradient SDS-polyacrylamide gel (Bio-Rad).  After 
electrophoresis at constant current of 30 mA for 45 minutes, the gel was stained with Coomassie 
brilliant blue (CBB) R-250 and then destained in 30% methanol and 10% acetic acid. Each lane 
was sliced into nine pieces and these gel slices were further destained by extensive washing using 
50% acetonitrile in 50 mM ammonium bicarbonate, pH 8.0, dehydrated with 100% acetonitrile, 
and dried briefly. Dried gel pieces were rehydrated with 10 mM TCEP in 50 mM ammonium 
bicarbonate and reduced for 1 h at room temperature.  After incubation, the reducing buffer was 
replaced with 55 mM iodoacetamide in 50 mM ammonium bicarbonate to alkylate Cys for 1 h at 
room temperature in the dark. Samples were then rinsed with ammonium bicarbonate, dehydrated 
with acetonitrile, and rehydrated/infiltrated with sequencing-grade trypsin solution containing 8 
µg trypsin per ml of 50 mM ammonium bicarbonate.  After digestion for 6-16 h at 37 °C, the 
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trypsinolytic peptides were extracted with 1% TFA, and used for subsequent analysis by mass 
spectrometry. 
 
LC-MS/MS analysis 
        Samples were analyzed on a hybrid LTQ-Orbitrap mass spectrometer (Thermo Fisher 
Scientific) coupled to a New Objectives PV-550 nanoelectrospray ion source and an Eksigent 
NanoLC-2D chromatography system.  Peptides were analyzed by trapping on a 2.5 cm pre-
column and analytical separation on a 75 µm ID fused silica column, using a vented column 
configuration packed in house with 10-cm of Magic C18 AQ and terminating with an integral 
fused silica emitter pulled in house.  Peptides were eluted using a 5-40% AcCN/0.1% formic acid 
gradient performed over 40 min at a flow rate of 300 nL/min. During elution, samples were 
analyzed using Big Six methodology, consisting of one full-range FT-MS scan (nominal 
resolution of 60,000 FWHM, 300 to 2000 m/z) and six data-dependent MS/MS scans performed 
in the linear ion trap mode. MS/MS settings used a trigger threshold of 8,000 counts, 
monoisotopic precursor selection (MIPS), and rejection of parent ions that had unassigned charge 
states, were previously identified as contaminants on blank gradient runs, or that had been 
previously selected for MS/MS (dynamic exclusion at 150% of the observed chromatographic 
peak width).  Column performance was monitored using trypsin autolysis fragments (m/z 
421.76), and via blank injections between samples to assay for contamination.   
 
Protein database construction 
        The protein database contains sequences from four sources: 1) M. sexta protein sequences 
downloaded from NCBI 2) translated DNA sequences from 06CIFH09 dataset in our 
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transcriptomic project; 3) translated DNA sequences from previously reported M. sexta gut 
transcriptomic sequences; 4) translated DNA sequences from M. sexta genome CUFFLINK 
sequences.  
 
Protein identifications 
        Centroided ion masses were extracted using the extract_msn.exe utility from Bioworks 3.3.1 
and were used for database searching with Mascot v2.2.04 (Matrix Science) and X! Tandem 
v2007.01.01.1 (www.thegpm.org). Searches were conducted using the following search 
parameters:   
        Charge state deconvolution and deisotoping were not performed. All MS/MS samples were 
analyzed using Mascot (Matrix Science, London, UK; version 2.2.04) and X! Tandem (The GPM, 
thegpm.org; version CYCLONE (2010.12.01.1)). X! Tandem was set up to search a subset of the 
Msexta_040612 database also assuming trypsin. Mascot was set up to search Msexta_040612 
database (unknown version, 1306670 entries) assuming the digestion enzyme is trypsin. Mascot 
and X! Tandem were searched with a fragment ion mass tolerance of 0.60 Da and a parent ion 
tolerance of 5.0 PPM. S-carbamoylmethylcysteine cyclization (N-terminus) of the N-terminus, 
oxidation of Methionine, N-Formylation of the N-terminus, acetylation of the n-terminus, 
iodoacetamide derivative of cysteine and acrylamide adduct of cysteine were specified in X! 
Tandem and Mascot as variable modifications.  
        Scaffold (version Scaffold_3.4.5, Proteome Software Inc., Portland, OR) was used to 
validate MS/MS based peptide and protein identifications. Peptide identifications were accepted 
if they could be established at greater than 80.0% probability as specified by the Peptide Prophet 
algorithm (Keller et al. 2002). Protein identifications were accepted if they could be established at 
greater than 99.0% probability and contained at least two identified peptides. Protein probabilities 
24 
 
were assigned by the Protein Prophet algorithm (Nesvizhskii et al. 2003). Proteins that contained 
similar peptides and could not be differentiated based on MS/MS analysis alone were grouped to 
satisfy the principles of parsimony. A reversed database served as a decoy protein database to 
determine the false discovery rate (FDR) as described before (Elmore et al. 2012). 
 
Sequence trimming and statistical analysis 
        Protein sequences from translated DNAs were manually trimmed – only the translated 
region from the starting Met to stop codon was kept. For those without starting Met or stop 
codon, the longest translated sequences were kept. BLASTP was used to determine the functions 
of these proteins. Based on the total spectral counts in each sample, the spectral counts for each 
protein were normalized. The normalized numbers were used for Student’s t-test to see if there 
was significant difference (p-value < 0.05) between induced and control samples. We defined I/C 
as the ratio of the average normalized spectral counts for induced sample (I) over the counts for 
control sample (C). In case that the average number for C was 0, we used 1 as the divisor for the 
calculation. We regarded the proteins with significant changes after immune challenge and the 
normalized spectral counts increased at least one fold (p-value < 0.05, I/C ≥ 2) or without 
significant changes but spectral counts increased at least four folds (p-value  ≥ 0.05, I/C ≥ 5) as 
up-regulated proteins. Similarly, we regarded those with p-value < 0.05 and I/C ≤ 0.5 or p-value ≥ 
0.05 and I/C ≤ 0.2 as down-regulated proteins. 
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CHAPTER IV 
 
 
RESULTS AND DISCUSSION 
 
Identification of differentially regulated genes in M. sexta by pyrosequencing  
        In order to find immunity-related genes expressed in fat body or hemocytes based on their 
expression profiles, we isolated mRNA of these two tissues from naïve and bacteria-injected 
larvae of M. sexta, a lepidopteran insect whose genome sequence has not yet been determined. 
Using random dodecanucleotide primers that annealed to different regions of mRNA molecules, 
we generated four cDNA libraries: CF, CH, IF and IH. To facilitate assembly and ORF 
identification, we adopted long-read Titanium chemistry to sequence these libraries on a 454 GS-
FLX pyrosequencer and obtained a total of 227,302 reads from CF, 647,587 reads from CH, 
405,739 reads from IF, and 541,024 reads from IH (Table 1). The total number of reads from two 
plates (0.5 plate per library) was 1,821,652, which was 19.1-fold higher than that from one plate 
(95,358 reads) sequenced on a 454 GS20 in 2006 (Zou et al., 2008). There also was a substantial 
increase in average read length from 185 bp to 289 bp, but that was still much lower than what 
the manufacturer claimed (>400 bp) (http://454.com/about-454/index.asp). 
 
        We assembled the reads into five datasets: CF, CH, IF, IH, and CIFH (Fig. 1). The first four 
each came from its respective library, whereas the 5
th
 dataset was assembled from the 1,821,652 
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reads in the four libraries sequenced in 2009. In CF, CH, IF and IH, 84.1~86.6% of the total reads 
were incorporated into contigs at average sizes of 764~832 bp; In CIFH, 1,677,738 (92.1%) of 
the 1,821,652 reads were assembled to 19,020 contigs at 923 bp per contig (Table 1). These 
assemblies were better than the previous one, that integrated 69,429 (72.8%) of the 95,358 reads 
into 7,231 contigs at an average length of 300 bp (Zou et al. 2008). To improve the transcriptome 
coverage, we used the latest version of Newbler to re-analyze the previously generated 
flowgrams, assembling 64,874 of the reads into 1,471 contigs with an average of 391 bp per 
contig in the 6th dataset (“06”) (Table 1). Finally we assembled all the source libraries (2006, CF, 
CH, IF, and IH) into “06CIFH”, which contained 19,504 contigs (average size: 911 bp) and 
120,670 singletons. 
        We used numbers of CH, CF, IH, and IF reads for each CIFH contig to identify differentially 
regulated genes. Since read numbers depended on library sizes and needed to be normalized 
against control genes, we compared frequencies of commonly used internal standards in each of 
the four libraries and found that six ribosomal protein genes (rpS2-rpS5, rpL4 and rpL8) showed 
low coefficients of variation (<30%) and high total read numbers (>1,000). So, we used the sums 
of their read numbers 825 (CF), 3,980 (CH), 1,618 (IF), and 3,352 (IH) as library normalization 
factors (LNFs) to calibrate read numbers and calculate relative abundances (RAs) (Fig. 1). Based 
on the RA values, 920 or 4.84% of the 19,020 contigs in CIFH were categorized into four groups: 
UP and DN for up- and down-regulated genes upon immunization; HC and FB for genes 
preferentially expressed in hemocytes and fat body, respectively. 
 
Sequence analysis and function prediction of UP genes  
        We discovered 528 CIFH contigs whose RAIF/CF or RAIH/CH was greater than 5 and 8, 
respectively, or whose adjusted number of IF (or IH) reads (ARN) was >10 when the CF (or CH) 
read was zero – the adjustment for IF was read # × 825/1618 and that for IH was read # × 
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3980/3352. As we anticipated, these contigs encoded polypeptides either identical to immunity-
related proteins previously isolated from M. sexta (e.g. hemolin), or similar in sequence or 
domain structure to defense factors found in other insects (e.g. Spodoptera frugiperda X-tox), or 
related to proteins previously not known to play a role in immune responses (e.g. 
carboxylesterase), or having no significant sequence similarity to known proteins. In the 
following, we describe these contigs in the order of their putative immune functions. 
 
A. Recognition of molecular patterns associated with microbes 
        To reinforce detection of invading organisms, certain pattern recognition receptors (PRRs) 
are synthesized in insects at higher levels after the initial encounter of foreign entities or 
abnormal host components. For instance, we found an Ig-domain protein (contig 03442) had an 
RAIF/CF of 748.5 (Table 2). This protein, M. sexta hemolin, was reported previously as a highly 
inducible PRR that recognizes LPS of Gram-negative bacteria (Ladendorff and Kanost 1991). 
Other PRRs included M. sexta immulectin-2 (contig 04775, RAIF/CF: 45.4), immulectin-4 (contig 
04808, ARNIF: 217.2), peptidoglycan recognition protein-1 (PGRP1) (contig 13190, ARNIH: 10.7; 
contig 14104, RAIF/CF: 6.3; ARNIH: 15.4), PGRP2 (contig 14700, residues 1-96, ARNIF: 93.3; 
contig 14752, residues 98-196, ARNIF: 60.2), β-1,3-glucan recognition protein-2 (βGRP2) (contig 
01326, RAIF/CF: 9.7; RAIH/CH: 9.2). These data not only confirmed the published PRR sequences 
but also provided information on fold increases in their transcript abundances. Contig 06630 
(RAIF/CF: 11.2), 58% identical to M. sexta immulectin-3 (Yu et al., 2005) in residues 1-276, 
represented a previously unknown immulectin discovered based on its induced expression as well 
as sequence similarity. Newly identified PRRs also included PGRP3 (contig 00575, RAIF/CF: 
44.0), homologs of Bombyx mori PGRP5 (contig 11845, RAIH/CH: 10.1) and PGRP-S6 (contig 
08467, ARNIF: 57.6), homologs of B. mori CTL10 (contig 14515, residues 54-182, RAIF/CF: 8.7; 
contig 15639, residues 233-308, RAIF/CF: 5.6; contig 11458, residues 54-306, ARNIF: 28.0), 
homolog of B. mori Gram-negative binding protein (contig 08247, RAIH/CH: 10.7) (Tanaka et al. 
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2008), LPS-binding leureptin (contig 15857, RAIH/CH: 10.7) (Zhu et al. 2010), Ig domain-
containing hemicentin-1 (contig 00131, RAIF/CF: 6.4) and -2 (contig 14278, RAIF/CF: 8.7) (Vogel 
and Hedgecock 2001). Therefore, expression profiling and sequence similarity together provided 
a powerful tool to discover process-related genes without a priori genome sequence. 
 
B. Extracellular signal transduction and modulation 
        Hemolymph proteinases (HPs) in insect plasma form enzyme cascades to detect pathogen-
PRR complexes and activate precursors of defense proteins (e.g. PO, spätzle, serine proteinase 
homolog (SPH), and plasmatocyte-spreading peptide (PSP) by limited proteolysis (Jiang and 
Kanost 2000). We found eight HPs in the UP list: M. sexta HP7 (ARNIF: 11.2), HP9 (RAIH/CH: 
28.5), HP17 (ARNIH: 15.4), HP18 (RAIH/CH: 40.4), HP19 (RAIF/CF: 7.1), HP22 (RAIF/CF: 5.1), 
proPO-activating proteinase-2 (PAP2) (ARNIF: 50.0), and PAP3 (ARNIF: 22.9) (Table 3). 
Expression profiles associated with the immune inducibility agreed well with the RT-PCR and 
northern blot results published earlier (Jiang et al. 2003a; Jiang et al. 2003b; Jiang et al. 2005). 
We also found six contigs encoding isoforms of a strongly inducible protein (scolexin) that 
contained all three catalytic residues of S1A proteinases but did not display any amidase activity 
(Finnerty et al. 1999). The high ratios and read numbers of these contigs (RAIF/CF: 338.6 and 
551.2; ARNIF: 70.9, 129.5, 145.3, 169.8) suggested that primer binding and reverse transcriptase 
pausing were biased at certain sites of the template because, otherwise, there should not have 
been any gap for such a short ORF of ~1.36 kb. The exact role of scolexin in defense is still 
unclear. 
        In the reaction of proPO activation, a high molecular weight complex of SPH1 and SPH2 
has to be present along with PAP and proPO to generate active PO (Gupta et al. 2005). In this 
study, we identified SPH1 (contig 02813, RAIH/CH: 9.5) and SPH2 (contig 6149, RAIF/CF: 16.7; 
contig 14393, RAIF/CF: 33.7) and confirmed their induced expression (Yu et al. 2003). Besides, 
contig 02985 (RAIF/CF: 27) contained a complete ORF coding for a regulatory clip domain 
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followed by a serine proteinase-like domain. The protein, designated M. sexta SPH4, is 49% and 
92% identical to SPH1 in the amino- and carboxyl-terminal domains, respectively. Such a 
disparity in sequence alterations suggests that the selection pressures or structural constraints for 
these two regions differ dramatically. 
        Functions of serine proteinases are modulated not only by SPHs but also by their inhibitors. 
Particularly, some members of the serpin superfamily regulate serine proteinase activities by 
forming covalent complexes with their cognate enzymes (Kanost 1999). We have identified six 
serpins in the UP list (Table 3), five of which are known as M. sexta serpin-1 (contig 7639: 
ARNIH: 16.6), serpin-2 (four contigs, ARNIH: 61.7, RAIH/CH: 13.3, 15.4, 20.2), serpin-2 homolog 
(four contigs, RAIH/CH: 19.8, 38.8, 77.2, 112.8), serpin-3 (contig 2693, RAIF/CF: 7.5), serpin-5 
(three contigs, RA: 5.9, 11.9, 16.5). We have found a new serpin (contig 6215, RAIH/CH: 9.5) and 
its ortholog in B. mori, SLP or serpin-12. The silkworm serpin was expressed in fat body of 
bacteria-injected larvae but not in fat body of naïve ones (Zou et al. 2009). Its transcription in 
hemocytes also was similar to that of the M. sexta serpin: the mRNA was low in naïve larvae and 
became higher in induced ones. 
        Besides serine proteinases, SPHs and serpins, we also have found other proteins that either 
mediate or regulate immune responses in M. sexta or other moths (Table 3). These include: 
tyrosine hydroxylase (contig 2023, RAIF/CF: 16.8) (Gorman et al. 2007), dopa decarboxylase 
(contig 00940, ARNIF: 106.6) (Noguchi et al. 2003), PSP-binding protein (contig 15055, RAIF/CF: 
8.2) (Matsumoto et al. 2003), and Zn proteinase (contig 0915, ARNIF: 11) (Altincicek and 
Vilcinskas 2008). Four immunity-related proteins, Hdd1, Hdd11, Hdd13, and Hdd23 (Shin et al. 
1998), are included here even though their functions remain unknown. 
 
C. Intracellular signaling pathways and their components 
        Pathogen recognition and signal transduction can either go through a PRR-SP system in 
insect plasma (e.g. spätzle processing for Toll activation) or directly binds to PRRs on the surface 
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of immune tissues/cells (e.g. PGRP-LC binding for Imd activation in Drosophila). After that, 
intracellular proteins are mobilized to relay signals into the cell nucleus where transcriptional 
regulation occurs. As shown in Table 4, we have detected increase in transcript levels of the 
putative pathway members: Toll-like receptors (contigs 06893 and 18001, 68% and 94% similar 
in amino acid sequence to ABO21763) (Ao et al. 2008), cactus (contig 01044) (Furukawa et al. 
2009), relish (contigs 04802 and 15532) (Tanaka et al. 2007), and eiger (contig 01139, a 
membrane-bound TNF homolog) (Kauppila et al. 2003). Other intracellular proteins possibly 
involved in signal transduction or modulation include a Ser/Thr protein kinase, GTP/GDP 
exchange factors, a receptor Tyr phosphatase, a protein phosphatase 2c, ankyrin repeat proteins, 
and vrille transcription factor. 
 
D. Antimicrobial peptides/proteins 
        Overproduction of effector proteins that immobilize pathogens, block their proliferation, or 
directly kill them is a hallmark of insect immunity (Bulet et al. 2004). Consistent with this notion, 
we have detected 65 UP contigs encoding: A) antimicrobial peptides, B) low molecular weight 
proteinase inhibitors, C) lysozymes, and D) transferrins (Table 5). In group A, twenty-five 
contigs (06782, 07203, 08902, 11040, 11711, 13563, 14343, 14380, 14641, 15159, 15732, 15744, 
15953, 15997, 16129, 16150, 16576, 17135, 17304, 17350, 17632, 17705, 18324, 18814, 18977) 
code for at least six attacins (Fig. 2), eight (03746, 14568, 15998, 16292, 17184, 18150, 18699, 
18819) for at least three X-tox (Girard et al. 2008), six (04913, 07116, 10853, 13916, 17301, 
17343) for four lebocin-related proteins (Rayaprolu et al. 2010a), four (12151, 13894, 14997, 
15041) for three cecropins (Zhu et al. 2003), two (09484, 17439) for two moricins (Dai et al. 
2008), and one (02067) for gloverin (Zhu et al. 2003). Group B consists of eight contigs (03142, 
03674, 04175, 05197, 08286, 10722, 13936, 16018) encoding proteinase inhibitor-like proteins 
which may block proteinases released by bacteria, fungi, or parasites (Zang and Maizels 2001; 
Armstrong 2006). Group C has three contigs (08421, 15931, 16133) coding for two lysozymes 
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(Mulnix and Dunn 1994) that hydrolyze bacterial peptidoglycans. Group D includes seven 
contigs (02145, 11027, 14937, 16606, 17206, 18239, 18308) encoding at least two transferrins 
that may sequester iron and, by doing so, prevent bacteria from proliferation (Nichol et al. 2002). 
 
E. Other up-regulated genes 
 
        Among the 528 UP contigs, 177 did not have any BLAST hits, indicating that some of them 
may encode polypeptides previously not known to be involved in immunity. To ensure these 
sequences are indeed up-regulated, we selected contigs with RA >15 (or ARN >30) and total read 
numbers >70. We then extended these contigs, if possible, with sequences in dataset “06” (Table 
1) and in the M. sexta gut EST dataset (Pauchet et al. 2010). After eliminating the contigs with 
GC-contents <35% (hence, likely representing 5’ or 3’ AT-rich untranslated regions of up-
regulated genes), we examined the remaining ones in greater detail (Table 6). Contigs 00327, 
01714, 04720, 05523, and 07536 contain ORFs with a secretion signal peptide. The putative 
mature proteins (41, 61, 37, 86, 179 residues long) could be novel AMPs or in other ways 
involved in immunity. Contig 02467 encodes a secreted protein containing ten Cys that may 
tether the 139-residue polypeptide into a stable domain functioning as a proteinase inhibitor or an 
antifungal protein (Kanost 1999). Contigs 15852 and 17316 encode proteins with 2 and 3 Kazal-
type proteinase inhibitor domains, respectively. Contigs 17537 and 17568 encode proteins with a 
DM9 domain. Contigs 03381 and 15910, after extension, are found to be a part of cactus and 
serpin-2 transcripts. The other contigs encode sequences similar to B. mori heat shock protein 
25.4, SPH, and esterases. 
 
Sequence analysis and function prediction of DN genes 
        The analysis of down-regulated genes yielded results that surprised us at first: among the 53 
DN CIFH contig groups with BLAST hits, ten were closely related to immune responses (Table 
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7). A contig group represents a single contig in most cases but, in other times, has multiple 
contigs with the same BLAST hit, which may come from different genes. They include lectins 
(06497, 07642, 11280, 13813, 14570, 14760), lacunin (00015), HP1 (16288), and proPOs (17085 
and 17958). A closer inspection of the data indicated that the decreases in mRNA levels seem to 
always occur in fat body instead of hemocytes. Since these genes were all expressed at much 
higher levels in hemocytes than fat body (RACH/CF or IH/IF >40), we suggest the apparent down 
regulation in fat body were caused by unequal contamination of fat body tissue by hemocytes: 
somehow there was much less contamination in induced fat body of these hemocyte-specific 
transcripts. In hemocytes, their average RACH/IH was only 2.1 – no major down-regulation was 
observed for these immunity-related genes in cells mainly expressing them. It is likely that 
similar contamination of fat body tissue by hemocytes also resulted in the observation of genes 
not known to be directly related to immunity, which includes 11 contig groups (00010, 00248, 
00379, 00623, 00628, 03286, 03654, 07139, 08686, 10124, 13842) with RACH/CF or IH/IF >40 
(hemocyte-specific) and RACF/IF >10 (fat body DN) but RACH/IH <3. 
        After eliminating contigs whose RACH/CF or IH/IF calculated from low read numbers, we have 
found four DN contigs: 02730 encodes a β-glucosidase, 11098 a Met-rich storage protein, 12848 
a proteinase inhibitor, and 14781 a phosphoserine amino transferase. Follow-up studies are 
needed to confirm their down-regulation and explore physiological relevance of the decrease in 
transcript levels. 
 
Tissue-specifically regulated genes in larval hemocytes 
        Using the same set of read numbers in CIFH, we found 45 contig groups representing genes 
preferentially expressed in hemocytes. Interestingly, this tissue-specific pattern (RA >40 or 
ARNIH >80) was only found in the induced samples but not in the control ones (Table 8). A closer 
examination of the data uncovered the possible reason for this bias: although fat body was 
collected under the same conditions, more hemocytes attached to the control fat body tissue than 
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the induced one. Consequently, higher read numbers from contaminating hemocytes in control fat 
body led to much lower RACH/CF values than their corresponding RAIH/IF’s. While the same reason 
caused wrong identification of some contigs as down-regulated ones (Table 7), the skewing of 
RAs against the control samples (i.e. lower RACH/CF) did not seem to affect the correct calling of 
hemocyte-specificity in a qualitative term. For the entire contig groups, the sums of CF and CH 
reads were 2173 and 105143, respectively. The average RACH/CF of 10.0 was much lower than the 
cutoff value of 40 but still substantially higher than 2-5, thresholds commonly used in microarray 
or qPCR studies to assess differential expression. In comparison, the sum of IF and IH reads were 
302 and 62907, respectively, and their average RAIH/IF was 100.5. 
        The hemocyte-specific gene expression is, in several cases, supported by previous studies on 
M. sexta defense proteins such as lacunin (Nardi et al. 1999), HP1 (Jiang et al. 1999), serpin-2 
(Gan et al. 2001), and proPO (Jiang et al. 1997). Lacunin is an extracellular matrix protein 
responsible for transforming circulating non-adhesive hemocytes to adhesive ones that aggregate 
on foreign surfaces (Nardi et al. 2005). Contigs 16288, 16719 and 17102 encodes clip-domain 
HP1; contigs 08524 and 12527 encode an HP1 homolog ~97% identical in sequence to the 
published one (Jiang et al. 1999). HP1 may be involved in a serine proteinase cascade that 
proteolytically activates proPO in plasma. Hemolymph proPO is synthesized in oenocytoids only 
(Jiang et al. 1997): 6 contigs encode proPO subunit-1 and 9 encode proPO subunit-2. 
        Based on sequence homology, we also discovered 51 contigs that were not known to be 
related to hemocyte-mediated immunity in M. sexta (Table 8). Contigs 11280, 13813, 15506, 
15594, and 18551 probably encode parts of hemolectin or hemocytin, a >300 kDa protein 
participating in hemolymph coagulation (Lesch et al. 2007). As many as 37 contigs encodes 
multiple lectins that bind to carbohydrates. Contigs 05933, 08686, 13271, 15116, 15350, and 
15564 encode scavenger receptor C-like proteins that could also recognize carbohydrates. 
Apparently, hemocytes play critical roles in the recognition of pathogens that are covered with 
polysaccharides on the surface. Contig 02473 encodes a protein homologous to Drosophila eater 
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that mediates bacteria phagocytosis by hemocytes (Kocks et al. 2005). Contigs 03287 and 07139 
may be related to antiviral and antiparasitoid responses, respectively (Abdel-latief and Hilker 
2008; Liu et al. 2010). 
        Inside hemocytes, proteins may relay signals in a cell-specific manner. These include contigs 
00541, 00752, 03246, 06319 (G-protein coupled receptors), 00882 (GTP-binding protein) 00010 
(cAMP-dependent kinase), 00839 (receptor-type Tyr-protein phosphatase), 02159 (septin for 
ubiquitination), 15584 (GTPase atlastin), 14248, 15111, 16917, 17058, and 17751 (serpin-2 and 
2’). It is unclear how these two highly inducible, intracellular serpins may inhibit a proteinase 
during apoptosis. Nor is it known how the other proteins may transduce signals dependent on the 
immune status of hemocytes. 
 
Specific gene expression in fat body from feeding larvae 
        Because hemocyte samples collected through cut prolegs of feeding larvae were unlikely 
contaminated with fat body tissue, the 132 fat body-specific (i.e. FB) contig groups had high 
RACF/CH or IF/IH values (Table 9). Moreover, since chances for such contamination were equal 
for hemocytes from naïve and challenged M. sexta larvae, there was no globally uneven 
distribution of RAs or ARNs between the CF/CH and IF/IH groups. In other words, the data on 
fat body- specific gene expression were unbiased and reliable. 
        Insect fat body, equivalent to combined mammalian liver and adipose tissue, is the site 
where most intermediary metabolism takes place (Arrese and Soulages 2010). It also is the 
principal source of plasma proteins, including those participating in innate immune responses 
(Jiang 2008). These notions are strongly supported by the identification of FB contigs and 
BLAST search: 61 or 46% of the 132 FB contig groups are metabolism-related, whereas 32 or 
24% are immunity- related (Table 9). Since metabolism-related genes and their transcript level 
changes after the immune challenge will be reported elsewhere, we only discuss fat body-specific 
gene expression involved in antimicrobial defense responses and the UP contigs covered in 
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Section 3.2 are not repeated here. β-1,3-glucan recognition protein-1 (02979) (Ma and Kanost 
2000), immulectin-3 (01097) (Yu et al. 2005), and leureptin (04012 and 08453) (Zhu et al. 2010) 
are pattern recognition receptors binds fungi and bacteria (Table 9). HAIP (02947), a chitinase-
like protein, inhibits hemocyte aggregation (Kanost et al. 1994). Contig 05348 encodes a protein 
with at least three Ig domains. Contig 00535 encodes a thrombospodin-like protein with eight 
EGF-like domains and one coiled coil for protein-protein interaction. Contig 07671, after 
extension, is found to encode a >60 kDa protein with at least four EGF domains. Hemicentin 
(00465) is a cell adhesion protein containing a von Willebrand A domain (Vogel and Hedgecock 
2001). Contig 08820 encodes a fibrillin-like nimrod B which may play a role in pathogen 
recognition and phagocytosis (Kurucz et al. 2007). 
        We have found six proteinase inhibitor-like proteins, including homologs of B. mori 
serpin12 (or SLP: 03776, 06215, 06531, 17814), serpin13 (02184) and serpin22 (03224) (Zou et 
al. 2009), two Cys-rich secreted protein (06175, 06597), and cationic protein-8 (16281, 17312) 
(Ling et al. 2009). Contig 02651 encodes three cytokines that may regulate cellular immune 
responses (Kanamori et al. 2010). 
 
Proteomics workflow and protein identification 
        In order to identify M. sexta plasma proteins, especially those involved in immune 
responses, we collected hemolymph samples from the larvae injected with buffer or bacteria. 
After hemocyte removal, the cell-free hemolymph samples and their biological replicates were 
separated on a 4-15% gradient SDS-polyacrylamide protein gel which was subsequently cut into 
nine slices for each lane according to the staining pattern (Fig. 2). Proteins in the gel pieces were 
digested with trypsin and the resulting mixtures (referred to as “protein” samples) were analyzed 
on LTQ-Orbitrap mass spectrometer. As anticipated, some peptides had left the gel and, 
therefore, were undetectable by this method. To locate these small molecules, including 
antimicrobial peptides – effectors of the insect immune system, we used equal amount of 
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acetonitrile (AcCN) to precipitate large proteins in the naïve and induced plasma samples. After 
centrifugation, the supernatants containing small peptides and some AcCN-stable proteins were 
treated with trypsin. The resulting mixtures (referred to as “peptide” samples) were analyzed by 
LC-MS/MS on the mass spectrometer. For each “protein” or “peptide” sample, we performed at 
least three technical replicates.  
        For the “protein” samples from the gel slices, Scaffold reports showed a dataset of 1,594,513 
spectra, 314866 or 19.7% of which matched those of trypsinolytic peptides derived from the 
protein sequences in silico. The matched spectra corresponded to 785 independent proteins in the 
database (Table 10). In the “peptide” samples treated with AcCN, we detected 202,077 spectra. 
Of thess 41,706 or 20.6% matched spectra corresponding to 270 independent proteins, mostly 
peptides. The protein and peptide FDRs were 0.4-0.5% and 0.0% for the gel-derived and AcCN 
treated samples, respectively. The low FDRs suggested our positive identifications have high 
reliability. Since 157 proteins were detected in both samples, we identified a total of 898 
hemolymph proteins, substantially more than 55 found in the previous study (Furusawa et al. 
2008). The successful identification is partly caused by increases in M. sexta sequences: based on 
the sequences deposited at GenBank over the years, we identified 126 hemolymph proteins in the 
gel slices; including the fat body and hemocyte transcriptome data added 349 new IDs; using the 
genome sequence resulted in another 292 new ones (Fig.4). Similarly, we found 54, 161, and 205 
proteins/peptides in AcCN-treated samples using GenBank, transcriptome, and genome sequence 
data, respectively. Since there is no major increase in M. sexta sequences at GenBank since the 
proteomic study was published, our identification of 126 proteins (instead of 55 in the early 
study) is a result of method/instrumental improvements. The selection of day 1, 5
th
 instar larvae 
also seems critical: the insects were large enough to provide adequate hemolymph yet not too 
many storage proteins had accumulated at high levels in the plasma of late 5
th
 instar larvae. These 
abundant proteins tend to mask signals from other proteins. Besides, the gradient gel better 
separated proteins based on sizes and slicing gel on the basis of staining pattern allowed us to 
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load appropriate amount of proteins to the mass spectrometer individually according to the 
relative abundances. 
 
Quantitative analysis using spectral count 
        Spectral counting has been widely adopted as a robust label free method for quantitative 
analysis in proteomic studies. Spectral counts (SCs), defined as the number of observations of 
certain proteins in an MS/MS experiment, were used to estimate protein abundances in this study. 
The SCs for individual proteins were first normalized based on the total number of spectral 
counts in each sample. The pairwise Pearson correlation coefficients (Table 11) indicate the data 
consistency between/within all the induced hemolymph and control hemolymph samples, as well 
as gel-extracted and AcCN-treated samples. We detected strong correlation between samples after 
the same biological treatment (C or I). The correlation coefficients between control or those 
between induced were 0.971~0.990 in the “protein” group, whereas those for the “peptide” 
samples were 0.936~0.965. On the other hand, the Pearson correlation coefficients between C and 
I were relatively lower. For the “peptide” samples, the correlation coefficients were 0.554~ 0.654, 
indicating drastic differences in peptide levels after the bacterial injection. For the “protein” 
samples, the correlation coefficients were 0.933~ 0.950, suggesting that a smaller proportion of 
proteins underwent less dramatic changes after immune challenge.  
        To compare the methods of sample preparation, we analyzed the 157 proteins that were 
identified in both “protein” and “peptide” samples and noticed some interesting differences 
(Table 12). Fifty-one proteins showed significant changes and 46 proteins had insignificant 
changes after the immune challenge in both samples, as supported by the t-test results. This 
showed the consistency of t-test results for most proteins identified in both sources. However, 60 
other proteins showed significant changes in one sample but not in the other. This may be related 
to differences in sample handling: while gel-extracted samples went through gel electrophoresis, 
staining and excision, and in-gel trypsin digestion, AcCN treatment is simple and does not 
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introduce much operational error. On the other hand, dependent on their properties and 
concentrations, AcCN might introduce inequality to proteins/peptides, especially the high 
molecular ones. Consequently, when different quantitative results were obtained from these two 
sources, we relied more on data from AcCN-treated samples for small peptides and from gel-
extracted samples for large proteins. We checked the percentage of proteins showing significant 
changes after immune challenge. The percentages for total proteins from the gel-extracted and 
AcCN-treated samples were 25.6 and 57.8%, respectively. Comparing with the numbers for 
overlapping proteins (gel: 65/157, AcCN: 97/157), we could see the difference for gel-extracted 
samples. The reason appears to be that most of the overlapping proteins were small peptides 
whose expression levels were highly induced after the immune process. In fact, Pearson pairwise 
correlation data (Table11) showed drastic changes of small peptides after immune challenge.  
 
Up-regulated proteins 
        After t-test and ratio calculation, we found 94 and 48 up-regulated proteins from the 
“protein” and “peptide” samples, respectively. As we anticipated, a majority of the proteins are 
associated with immune responses (Table 13). These include 8 PRRs, such as hemolin, PGRPs, 
immulectins and hemicentin. Their corresponding mRNA levels were also up-regulated after the 
immune challenge, suggesting a reinforcement of pathogen detection. We also found 24 signaling 
proteins including hemolymph proteases, protease inhibitors, and an intracellular signaling 
protein called Dorsal. The most drastic up-regulation was observed in the category of AMPs, such 
as attacins, cecropins, lebocins, gloverin, gallerimycin, and psychimicin. Most of their levels 
increased more than 10 folds after immune challenge. Some attacins showed 500-fold changes. 
These data are consistent with the fact that AMPs mRNA levels elevated greatly after the immune 
challenge (See above). Besides we also found some proteins in the up-regulated protein list, 
which are not known to be immunity-related. For instance, a cysteine-rich peptide (contig04199) 
was highly up-regulated and similar in sequence to a salivary protein. We suspect it could be a 
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new antimicrobial protein whose structure is stabilized by disulfide bonds. Similarly, another 
hypothetical protein (lrc512) containing eight Cys residues is also induced after the immune 
challenge. Several homologs of heat shock protein 25.4 (contig04865, contig04960, contig05548, 
contig05861, contig08771) are involved in stress responses, in this case, presence of microbes 
and their surface molecules injected into the hemocoel. Another up-regulated protein named 
“cold-related protein” (CUFF.24081.1) may also be a stress response protein. Additionally, we 
noticed coherent increase of mRNA and protein levels of several lipases and esterases 
(CUFF17912.1, CUFF.17913.2, CUFF.19298.1, CUFF.19800.1, CUFF.22549.1, CUFF.25705.2, 
CUFF25705.3, c707). Perhaps, due to increased energy need for fighting infection, lipid 
mobilization and metabolism are enhanced by these hydrolytic enzymes.  
 
Down-regulated proteins 
        We, based on the I/C values and statistical analysis, identified 103 and 62 proteins from 
“protein” and “peptide” samples respectively, whose levels significantly reduced after the 
immune challenge (Table 14). Several immunity-related proteins were found in this list including 
signaling proteins and proteins involved in cellular response. Some proteinases and serine 
protease inhibitors were down-regulated to modulate immunity signals to appropriate levels. The 
precursor of plasmatocyte-spreading peptide (PSP) and its binding protein were both found to be 
down-regulated after the bacterial injection. Interestingly, some ribosomal proteins account for a 
substantial portion of the down-regulated protein lists. 
  
Immunity-related proteins 
        Among all the identified proteins in both samples, 220 may participate in immune responses 
of M. sexta including PRRs, signaling proteins, AMPs and others (Table 15). PRRs recognize 
surface components of invading microbes. In addition to ones described above as up-regulated, 
we also identified different PRRs including immulectins, microbe binding protein (MBP), β-1,3-
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glucan recognition proteins (βGRPs), leureptins, nimrod, and draper. Most of these PRRs did not 
show significant change after immune challenge. Nearly half of the identified immunity-related 
proteins were extracellular proteins involved in signal transduction and regulation, such as 
hemolymph protease and protease inhibitors. Some of the proteases may function as components 
of an enzyme network that respond to pathogen recognition by PRRs through specific proteolytic 
activation of zymogens in a cascade mode. Protease inhibitors form inactive complexes with the 
pathway members that diffuse away from the site of infection. While some of the proteases and 
inhibitors are up-regulated (Table 13), others did not change much or even decreased. Such 
orchestrated changes in mRNA and protein levels may finally result in a more potent yet balanced 
immune reaction against secondary infection. Interestingly, in the plasma proteomes, we 
identified four intracellular proteins suggesting that our analysis was sensitive enough to detect 
small amount of intracellular proteins released from ruptured cells.  
        Of all the defense proteins, AMPs are induced to high ratios after the immune challenge 
(Fig. 5). As the major effectors of the immune system, almost all the AMPs were up-regulated 
and some attacins showed ~500-fold increase after bacterial injection. In our dataset, we found 
attacins, cecropins, lebocins, gloverins, lysozymes and tranferrins that attack bacteria. We also 
identified homologs of antifungal peptides such as gallerimycin, diapausin and psychimicin. 
Activity assays are needed to confirm the predicted antimicrobial functions of highly induced 
small proteins with multiple Cys residues in their sequences (see above). While almost all the 
currently known AMPs are identified in the M. sexta plasma proteome, we did not find moricin, a 
Lys-rich peptide that may not yield peptides at appropriate sizes after trypsinolysis. 
  
Protein VS mRNA 
        In this proteomic study, we used the fat body and hemocyte transcriptome data to construct 
the protein database for mass data analyses (Fig.2). Consequently, we found mass spectra of the 
gel-extracted and AcCN-treated samples matched to 336 “protein” and 135 “peptide” sequences 
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from their cDNAs. Of these, 296 “proteins” and 134 “peptides” and their respective contigs were 
identified for retrieving the read numbers for CF, IF, CH, and IH. Using these and corresponding 
spectra counts, we attempted to first correlate the mRNA and proteins levels after the immune 
challenge. As shown in Fig. 5 (A, B), there was a positive correlation between CF and C (0.66, 
gel) and between IF and I (0.51, gel). The positive correlations remained when “peptide” data 
were analyzed, but the correlation coefficients reduced to 0.38 (CF vs. C) and 0.33 (IF vs. I) 
(Fig.5, C and D). When we plotted the IH and CH read numbers with the “protein” and “peptide” 
data in the “C” and “I” groups (Fig. 5, E-H), the coefficients (-0.14~+0.08) did not indicate either 
positive or negative correlation. Perhaps, due to its sheer volume and contribution to hemolymph 
factors, a moderate positive correlation exists between fat body mRNA and plasma protein levels. 
Hemocytes do play critical roles in cellular immune responses but, due to lower cell number and 
protein synthesis, their contribution to the plasma protein pool seems limited. As we understand, 
since transcript abundance is only one of the factors that govern final protein levels, the positive 
correlation coefficients (0.33~0.66) between fat body mRNA and plasma protein levels seem 
reasonable.  
        We then tested if there is a stronger correlation between the mRNA and protein level 
changes after the immune challenge. To make sure the comparisons are of statistical significance, 
we selected “proteins” or “peptides” whose levels significantly changed (> 5-fold change or >2-
fold change with t-test significance) after the bacterial injection. The logarithm scatter plot (Fig. 
6) clearly demonstrated a positive correlation: most proteins showed the same tendency of change 
with their mRNAs and only a small number of proteins showed mRNA level increases but protein 
level decreases or vice versa. Interestingly, most of the inconsistent ones participate in immune 
signal transduction and regulation. Perhaps the dynamics of these mRNAs and proteins are 
unusual as compared with other defense gene products. The better correlation from the “peptide” 
samples (including most AMPs) suggests that differences in gene expression and functions do 
impact overview of the system.  
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CHAPTER V 
 
 
SUMMARY AND CONCLUSIONS 
 
        We used pyrosequencing technology and mass spectrometry to quantify transcriptomic and 
proteomic changes in the 5
th
 instar larvae of M. sexta after a bacterial injection. We obtained 
19,020 fat body and hemocyte cDNA contigs and identified 898 proteins from the plasma 
samples. With the read numbers and spectral counts available, our quantitative analyses helped us 
identify hundreds of differentially expressed cDNAs and proteins from M. sexta after immune 
challenge. These are the first quantitative transcriptome and proteome studies of this biochemical 
model insect. 
        The transcriptomic study expanded our knowledge on M. sexta mRNAs sequences as well as 
their expression levels in different tissues and physiological states. It proved the value of NGS 
technologies in quantitative transcriptomic studies. Since pyrosequencing offers the longest 
fragment sequences among different NGS technologies, it has particular advantages in studies on 
organisms with unknown genome sequences. Compared with microarray technology, NGS 
provides digital data on the expression levels which are interfered with much lower, if any, 
background noise. NGS-based transcriptomic studies do not necessarily rely on genome 
sequences. With constantly decreasing cost of sequencing, NGS technologies have been regarded 
as cost-effective methods in biological research. 
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As the second study on M. sexta plasma proteome, this work made greater progress, when 
compared with the first one published in 2008. We identified a lot more proteins along with 
information on their relative abundances. The improvements are based on the following factors: 
advanced instrument, improved protein database, and optimized sample preparation. The 
normalized spectral counts served well for the quantitative analysis and this work proved the 
robustness of spectral counting as a semi-quantitative analysis method. Biological and technical 
replicates were utilized to decrease the random error. Pairwise Pearson correlation tests 
confirmed superb reproducibility of our work. However, due to the treatment to the plasma 
samples (gel electrophoresis or AcCN precipitation) for more protein IDs, we sacrificed the 
quantitative accuracy to some extent. Moreover, although the transcriptome and draft genome 
sequences helped us identify more proteins, the redundant protein database affected the quality of 
our lists and caused the “grouping ambiguity” problem. It is necessary to redo protein 
identification when the official M. sexta protein dataset is released. 
        The transcriptomic and proteomic data showed hundreds of immunity-related genes. 
Different PRRs were identified and some were up-regulated at mRNA- and protein-levels after 
the immune challenge, such as hemolins, PGRPs, and some immulectins. Signaling proteins 
constituted the largest category among all the identified proteins including hemolymph proteases 
and protease inhibitors. Some of them were up- regulated, others down-regulated after the 
bacterial injection, but most did not show drastic changes.  Antimicrobial peptides, as major 
defense effectors, were highly induced at both mRNA- and protein-levels. Based on this feature, 
we also found some highly up-regulated small protease inhibitors and Cys-rich proteins and 
hypothesize they have antimicrobial activity. The two “omics” projects provided long lists of 
DNAs/proteins, some of which are key molecules in the insect immune system. They are valuable 
in terms of what systems biology could offer. Nevertheless, we still need to focus on 
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characterizing selected candidate molecules by traditional biochemical techniques to elucidate 
their specific functions. 
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Table 1. Summary statistics for pyrosequencing analysis of M. sexta ESTs 
 
 
a Results from reanalysis of the 2006 sequence data. The numbers in parentheses (adopted from Zou et al., 2008) are 
listed for comparing with the new results.  b Analysis of the 2009 EST sequences of control fat body (CF), control 
hemocytes (CH), induced fat body (IF), and induced hemocytes (IH) from M. sexta larvae.  c Analysis of the combined 
reads of 2006 (raw flow signals interpreted with the up-graded software) and 2009 (CF, CH, IF, and IH). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 06
 a
 CF CH IF IH CIFH
 b
 06CIFH
 c
 
Total number of reads 95,458 (95,358) 227,302 647,587 405,739 541,024 1,821,652 1,917,110 
Average reads length (bp) 185 (185) 296 287 293 287 289 284 
Total number of contigs 1,471 (7,231) 2,118 11,540 4,063 10,600 19,020 19,504 
Contigs size (avg./longest in 
bp) 
391/3,552 
(300/3,909) 
770/12,740 827/11,667 764/8,482 832/10,591 923/23,095 911/23,097 
Total assemebled reads 64,874 (69,429) 191,156 561,054 349,028 465,561 1,677,738 1,757,333 
Singlet reads 28,518 (25,929) 32,518 68,861 49,444 61,108 108,587 120,670 
Singlet length (avg. in bp) 179 244 245 235 254 209 200 
Total BLASTable sequences 29,989 34,636 80,401 53,507 71,708 127,607 140,174 
Orphan sequences (no 
BLAST match, #/%) 
19,963/67 17,982/52 51,968/65 28,649/54 46,521/65 73,915/58 89,948/64 
Contigs and reads with 
functional assignment 
10,026 16,654 28,433 24,858  25,187 53,692 50226 
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Table 2. A list of 19 UP CIFH contigs with similarity to pattern recognition 
receptors* 
 CIFH 
contig # 
Original read # 
CF       CH       IF       IH     Total 
RA or ARN 
IF/CF  IH/CH 
BLAST results 
00131 11 41 137 61 250 6.4 1.8 gi|198430641|ref|XP_002123478.1| ~ hemicentin 1, Ig domains [Ciona intestinalis] 
00575 3 0 259 5 267 44.0 5.9 gi|154240658|dbj|BAF74637.1| peptidoglycan recognition protein-D [Samia cynthiaricini] 
01326 1 9 19 70 99 9.7 9.2 gi|52782739|sp|Q8ISB6.1|BGBP2_MANSE Beta-1,3-glucan recognitionprotein 2 
03442 1 12 1468 40 1521 748.5 4.0 gi|511297|gb|AAC46916.1| hemolin [Manduca sexta] 
04775 1 0 89 0 90 45.4 0.0 gi|237869126|gb|AAF91316.3|AF242202_1 immulectin-2 [Manduca sexta] 
04808 0 0 426 2 428 217.2 2.4 gi|237861314|gb|AAV41237.2| immulectin-4 [Manduca sexta] 
06630 2 40 44 77 163 11.2 2.3 gi|55139125|gb|AAV41236.1| immulectin-3 [Manduca sexta] 
08247 27 2 122 18 169 2.3 10.7 gi|208972535|gb|ACI32828.1| beta-1,3-glucan recognition protein 3 [Helicoverpa armigera] 
08467 0 0 113 0 113 57.6 0.0 gi|112983866|ref|NP_001036858.1| peptidoglycan recognition protein-6 [Bombyx mori] 
11458 0 0 55 0 55 28.0 0.0 gi|148298818|ref|NP_001091784.1| multi-binding protein [Bombyx mori] 
11845 0 2 9 17 28 4.6 10.1 gi|18202160|sp|O76537.1|PGRP_TRINI peptidoglycan recognitionprotein;  
13190 15 0 117 9 141 4.0 10.7 gi|27733423|gb|AAO21509.1|AF413068_1 peptidoglycan recognition protein 1A [Manduca sexta] 
14104 14 0 173 13 200 6.3 15.4 gi|27733423|gb|AAO21509.1|AF413068_1 peptidoglycan recognition protein 1A [Manduca sexta] 
14278 1 34 17 179 231 8.7 6.3 gi|83583693|gb|ABC24706.1| hemicentin-like protein 1, Ig domains [Spodoptera frugiperda] 
14515 2 0 34 0 36 8.7 0.0 gi|148298818|ref|NP_001091784.1| multi-binding protein [Bombyx mori] 
14700 0 0 183 2 185 93.3 2.4 gi|260765453|gb|ACX49764.1| peptidoglycan recognition protein 2 [Manduca sexta] 
14752 0 0 118 2 120 60.2 2.4 gi|260765453|gb|ACX49764.1| peptidoglycan recognition protein 2 [Manduca sexta] 
15639 10 0 109 0 119 5.6 0.0 gi|148298818|ref|NP_001091784.1| multi-binding protein [Bombyx mori] 
15857 0 1 0 9 10 0.0 10.7 gi|27733411|gb|AAO21503.1|AF413062_1 leureptin, LPS-binding [Manduca sexta] 
* RA and ARN are calculated using original read numbers as described in Section 2.3. Listed here are contigs with RAIF/CF >5, RAIH/CH 
>8, ARNIF >10 when RNCF =0, or ARNIH >10 when RNCH =0. RAIF/CF and RAIH/CH values are shown in red if they are greater than 5 
and 8, respectively. ARNIF and ARNIH values are shown in blue if they are higher than 10. In the columns of RA or ARN, cells shaded 
yellow and blue represent fat body- and hemocyte-specific gene expression, respectively.  
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Table 3. A list of 40 UP CIFH contigs with similarity to extracellular signal 
modulators* 
CIFH 
contig # 
Original read # 
CF       CH       IF       IH     Total 
RA or ARN 
IF/CF  IH/CH 
BLAST results 
00915 0 21 21 26 68 10.7 1.5 gi|91084647|ref|XP_966816.1| ~ AGAP002414-PA, Zn protease [Tribolium castaneum] 
00940 0 0 209 7 216 106.6 8.3 gi|1352212|sp|P48861.1|DDC_MANSE dopa decarboxylase (DDC) 
02023 1 0 33 7 41 16.8 8.3 gi|148611442|gb|ABQ95973.1| tyrosine hydroxylase isoform A [Manduca sexta] 
01667 0 7 98 33 138 50.0 5.6 gi|26006435|gb|AAL76085.1| prophenoloxidase-activating proteinase-2 [Manduca sexta] 
01818 0 26 45 66 137 22.9 3.0 gi|60299972|gb|AAX18637.1| prophenoloxidase-activating proteinase-3 [Manduca sexta] 
02361 7 4 70 1 82 5.1 0.3 gi|56418425|gb|AAV91020.1| hemolymph proteinase 22 [Manduca sexta] 
02382 0 2 109 69 180 55.6 41.0 gi|4090964|gb|AAD09279.1| immune-related Hdd1 [Hyphantria cunea] 
02693 21 7 310 19 357 7.5 3.2 gi|27733415|gb|AAO21505.1|AF413064_1 serpin 3a [Manduca sexta] 
02813 108 9 313 72 502 1.5 9.5 gi|242351233|gb|ACS92763.1| serine proteinase-like protein 1b [Manduca sexta] 
02985 3 0 158 0 161 26.9 0.0 gi|56418466|gb|AAV91027.1| serine proteinase-like protein 4 [Manduca sexta] 
03018 0 54 22 79 155 11.2 1.7 gi|56418395|gb|AAV91005.1| hemolymph proteinase 7 [Manduca sexta] 
03778 0 11 192 28 231 97.9 3.0 gi|74813957|sp|Q86RS3.1|DFP_MANSE putative defense protein Hdd11-like, precursor 
03989 0 1 8 24 33 4.1 28.5 gi|56418399|gb|AAV91007.1| hemolymph proteinase 9 [Manduca sexta] 
05186 0 0 8 13 21 4.1 15.4 gi|56418413|gb|AAV91014.1| hemolymph proteinase 17 [Manduca sexta] 
05606 1 0 19 4 24 9.7 4.7 gi|4090968|gb|AAD09281.1| immune-related Hdd13 [Hyphantria cunea] 
05831 3 8 97 25 133 16.5 3.7 gi|45594232|gb|AAS68507.1| serpin-5A [Manduca sexta] 
06149 21 22 686 32 761 16.7 1.7 gi|27733421|gb|AAO21508.1|AF413067_1 serine protease-like protein [Manducasexta] 
06215 29 1 108 8 146 1.9 9.5 gi|112983872|ref|NP_001036857.1| Serpin-like protein (SEP-LP) or serpin-12 [Bombyx mori] 
06581 0 0 13 10 23 6.6 11.9 gi|4090970|gb|AAD09282.1| immune-related Hdd23 [Hyphantria cunea] 
07639 651 0 1237 14 1902 1.0 16.6 gi|134436|sp|P14754.1|SERA_MANSE serpin-1 
08231 0 1 0 34 35 0.0 40.4 gi|56418417|gb|AAV91016.1| hemolymph proteinase 18 [Manduca sexta] 
10791 1 0 1081 1 1083 551.2 1.2 gi|4262357|gb|AAD14591.1| scolexin A [Manduca sexta] 
10792 0 0 333 0 333 169.8 0.0 gi|4262357|gb|AAD14591.1| scolexin A [Manduca sexta] 
13453 5 4 58 7 74 5.9 2.1 gi|45594232|gb|AAS68507.1| serpin-5A [Manduca sexta] 
13454 0 1 17 10 28 8.7 11.9 gi|45594232|gb|AAS68507.1| serpin-5A [Manduca sexta] 
14093 1 0 14 0 15 7.1 0.0 gi|56418419|gb|AAV91017.1| hemolymph proteinase 19 [Manduca sexta] 
14248 0 6 0 196 202 0.0 38.8 gi|2149091|gb|AAB58491.1| serpin-2 [Manduca sexta] 
14393 2 4 132 11 149 33.7 3.3 gi|27733421|gb|AAO21508.1|AF413067_1 serine protease-like protein [Manduca sexta] 
14456 0 0 1 52 53 0.5 61.7 gi|2149091|gb|AAB58491.1| serpin-2 [Manduca sexta] 
15055 1 1 16 0 18 8.2 0.0 gi|112983896|ref|NP_001037394.1| paralytic peptide binding protein 1 [Bombyxmori] 
15111 1 48 8 800 857 4.1 19.8 gi|2149091|gb|AAB58491.1| serpin-2 [Manduca sexta] 
16520 1 0 664 1 666 338.6 1.2 gi|4262357|gb|AAD14591.1| scolexin A [Manduca sexta] 
16917 0 40 2 519 561 1.0 15.4 gi|2149091|gb|AAB58491.1| serpin-2 [Manduca sexta] 
17048 0 1 0 95 96 0.0 112.8 gi|2149091|gb|AAB58491.1| serpin-2 [Manduca sexta] 
17058 0 32 4 545 581 2.0 20.2 gi|2149091|gb|AAB58491.1| serpin-2 [Manduca sexta] 
17751 0 24 1 269 294 0.5 13.3 gi|2149091|gb|AAB58491.1| serpin-2 [Manduca sexta] 
18441 0 1 0 65 66 0.0 77.2 gi|2149091|gb|AAB58491.1| serpin-2 [Manduca sexta] 
18669 0 0 285 0 285 145.3 0.0 gi|4262357|gb|AAD14591.1| scolexin A [Manduca sexta] 
18670 0 0 139 0 139 70.9 0.0 gi|4262357|gb|AAD14591.1| scolexin A [Manduca sexta] 
18963 0 0 254 0 254 129.5 0.0 gi|4262357|gb|AAD14591.1| scolexin A [Manduca sexta] 
* See Table 2. 
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Table 4. A list of 18 UP CIFH contigs with similarity to intracellular signal 
transducers* 
CIFH 
contig # 
Original read # 
CF       CH       IF       IH      Total 
RA or ARN 
IF/CF  IH/CH 
BLAST results 
00461 1 48 14 108 171 7.1 2.7 
gi|47217104|emb|CAG02605.1| unnamed protein product, integrin β6 precursor [Tetraodon 
nigroviridis] 
00537 1 32 10 32 75 5.1 1.2 gi|270009406|gb|EFA05854.1| TcasGA2_TC008649 Tyr protein kinase [Triboliumcastaneum] 
00671 1 12 10 46 69 5.1 4.6 
gi|189235637|ref|XP_967498.2| ral guanine nucleotide exchange factor, putative [Tribolium 
castaneum] 
01020 42 4 63 27 136 0.8 8.0 gi|91082721|ref|XP_972476.1| ~ eiger CG12919-PA, JNK [Triboliumcastaneum] 
01044 9 70 163 105 347 9.2 1.8 gi|289629214|ref|NP_001166191.1| cactus [Bombyx mori] 
01313 2 52 33 35 122 8.4 0.8 
gi|242009174|ref|XP_002425367.1| Ser-Thr protein kinase, plant-type, putative [P. humanus 
corporis] 
01390 1 31 14 19 65 7.1 0.7 gi|46403173|gb|AAS92609.1| vrille transcription factor [Antheraea pernyi] 
01970 1 16 12 29 58 6.1 2.2 gi|157118595|ref|XP_001659169.1| guanine nucleotide exchange factor [Aedes aegypti] 
04802 2 42 25 66 135 6.4 1.9 gi|157412326|ref|NP_001098704.1| BmRelish2 [Bombyx mori] 
05836 2 1 0 7 10 0.0 8.3 gi|189235110|ref|XP_971078.2| receptor tyrosine phosphatase type r2a [Tribolium castaneum] 
06304 1 0 11 1 13 5.6 1.2 
gi|170038257|ref|XP_001846968.1| dipeptidyl peptidase 4, apoptosis, immunity [Culex 
quinquefasciatus] 
06868 0 1 1 11 13 0.5 13.1 gi|193713771|ref|XP_001946690.1| ankyrin repeat domain 54 [Acyrthosiphon pisum] 
06893 0 1 1 20 22 0.5 23.7 gi|126635756|gb|ABO21763.1| Toll receptor [Manduca sexta] 
11311 0 1 3 9 13 1.5 10.7 gi|189237512|ref|XP_972880.2| protein phosphatase type 2c [Tribolium castaneum] 
11356 0 1 4 7 12 2.0 8.3 gi|156551808|ref|XP_001603899.1| arf6 guanine nucleotide exchange factor [Nasonia vitripennis] 
13966 0 1 0 9 10 0.0 10.7 
gi|190570736|ref|YP_001975094.1| Ankyrin repeat domain protein [Wolbachia of C. 
quinquefasciatus Pel] 
15532 1 19 12 9 41 6.1 0.6 gi|157412326|ref|NP_001098704.1| BmRelish2 [Bombyx mori] 
18001 0 1 0 7 8 0.0 8.3 gi|126635756|gb|ABO21763.1| toll receptor [Manduca sexta] 
* See Table 2. 
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Table 5. A list of 65 UP CIFH contigs with similarity to antimicrobial proteins* 
CIFH 
contig # 
Original read # 
CF       CH       IF       IH      Total 
RA or ARN 
IF/CF   IH/CH 
BLAST results 
02067 1 0 280 82 363 142.8 97.4 gi|110649240|emb|CAL25129.1| gloverin [Manduca sexta] 
02145 0 15 20 95 130 10.2 7.5 gi|157134051|ref|XP_001663123.1| transferrin [Aedes aegypti] 
03142 1 7 420 121 549 214.2 20.5 
gi|33860163|sp|P82176.2|IMPI_GALME Inducible metalloproteinase inhibitor protein; IMPIα 
precursor 
03674 1 0 5 21 27 2.5 24.9 gi|110347837|gb|ABG72720.1| protease inhibitor-like protein [Antherae amylitta] 
03746 0 7 55 389 451 28.0 66.0 gi|148298709|ref|NP_001091749.1| possible antimicrobial peptide [Bombyx mori] 
04175 0 7 40 45 92 20.4 7.6 gi|114052803|ref|NP_001040277.1| salivary cysteine-rich peptide [Bombyx mori] 
04903 0 0 279 6 285 142.3 7.1 gi|187281722|ref|NP_001119732.1| lebocin 3 precursor [Bombyx mori] 
05197 0 0 20 1 21 10.2 1.2 gi|115392217|gb|ABI96910.1| brasiliensin precursor, thrombin inhibitor [Triatoma brasiliensis] 
06782 0 0 102 17 119 52.0 20.2 gi|67906420|gb|AAY82587.1| attacin-1 [Manduca sexta] 
07116 1 4 902 3 910 459.9 0.9 gi|171262319|gb|ACB45566.1| lebocin-like protein [Antheraea pernyi] 
07203 2 3 312 22 339 79.5 8.7 gi|67906420|gb|AAY82587.1| attacin-1 [Manduca sexta] 
08286 0 0 139 23 162 70.9 27.3 gi|56462340|gb|AAV91453.1| protease inhibitor 6 [Lonomia obliqua] 
08421 4 2 28 99 133 3.6 58.8 gi|7327646|gb|AAB31190.2| lysozyme [Manduca sexta] 
08902 0 0 164 14 178 83.6 16.6 gi|67906420|gb|AAY82587.1| attacin-1 [Manduca sexta] 
09484 1 0 134 56 191 68.3 66.5 gi|29469961|gb|AAO74637.1| antimicrobial peptide moricin [Manduca sexta] 
10234 0 1 249 7 257 127.0 8.3 gi|169264911|dbj|BAG12297.1| gallerimycin [Samia cynthia ricini] 
10722 9 3 102 3 117 5.8 1.2 gi|110347833|gb|ABG72718.1| protease inhibitor-like protein [Antherae amylitta] 
10853 0 0 113 1 114 57.6 1.2 gi|171262319|gb|ACB45566.1| lebocin-like protein [Antheraea pernyi] 
11027 59 0 694 0 753 6.0 0.0 gi|136206|sp|P22297.1|TRF_MANSE transferrin precursor 
11040 0 4 51 249 304 26.0 73.9 gi|29469969|gb|AAO74640.1| antimicrobial protein attacin 2 [Manduca sexta] 
11711 0 7 85 1317 1409 43.3 223.4 gi|29469969|gb|AAO74640.1| antimicrobial protein attacin 2 [Manduca sexta] 
12151 0 0 153 0 153 78.0 0.0 gi|116084|sp|P14665.1|CEC5_MANSE Bactericidin B-5P; Cecropin-like; 
13563 0 0 657 0 657 335.0 0.0 gi|110347786|gb|ABG72695.1| attacin-like protein [Antheraea mylitta] 
13894 0 0 48 29 77 24.5 34.4 gi|112984238|ref|NP_001037460.1| cecropin B precursor [Bombyx mori] 
13916 1 0 741 0 742 377.8 0.0 gi|219958086|gb|ACL68097.1| lebocin-related protein precursor [Manduca sexta] 
13936 0 0 25 0 25 12.7 0.0 gi|123725|sp|P26227.1|HTIB_MANSE hemolymph trypsin inhibitor B, BPI-type 
14343 0 0 186 7 193 94.8 8.3 gi|67906420|gb|AAY82587.1| attacin-1 [Manduca sexta] 
14380 0 0 106 0 106 54.0 0.0 gi|67906420|gb|AAY82587.1| attacin-1 [Manduca sexta] 
14568 0 0 2 68 70 1.0 80.7 gi|148298709|ref|NP_001091749.1| possible antimicrobial peptide [Bombyx mori] 
14641 0 0 157 0 157 80.1 0.0 gi|67906420|gb|AAY82587.1| attacin-1 [Manduca sexta] 
14937 13 0 164 0 177 6.4 0.0 gi|136206|sp|P22297.1|TRF_MANSE: transferrin precursor 
14997 0 0 34 10 44 17.3 11.9 gi|29469965|gb|AAO74638.1| antimicrobial peptide cecropin 6 [Manduca sexta] 
15041 0 0 36 0 36 18.4 0.0 gi|116084|sp|P14665.1|CEC5_MANSE Bactericidin B-5P; Cecropin-like;  
15159 0 0 0 15 15 0.0 17.8 gi|15963410|dbj|BAB69462.1| attacin [Samia cynthia ricini] 
15732 0 1 253 43 297 129.0 51.1 gi|67906420|gb|AAY82587.1| attacin-1 [Manduca sexta] 
15744 0 0 0 35 35 0.0 41.6 gi|29469969|gb|AAO74640.1| antimicrobial protein attacin 2 [Manduca sexta] 
15931 40 37 1504 364 1945 19.2 11.7 gi|7327646|gb|AAB31190.2| lysozyme [Manduca sexta] 
15953 1 0 43 6 50 21.9 7.1 gi|67906420|gb|AAY82587.1| attacin-1 [Manduca sexta] 
15997 0 0 142 4 146 72.4 4.7 gi|67906420|gb|AAY82587.1| attacin-1 [Manduca sexta] 
15998 0 0 1 10 11 0.5 11.9 gi|73921456|gb|AAZ94260.1| immune related protein X-tox [Spodoptera frugiperda] 
16018 0 0 40 12 52 20.4 14.2 gi|116833115|gb|ABK29470.1| immune reactive putative protease inhibitor [Helicoverpa armigera] 
16129 1 0 212 35 248 108.1 41.6 gi|67906420|gb|AAY82587.1| attacin-1 [Manduca sexta] 
16133 47 57 1719 440 2263 18.6 9.2 gi|233964|gb|AAB19535.1| lysozyme (peptide partial, 120 aa] 
16150 0 1 145 3 149 73.9 3.6 gi|67906420|gb|AAY82587.1| attacin-1 [Manduca sexta] 
16292 0 0 1 34 35 0.5 40.4 gi|148298709|ref|NP_001091749.1| possible antimicrobial peptide [Bombyx mori] 
16576 0 0 0 18 18 0.0 21.4 gi|74767320|sp|Q5MGE6.1|DFP3_LONON Defense protein 3 precursor, attacin E 
16606 8 0 164 0 172 10.5 0.0 gi|136206|sp|P22297.1|TRF_MANSE transferrin precursor 
17135 0 9 103 1157 1269 52.5 152.6 gi|110649242|emb|CAL25130.1| attacin II [Manduca sexta] 
17184 0 11 76 449 536 38.8 48.5 gi|73921456|gb|AAZ94260.1| immune related protein, X-tox [Spodoptera frugiperda] 
17206 3 0 136 0 139 23.1 0.0 gi|136206|sp|P22297.1|TRF_MANSE transferrin precursor 
17301 1 0 272 0 273 138.7 0.0 gi|219958086|gb|ACL68097.1| lebocin-related protein precursor [Manduca sexta] 
17304 0 1 412 13 426 210.1 15.4 gi|67906420|gb|AAY82587.1| attacin-1 [Manduca sexta] 
17350 0 0 205 0 205 104.5 0.0 gi|29469969|gb|AAO74640.1| antimicrobial protein attacin 2 [Manduca sexta] 
17434 1 0 314 0 315 160.1 0.0 gi|219958086|gb|ACL68097.1| lebocin-related protein precursor [Manduca sexta] 
17439 0 0 98 31 129 50.0 36.8 gi|110649236|emb|CAL25127.1| like moricin [Manduca sexta] 
17632 0 0 83 6 89 42.3 7.1 gi|67906420|gb|AAY82587.1| attacin-1 [Manduca sexta] 
17705 0 0 36 0 36 18.4 0.0 gi|67906420|gb|AAY82587.1| attacin-1 [Manduca sexta] 
18150 0 0 0 18 18 0.0 21.4 gi|148298709|ref|NP_001091749.1| possible antimicrobial peptide [Bombyx mori] 
18239 3 0 67 0 70 11.4 0.0 gi|136206|sp|P22297.1|TRF_MANSE transferrin precursor 
18308 15 0 169 0 184 5.7 0.0 gi|136206|sp|P22297.1|TRF_MANSE transferrin precursor 
18324 0 0 25 0 25 12.7 0.0 gi|67906420|gb|AAY82587.1| attacin-1 [Manduca sexta] 
18699 0 1 26 114 141 13.3 135.4 gi|148298709|ref|NP_001091749.1| possible antimicrobial peptide [Bombyx mori] 
18814 0 0 235 29 264 119.8 34.4 gi|67906420|gb|AAY82587.1| attacin-1 [Manduca sexta] 
18819 0 5 59 405 469 30.1 96.2 gi|73921456|gb|AAZ94260.1| immune related protein X-tox [Spodoptera frugiperda] 
18977 0 1 20 2 23 10.2 2.4 gi|67906420|gb|AAY82587.1| attacin-1 [Manduca sexta] 
See Table 2. 
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Table 6. A list of 22 UP CIFH contigs without BLAST hit* 
CIFH 
contig # 
Original read number 
CF   CH   IF   IH  total 
RA or ARN 
IF/CF  IH/CH 
Length 
(aa) 
domain Protein sequence 
00327 2 9 154 31 196 39.3 4.1 60  MSHSHTFILVSIALTIVEGVGYRSFYANRSSIKSLFAKILKKNHTFFFHIYNILNKYNIE* 
01714 3 2 90 1 96 15.3 0.6 84  MIAFTRLYLLVILASLAIIQSDANEDSVQLNEIADIYSNTVGGRIEVSYHDSNGNIVDQEVPVEGNHYVMWPSPQSNERDSRRY* 
02467 1 37 45 46 129 22.9 1.5 160  
MAKSVAITLAFLLAVFEIGSCLRCYQCNSQEDPACADPYKSAKAPVDCASQDSINYNQLYLRNMLPPEVFGTVAGAPRYCHKIVTQTGTTVRTCLDA
NPADINHTCRLIENSSKMASVESKKIKHCSVCDKDNCNGSGTVSLSAPLAALALVASYLYYKQ* 
02669a 2 0 158 0 160 40.3 0.0 
>135  
&179 
hsp25.4 
…QNMQRNMPKSGASIEITNNHYILQVYLNGYEDKDIEVKSKPGWVMIKAIHRDQNGKDKNYLEMLSLPDNVDPAGEWTYSQGVLKIDFKIKNSFE
NSNVIWHSVISVDNNNIYGHNVGQAEVQHDNNDQMYINVKH* and 
MFFVVLCSVLLGTAAAHTDSYSDEQNQYNAPSLNRNFDKFWDKFNRSMDKFDRGIAKLQREIEKLWRKMPHTRKNIEVTDNRYTLKMYFNVKFRD
IEVKSKPGTVMIKAIYKGKDGRDKNYSDVLSLPDNVDPAGKWTYSQGVLKIDFKKKNGPENPVVISDSVVDVDNDLNEYDVEYE* 
03381 1 32 34 44 111 17.3 1.6 322 5 ankyrin 
MSAKKGYETKIVEEENMDSGIVSGELESYEISGEVDSGVIDCDKKYEGVPSEVLELTDKFKSVNVREKSCPDVPPLADLFHPDNDGDTQLHIASVHGC
EKSVSTIIRVCPDKEWLDLPNDYGHTPLHLAVMSGNAVVTRMLVIAGASLAIRDFMGETPLHKATAARNQECLKALLAPVPEQPNRKLSSILDQRNY
NGQCCVHLAASIGSVETLQTLVYYGADINARENLAGWTALHIAARRGDVRVVQFLRSRCAGAATRPRDYAGRTPRRLARRTKAAAAFDDKDDSDS
DSDSDDDDMYDSDSETLFEKLRESLSTSINVA* 
04720 26 1 1025 0 1052 20.1 0.0 66  MYSWKAAVLRFRVGQLYWVFLLSISPESGIYPRYGDRLAPHHIMGCNTHGEKGMQRCASAYSFKDM* 
05532b 0 0 110 0 110 56.1 0.0 100 hsp25.4 
MFIVLASLVSLAAAAPRLAPNTRFSQSDIEQYANIYPNMDDFGVTKNQLYLQFNSAPWTVTTKDLQYVMSMPMPGYNKEDIEVLALNKGITVRAIT
KKRK* 
06987b 0 0 74 0 74 37.7 0 152 hsp25.4 
MFIVLASLVTFAAAAPRVAPYTHFSQSDIEQYSNIYPNLDDLGVTKNQFYLQFNSAPWTVSTKDLQYVMSMPMPGYNKEDIEVLALNKGITVRAIQK
EGDDIVKSQIVVTLLPAYVNPLGRWTYDGVLRIAFPIKWFSDDGSSYAIPVIIDA* 
07536 7 0 383 2 392 27.9 2.4 199  
MPTIKPYLLFILLGVACATAQSYYGVSVHDNNVQGSVEINLSDAKLQTYNSRRQNPSGQGNNVPPQNVPQGSYDQQRNFNSGPSQQGPYDGDSNTQ
TIRLNGPGQADVRLFQEIGEDGSTRRAINYGDSRRQDYPSYRQDNSERNPQSQPITHKVTVEDFESTTKRYFTRSTDNSNYGWDAVPVTYNGRKKVC
YCPKRS* 
08371 0 0 79 0 79 40.3 0.0 125  
MFLKTSVFCACIAMIAAQDFNLDVSNKTLAPKPEKFKNIEGCYIPEKDTVIPLNARVAWKDKCLEYRCYSQSYEIAECSTQVPDFKNNPKCFMHRDY
EKPYPECCPKIACYIRSISGVNAFDNIF* 
08751b 1 0 72 0 73 36.7 0.0 163 hsp25.4 
MFLLLASLVTLAAAAPHTLPEAHFTKSAFKQYFQNIFPDKNSLGVTMNTFNILYDSAPWTITSTGTEYTLSMPMSGYQKEDIAVMAHTGILAMRAIH
KERGVIKKSETSLNFLPLLVNPAGWWTYHDGVLKVTFPINGRNTDAGATRDVNASDVEQIVLDGNN* 
13238a 3 1 524 0 528 89.1 0.0 
156 
&179 
hsp25.4 
MTSIRVWMNFIAAWTSYNAAYQNMQRNMPKSGASIEITNNHYILQVYLNGYEDKDIEVKSKPGWVMIKAIHRDQNGKDRNYLEMLSLPDNVDPAG
EWTYSQGVLKIDFKIKNSFENSNVVWHSVISVDNNNIYGHNVGQAEVQHDNNDQMYINVKH* and 
MFFVVLCSVLLGTAAAHTDSYSDEQNQYNAPSLNRNFDKFWDKFNRSMDKFDRGIAKLQREIEKLWRKMPHTRKNIEVTDNRYTLKMYFNVKFRD
IEVKSKPGTVMIKAIYKGKDGRDKNYSDVLSLPDNVDPAGKWTYSQGVLKIDFKKKNGPENPVVISDSVVDVDNDLNEYDVEYE* 
15852c 0 0 134 0 134 68.3 0.0 >375 kazal 
MQNSYVVILTFAVLGNTATATFWRRHGHGNWGHRPHWGHPHHVGYAYGQHPYHHLHPHNWGFNQGYPNWGYPINTITSPPPHFPSLPNSEIGTNF
IPGLPTATVGTIQQTINPPNTIGTIQQTINPPNTIGTIQQTIKPTHAIGTTQQTLLPSDTTKPNHPPSNYTSVHINPPRITPSVTTPVYQPVCGTNYATYENM
DQFLSAQKSGKNIRIFLRRPCPLLAVGETKSIKVQCIASCYKSEDNQPICGSDDITYDNPAMLLCVQMCGYDVKVKHISPCRQVNNYTNNNPSISNGN
DQTVNPLSPAVQISMNTFMDIIELCMTMNVSSNQIDYEQYCGDNIATLQNLLCTQNDNVNQIIITTPTPSATPTPTPTP… 
15910 1 31 4 472 508 2.0 18.1 381 serpin2 
MDAAAFSSAVAQFSTKFCNELDNTTNIVCSPLSAENLLALLTLGSTDPARTELLKALGFPDNDDHKSIRSTFGALNGKLKAIKGVTLLVANKIYIKDG
GYEVEPELKKDAEDIFDTEFEKINFKDSASAAQLINQWVEHKTKNQIKDLFSSSSFSAFTRLVLVNALYFKGVWKNQFNPKDTIKQVFHLDDKKTVKI
PMMFKEQKFNYYASPDLQAQLLEVSYAGEETSMVFILPDDIVGLNAVMQNLADGHDLMSEIKKMTPTKVKATLPKFKVETEIDLTKLLPQLGIKAIF
NKDDSGLSELLSPAQEVYVTEAIQKVYIEVNETGREGGDGSGIDIRPTSYMADAVTPQSAYFRAVHPFLYLLMGPDNTILFIGAYRGN* 
16754d 2 0 147 0 149 37.5 0.0 >85  MFFVILCLFLLSTTAAYTWQQTAYPEQQYQYNTPSLNLNFDQYWNDFNRGMNEFHRGMDELQRSIRKHARETCRRVEHPLKITKQ… 
16782d 1 0 228 0 229 116.3 0.0 >85  MFFVILCLFLLGTTAAYTWQQTAYPEQQYQYNAPSLNLNFDQYWNDFNKGMDEFHRGMDELQRGIRKHARETCRRVEHPLKITKQ… 
17202 0 0 216 1 217 110.1 1.2 185 SPH 
MFSSKQSVVLAVAAVLFGCACAAPNPGANDIQLNQKLSIEAKGAKQPIDTRAVNERYPYAVRSFGGFCGGTIISPTWILTAGHCSILYAGSGLPAGTN
ITEVSSLYRFPKRLVIHPLFSIGPVWLNATEFNFKQVAARWDFLLIELEEPLPLDGKILAAAKLDDQPDLPAGLDVGYPSYRPTLRG* 
17316c 0 0 98 0 98 50.0 0.0 496 Kazal 
MQNSYVVILTFAVLGNTATATFWRRHGHGNWGHRPHWGHPHHVGYAYGQHPYHHLHPHNWGFNQGYPNWGYPINTITSPPPHFPSLPNSEIGTNF
IPGLPTATVGTIQQTINPPNTIGTIQQTINPPNTIGTIQQTIKPTHAIGTTQQTLLPSDTTKPNHPPSNYTSVHINPPRITPSVTTPVYQPVCGTNYATYENM
DQFLSAQKSGKNIRIFLRRPCPLLAVGETKSIKVQCIASCYKSEDNQPICGSDDITYDNPAMLLCVQMCGYDVKVKHISPCRQVNNYTNNNPSISNGN
DQTVNPLSPAVQISMNTFMDIIELCMTMNVSSNQIDYEQYCGDNIATLQNLLCTQNDNVNQIIITTPTPSATPTPTPTPTTFWQPELVACVKVCPHTPE
YNPVCGTNGITFENLSILRCVQLCGVSVNIHRASACTPAVVTQQETNDKNENKPLPNNNSSETIPSEVPLDNFGGVTKTTTEADETIDIDPRILQIANNK
T* 
17537e 0 0 1 320 321 0.5 380.0 >209 DM9 
MYSVSPDAVFPPGTATSLNVRVSFLSAFPSNTMASPIRWIAATSDDASYLAPIAVVGGEDNYCNDKQALWVIRAKYECDLIPGELNSQRHTAYVPSD
GVAHAVKDIEVCCAPRDKIQWITAGNGEVPP…RIGDAIVFEGNADKNDTRTFSEVAVPGGKTASGETLYIGRAKEHKSLIPGKIQPSLGHLYVTFKG
KEIAKKYYEVLCTVN* 
17568e 0 0 0 400 400 0.0 474.9 >118 DM9 
…NCRAVASLNVRVSFLSAFPSNTMASPIRWIAATSDDASYLAPIAVVGGEDNYCNDKQALWVIRAKYECDLIPGELNSQRHTAYVPSDGVAHAVK
DIEVCCAPRDKIQWITAGNGEVPP… 
17610 9 2 82 159 252 4.6 94.4 >484 esterase 
…FGVPYAKVDEGNPFGNSLNQPAFKKPFIANDSTILCPQATVFVGGILQCLTLNIYVPNQAGPSNTKAVFVWFYGGGFFFGYAGQYGGQYLVQQDI
VVITVNYRLGPYGFLCLNDPKVPGNQGLKDQIAALRWIKANIGAFGGDPTKITIAGESYGGGSVDFHLYSMYEKLFDKTIVQSGSIFTPYVFGKGDPN
AAIELAGKMGHESMNNDDAIKYLARADPVEVMKFARNLTNILRPCKEKPFKGVSSFMTTDPYHFQNSAKIRNAKILIGYNSKETFDTFVDKDDAFYN
GLQNAFSERLGQIFTIKKEELETLAKIVRDFYLGGKPIAKESRLELSDFLSDFMVNHAAERSVNNYVKFGAEKVYKYIFSYIGGSPYKSLSGVGAFHTE
ELQYLFQMTQNLTSDEQIMMRNRMTEMWANFAKYGDPTPQVTSLLPVRWTPVTNTEARPYMNIDVNMEVKNYVNQQRMAFWDLIWNQYWKTS
PAI* 
18018 0 5 63 30 98 32.1 7.1 346 estarase 
MIQLLVLLVMAAASDAHRQHGAAPSTDGPLTTSPSGTFRGSWMTTRKGQRIEAYRGVRYAEPPVGELRFKPPRLITQYKDVVDATQEGPACPQPVQ
NDYPVDEDCLRLNVYTHGHKGKLLPVIMYMHAGGFYSVSGRSDVAGPDYLLDRDVVLVTINYRLGSLGFLSTGDEQAPGNNGFKDQVMAMRWIQ
RNIAAFGGDPNLVTITGYSAGSFSVFLHMVSPTSLKVLFHRAISMSGSPVSQIMIPEHQRHLAERQARLLGVSTDSSKAIVDGLKTKTAKELGDSLLG
MFEFDYDPVLLWVPVVEKDFGQERFLTMQPLDAIRQGKMHQVPYIISQTKDEFFWKAF* 
* RA and ARN are calculated using original read numbers as described in Section 2.3.  Listed here are contigs with RAIF/CF >15, 
RAIH/CH >15, ARNIF >30 when RNCF =0, or ARNIH >30 when RNCH =0.  Contigs with total read numbers lower than 70 or GC content 
lower than 35% are not listed.  Some of the contig sequences have been extended using sequences in dataset “06” (Table 1, Zou et al., 
2008) and in the M. sexta gut EST dataset (Pauchet et al., 2009).  RAIF/CF and RAIH/CH values are shown in red if they are greater than 
15, while ARNIF and ARNIH values are shown in blue if they are higher than 30.  In the two columns of RA or ARN, cells shaded 
yellow and blue represent fat body- and hemocyte-specific gene expression, respectively.  The contigs labeled with the same letter (a 
to e) in superscript indicate high sequence similarity between them, as highlighted with different colors at certain key sites of the 
protein sequences. 
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Table 7. A list of DN CIFH contigs with BLAST hits* 
CIFH 
contig # 
Original read # 
CF       CH       IF       IH      Total 
RA or ARN 
CF/IF  CH/IH 
BLAST results 
00010 29 464 3 286 782 19.0 1.4 gi|242005387|ref|XP_002423550.1| cAMP-dependent protein kinase subunit [Pediculus humanus corporis] 
00015 & 112 4705 17 3918 8752 12.9 1.0 gi|6164595|gb|AAF04457.1|AF078161_1 lacunin [Manduca sexta] [00015, 02717] 
00248 7 200 1 155 363 13.7 1.1 gi|157113908|ref|XP_001657920.1| n-acetyllactosaminidebeta-1,3-NAG transferase [Aedes aegypti] 
00379 10 308 1 184 503 19.6 1.4 gi|170037242|ref|XP_001846468.1| Leu-rich repeat-containing protein 1[Culex quinquefasciatus] 
00623 12 527 1 443 983 23.5 1.0 gi|157132531|ref|XP_001656056.1| odd Oz protein [Aedes aegypti] 
00628 7 38 1 39 85 13.7 0.8 gi|170030982|ref|XP_001843366.1| rho/rac/cdc GTPase-activating protein [Culex quinquefasciatus] 
00773 49 12 93 1 155 1.0 10.1 gi|157103945|ref|XP_001648193.1| dihydropyrimidine dehydrogenase [Aedes aegypti] 
00851 6 42 1 26 75 11.8 1.4 gi|158300087|ref|XP_320080.3| AGAP009284-PA [Anopheles gambiae] 
01289 7 45 1 31 84 13.7 1.2 gi|187281809|ref|NP_001119723.1| kinesin-like protein Ncd [Bombyx mori] 
02637 5 12 9 1 27 1.1 10.1 gi|116789445|gb|ABK25249.1| unknown [Picea sitchensis] 
02730 8 15 8 1 32 2.0 12.6 gi|2970687|gb|AAC06038.1| beta-glucosidase precursor [Spodoptera frugiperda] 
03286 etc. 62 1976 7 586 2631 17.4 2.8 gi|254746344|emb|CAX16637.1| C1A Cys protease precursor [Manduca sexta] [03286, 05560, 15201, 17978] 
03654 21 686 2 647 1356 20.6 0.9 gi|157134123|ref|XP_001663157.1| atlastin [Aedes aegypti] 
03792 7 20 1 5 33 13.7 3.4 gi|91090218|ref|XP_968156.1| PREDICTED: similar to E1a binding protein P400 [Tribolium castaneum] 
03996 6 6 1 6 19 11.8 0.8 gi|170052039|ref|XP_001862040.1| small GTP-binding protein [Culex quinquefasciatus] 
05824 8 0 1 4 13 15.7 0.0 gi|116326818|ref|YP_803355.1| hypothetical protein TNAV2c gp132 [Trichoplusiani ascovirus 2c] 
06497 etc. 225 10451 12 4266 14954 36.8 2.1 gi|217262|dbj|BAA03124.1| lectin [Bombyx mori] [06497, 15047, 15764, 16677, 16801, 16877, 16886, 17700] 
06713 0 12 0 1 13 0.0 10.1 gi|193613364|ref|XP_001943860.1| limkain b1 [Acyrthosiphon pisum] 
06902 12 3 2 0 17 11.8 2.5 gi|114050917|ref|NP_001040414.1| 3-hydroxyacyl-CoA dehydrogenase [Bombyx mori] 
07139 21 767 2 262 1052 20.6 2.5 gi|110649216|emb|CAL25117.1| dVA-AP3 [Manduca sexta] 
07515 7 1 1 0 9 13.7 0.8 gi|158295141|ref|XP_316035.4| AGAP005993-PA [Anopheles gambiae] 
07642 9 601 1 153 764 17.7 3.3 gi|55139125|gb|AAV41236.1| immulectin-3 [Manduca sexta] 
07754 0 12 1 1 14 0.0 10.1 gi|71895231|ref|NP_001026433.1| coiled-coil domain containing 93 [Gallus gallus] 
08686 & 21 854 3 680 1558 13.7 1.1 gi|82880638|gb|ABB92836.1| scavenger receptor C-like protein [Spodoptera frugiperda] [08686, 15116] 
08705 8 10 1 5 24 15.7 1.7 gi|224084416|ref|XP_002192181.1| selenium binding protein 1[Taeniopygia guttata] 
08707 6 9 1 13 29 11.8 0.6 gi|24585081|ref|NP_609923.2| CG10639 [Drosophila melanogaster] 
08801 1 14 1 1 17 2.0 11.8 gi|91081401|ref|XP_972667.1| exosome component 8[Tribolium castaneum] 
09847 0 13 0 1 14 0.0 10.9 gi|194745608|ref|XP_001955279.1| GF16313 [Drosophila ananassae] 
10124 etc. 115 4638 8 2848 7609 28.2 1.4 gi|114050871|ref|NP_001040411.1| carboxylesterase [Bombyx mori] [10124, 16922, 17330, 18860] 
10316 0 13 1 1 15 0.0 10.9 gi|157106599|ref|XP_001649397.1| hypothetical protein AaeL_AAEL004554 [Aedes aegypti] 
10439 12 0 1 0 13 23.5 0.0 gi|183979241|dbj|BAG30782.1| cuticular protein CPR41B [Papilio xuthus] 
11030 13 0 2 0 15 12.7 0.0 gi|3121953|sp|Q25504.1|CU16_MANSE larval cuticle protein 16/17 precursor 
11098 40 0 3 0 43 26.1 0.0 gi|159526|gb|AAA29320.1| methionine-rich storage protein 1 [Manduca sexta] 
11161 0 12 1 1 14 0.0 10.1 gi|125808686|ref|XP_001360831.1| GA18253 [Drosophila pseudoobscurapseudoobscura] 
11280 etc. 143 7866 11 2589 10609 25.5 2.6 gi|91090548|ref|XP_971239.1| hemolectin CG7002-PA [Tribolium castaneum] [11280, 15506, 15594, 18551] 
12095 10 0 1 0 11 19.6 0.0 gi|194741936|ref|XP_001953465.1| GF17208 [Drosophila ananassae] 
12848 0 16 0 1 17 0.0 13.5 gi|2822109|sp|P14730.2|EXPI_RAT extracellular peptidase inhibitor; WDNM1 precursor 
13013 7 1 1 0 9 13.7 0.8 gi|189031278|gb|ACD74812.1| cuticle protein 1 [Helicoverpa armigera] 
13094 15 10 1 5 31 29.4 1.7 gi|183979298|dbj|BAG30762.1| similar to CG5304-PA [Papilio xuthus] 
13813 31 2398 4 848 3281 15.2 2.4 gi|110758905|ref|XP_395067.3| PREDICTED: similar to Hemolectin CG7002-PA [Apis mellifera] 
13842 14 677 2 228 921 13.7 2.5 gi|138601|sp|P19616.1|VITM_MANSE microvitellogenin precursor 
14129 7 0 1 0 8 13.7 0.0 gi|91078692|ref|XP_971204.1| phospholipase A2, grp VI (cytosolic, Ca-independent) [Tribolium castaneum] 
14570 etc. 559 28386 29 10677 39651 37.8 2.2 
gi|162462371|ref|NP_001104817.1| lectin [Bombyx mori] [14570, 15250, 15380, 15792, 16289, 16291, 16594, 
16842, 17159, 17421, 17471, 17732, 17769, 18032, 18067, 18097, 18286, 18326, 18719, 18721, 18794, 18997] 
14760 etc. 57 3372 3 1184 4616 37.3 2.4 gi|156545430|ref|XP_001606650.1| CG7002-PA [Nasonia vitripennis] [14760, 18045] 
14781 28 0 3 1 32 18.3 0.0 gi|114052677|ref|NP_001040269.1| phosphoserine aminotransferase 1 [Bombyx mori] 
15132 9 0 1 0 10 17.7 0.0 gi|112984526|ref|NP_001037199.1| promoting protein [Bombyx mori] 
15465 6 0 1 1 8 11.8 0.0 gi|170574840|ref|XP_001892989.1| hypothetical protein Bm1_07595 [Brugia malayi] 
16105 10 23 1 42 76 19.6 0.5 gi|91087179|ref|XP_975411.1| CG9471-PB [Tribolium castaneum] 
16288 etc. 63 3044 4 1126 4237 30.9 2.3 gi|2738863|gb|AAB94557.1| hemocyte protease-1 [Manduca sexta] [16288, 16719, 17102] 
17085 etc. 236 11035 27 7455 18753 17.1 1.2 gi|74763772|sp|O44249.3|MANSE proPO-P1 [17085, 17315, 17420, 17612, 17629, 18065, 18463, 18887] 
17958 etc. 130 5309 19 3669 9127 16.3 1.2 gi|75038472|sp|Q25519.3|MANSE proPO-p2 [17958, 18004, 18516] 
18482 11 0 0 0 11 21.6 0.0 gi|114240|sp|P14296.1|ARYA_MANSE Arylphorin subunit alpha precursor 
18611 0 12 4 1 17 0.0 10.1 gi|12585261|sp|Q9U639.1|HSP7D_MANSE heat shock 70 kDa protein cognate 4, Hsp 70-4 
* RA and ARN are calculated using original read numbers as described in Section 2.3.  Listed here are contigs with RACF/IF >10, 
RACH/IH >10, ARNCF >20 when RNIF =0, or ARNCH >20 when RNIH =0.  RACF/IF and RACH/IH values are shown in red if they are 
greater than 10, whereas ARNCF and ARNCH values are shown in blue if they are higher than 20.  In the two columns of RA or ARN, 
cells shaded yellow and blue represent fat body- and hemocyte-specific gene expression, respectively.  Contigs with identical BLAST 
results are combined, with their average RAs or ARNs calculated based on the sums of original reads in CF, CH, IF, and IH for each 
group.  
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Table 8. A list of HC CIFH contigs with BLAST hits* 
CIFH 
contig # 
Original read # 
CF      CH      IF      IH     Total 
RA or ARN 
CH/CF  IH/IF 
BLAST results 
00010 29 464 3 286 782 3.3 46.0 
gi|242005387|ref|XP_002423550.1| cAMP-dependent protein kinase catalytic subunit, [Pediculus humanus 
corporis] 
00015 etc. 119 5073 20 4227 9439 8.8 102.0 gi|6164595|gb|AAF04457.1|AF078161_1 lacunin [Manduca sexta] (00015, 02717, 15269) 
00028 13 958 4 754 1729 15.3 91.0 gi|91081003|ref|XP_975140.1| ~ odd Oz protein [Triboliumcastaneum] 
00248 7 200 1 155 363 5.9 74.8 
gi|157113908|ref|XP_001657920.1| n-acetyllactosaminidebeta-1,3-n-acetylglucosaminyltransferase [Aedes 
aegypti] 
00379 10 308 1 184 503 6.4 88.8 gi|170037242|ref|XP_001846468.1| leucine-rich repeat-containing protein 1[Culex quinquefasciatus] 
00541 14 567 7 760 1348 8.4 52.4 
gi|170029717|ref|XP_001842738.1| Leu-rich repeat-containing G-protein coupled receptor 4 [Culex 
quinquefasciatus] 
00569 4 182 1 176 363 9.4 85.0 gi|283135216|ref|NP_001164363.1| homeobox protein prospero [Nasoniavitripennis] 
00623 12 527 1 443 983 9.1 213.8 gi|157132531|ref|XP_001656056.1| odd Oz protein [Aedes aegypti] 
00752 0 38 1 164 203 7.9 79.2 gi|194859640|ref|XP_001969420.1| GG23966 [Drosophila erecta] 
00802 3 203 3 253 462 14.0 40.7 gi|260840271|ref|XP_002613791.1| hypothetical protein BRAFLDRAFT_85332[Branchiostoma floridae] 
00839 3 340 1 226 570 23.5 109.1 gi|242021897|ref|XP_002431379.1| conserved hypothetical protein [Pediculushumanus corporis] 
00882 7 268 0 261 536 7.9 126.0 gi|112983326|ref|NP_001037620.1| ras-related GTP-binding protein Rab3 [Bombyxmori] 
01064 5 134 1 116 256 5.6 56.0 gi|48095930|ref|XP_394560.1| Jagged-1 precursor (Jagged1)(hJ1) (CD339 antigen) [Apis mellifera] 
01429 & 27 924 4 827 1782 7.1 99.8 gi|157134123|ref|XP_001663157.1| atlastin [Aedes aegypti] (01429, 03654) 
01609 1 71 1 144 217 14.7 69.5 gi|134001247|gb|ABO45233.1| reverse transcriptase [Ostrinia nubilalis] 
02159 3 101 1 144 249 7.0 69.5 gi|114052056|ref|NP_001040346.1| septin [Bombyx mori] 
02473 10 255 2 382 649 5.3 92.2 gi|281362668|ref|NP_651533.2| eater [Drosophila melanogaster] 
02852 23 1128 7 885 2043 10.2 61.0 gi|66391199|ref|YP_239364.1| hypothetical protein [Microplitis demolitorbracovirus] 
03225 1 25 1 143 170 5.2 69.0 gi|195445668|ref|XP_002070431.1| GK11035 [Drosophila willistoni] 
03246 & 4 182 2 245 433 9.4 59.1 gi|83583697|gb|ABC24708.1| G protein-coupled receptor [Spodoptera frugiperda] (03246, 06319) 
03287 7 493 0 237 737 14.6 114.4 gi|114052174|ref|NP_001040228.1| aminoacylase [Bombyx mori] 
04085 0 34 3 268 305 7.0 43.1 gi|206725499|ref|NP_001128673.1| cathepsin L like protein [Bombyx mori] 
04278 3 141 1 154 299 9.7 74.3 gi|270001550|gb|EEZ97997.1| hypothetical protein TcasGA2_TC000395 [Triboliumcastaneum] 
04746 etc. 0 0 16 1939 1955 0.0 58.5 gi|195486646|ref|XP_002091593.1| GE13745 [Drosophila yakuba] (04746, 13353, 14100) 
05560 24 965 4 440 1433 8.3 53.1 gi|254746344|emb|CAX16637.1| putative C1A cysteine protease precursor [Manducasexta] 
05577 4 157 22 1895 2078 8.1 41.6 gi|254746342|emb|CAX16636.1| putative C1A cysteine protease precursor [Manducasexta] 
05933 etc. 39 1862 8 1395 3304 9.9 84.2 
gi|82880638|gb|ABB92836.1| SR-C-like protein [Spodopterafrugiperda] (05933, 08686, 13271, 15116, 
15350, 15564) 
06497 etc. 237 11297 15 4531 16080 9.9 145.8 
gi|217262|dbj|BAA03124.1| lectin [Bombyx mori] (06497, 15047, 15764, 15986, 16677, 16801, 16877, 
16886, 17700) 
07139 21 767 2 262 1052 7.6 63.2 gi|110649216|emb|CAL25117.1| dVA-AP3 [Manduca sexta] 
07199 2 73 1 102 178 7.6 49.2 gi|110649250|emb|CAL25134.1| immulectin III [Manduca sexta] 
07480 3 248 2 193 446 17.1 46.6 gi|91086517|ref|XP_971701.1| ~ NtR CG6698-PA [Triboliumcastaneum] 
07642 etc. 17 1246 3 562 1828 15.2 90.4 gi|55139125|gb|AAV41236.1| immulectin-3 [Manduca sexta] (07642, 13452, 14991) 
07883 0 0 3 792 795 0.0 127.4 gi|157128533|ref|XP_001661472.1| hypothetical protein AaeL_AAEL011180 [Aedesaegypti] 
08524 etc. 74 3481 7 1984 5546 9.8 136.8 gi|2738863|gb|AAB94557.1| hemocyte protease-1 [Manduca sexta] (08524, 12527, 16288, 16719, 17102) 
10124 etc. 162 6970 18 4204 11354 8.9 112.7 
gi|114050871|ref|NP_001040411.1| carboxylesterase [Bombyx mori] (10124, 15112, 16627, 16922, 17330, 
18860) 
11280 etc. 143 7866 11 2589 10609 11.4 113.6 gi|91090548|ref|XP_971239.1| Hemolectin CG7002-PA[Tribolium castaneum] (11280, 15506, 15594, 18551) 
13813 31 2398 4 848 3281 16.0 102.3 gi|110758905|ref|XP_395067.3| ~ hemolectin CG7002-PA [Apismellifera] 
13842 14 677 2 228 921 10.0 55.0 gi|138601|sp|P19616.1|VITM_MANSE Microvitellogenin precursor 
14248 etc. 1 150 15 2329 2495 31.1 74.9 gi|2149091|gb|AAB58491.1| serpin-2 [Manduca sexta] (14248, 15111, 16917, 17058, 17751) 
14570 etc. 562 29402 26 11144 41134 10.8 206.9 
gi|162462371|ref|NP_001104817.1| lectin [B. mori] (14570, 15250, 15380, 15792, 16278, 16289, 16291, 
16594, 16842, 17159, 17421, 17471, 17732, 17769, 18032, 18067, 18073, 18089, 18097, 18286, 18326, 
18719, 18721, 18794) 
14760 & 57 3372 3 1184 4616 12.3 190.5 gi|156545430|ref|XP_001606650.1| ~CG7002-PA [Nasoniavitripennis] (14760, 18045) 
14811 5 136 1 121 263 5.6 58.4 
gi|221055473|ref|XP_002258875.1| hypothetical protein, conserved in Plasmodium [Plasmodium knowlesi 
strain H] 
15584 3 241 1 202 447 16.7 97.5 gi|66535330|ref|XP_623280.1| ~atlastin CG6668-PA, isoformA [Apis mellifera] 
16815 etc. 208 9161 39 6243 15651 9.1 77.3 gi|75038472|sp|Q25519.3|PRP2_MANSE proPO-2 (16815, 17417, 17958, 18004, 18516, 18811) 
17085 etc. 261 12058 33 8286 20638 9.6 121.2 
gi|74763772|sp|O44249.3|PRP1_MANSE proPO-1 (17085, 17315, 17420, 17612, 17629, 17562, 18065, 
18463, 18887) 
* RA and ARN are calculated using original read numbers as described in Section 2.3.  Listed here are contigs with RAIH/IF >40, 
RACH/CF >40, ARNIH >80 when RNIF =0, or ARNCH >80 when RNCF =0.  RAIH/IF and RACH/CF values are shown in red if they are 
greater than 40, whereas ARNIH and ARNCH values are shown in blue if they are higher than 80.  In the columns of RA or ARN, cells 
shaded green and orange represent down- and up-regulated gene expression, respectively.  Contigs with identical BLAST results are 
combined, with their average RAs or ARNs calculated based on the sums of original reads in CF, CH, IF, and IH for each group.   
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Table 9. A list of FB CIFH contigs with BLAST hits*  
CIFH 
contig # 
Original read # 
CF       CH       IF       IH     Total 
RA or ARN 
CF/CH       IF/IH 
BLAST results 
00051 291 1 329 0 621 1403.9 681.6 gi|183979376|dbj|BAG30740.1| muscle myosin heavy chain [Papilio xuthus] 
00153 etc. 2069 4 2563 1 4637 2495.3 5309.8 
gi|2498144|sp|Q25490.1 apoLp (00153 02405 02406 03748 04510 06831 06834 07770 14087 
14589) 
00194 37 0 81 1 119 178.5 167.8 
gi|48476133|gb|AAT44358.1| calcium-activated potassium channel alpha subunit[Manduca 
sexta] 
00285 & 298 23 921 5 1247 62.5 381.6 gi|73921301|gb|AAG42021.2|AF327882_1 JHE precursor[Manduca sexta] (00285, 00859) 
00409 168 0 216 0 384 810.5 447.5 gi|110750043|ref|XP_394261.3| plexin A CG11081-PA, isoform A [Apis mellifera] 
00414 58 1 50 0 109 279.8 103.6 gi|195382713|ref|XP_002050074.1| GJ21937 [Drosophila virilis] 
00423 149 0 220 0 369 718.8 455.8 gi|158295580|ref|XP_316291.4| AGAP006225-PA [Anopheles gambiae str. PEST] 
00465 134 1 230 0 365 646.4 476.5 gi|149755131|ref|XP_001491560.1| hemicentin 1 [Equuscaballus] 
00535 67 1 100 0 168 323.2 207.2 
gi|242015135|ref|XP_002428229.1| Thrombospondin-3 precursor [Pediculus humanus 
corporis] 
00575 3 0 259 5 267 14.5 107.3 gi|154240658|dbj|BAF74637.1| peptidoglycan recognition protein-D [Samia cynthiaricini] 
00609 324 0 762 0 1086 1563.1 1578.6 gi|225542786|gb|ACN91276.1| dentin sialophosphoprotein precursor [Bos taurus] 
00737 2 4 131 2 139 2.4 135.7 gi|198466442|ref|XP_002135189.1| GA23919 [Drosophila pseudoobscurapseudoobscura] 
00748 131 4 118 2 255 158.0 122.2 
gi|29346557|ref|NP_810060.1| glycine dehydrogenase [Bacteroidesthetaiotaomicron VPI-
5482] 
00766 45 0 74 1 120 217.1 153.3 gi|158293377|ref|XP_314728.3| AGAP008632-PA [Anopheles gambiae str. PEST] 
00773 49 12 93 1 155 19.7 192.7 gi|157103945|ref|XP_001648193.1| dihydropyrimidine dehydrogenase [Aedesaegypti] 
00785 120 2 139 2 263 289.5 144.0 gi|193795848|gb|ACF21977.1| paramyosin [Bombyx mandarina] 
00884 39 1 23 0 63 188.1 47.6 gi|156553304|ref|XP_001599652.1| GA21752-PA [Nasoniavitripennis] 
00960 52 2 99 1 154 125.4 205.1 gi|157107996|ref|XP_001650030.1| sarcosine dehydrogenase [Aedes aegypti] 
01095 64 0 99 1 164 308.8 205.1 gi|169639235|gb|ACA60733.1| venom acid phosphatase [Pteromalus puparum] 
01097 134 2 436 5 577 323.2 180.7 gi|55139125|gb|AAV41236.1| immulectin-3 [Manduca sexta] 
01127 41 1 52 1 95 197.8 107.7 gi|189491898|gb|ACE00761.1| adipokinetic hormone receptor [Manduca sexta] 
01454 599 3 1337 3 1942 963.2 923.3 
gi|91082539|ref|XP_973726.1| inter-α (globulin) inhibitor H4 (Kallikrein-sensitive) [T. 
castaneum] 
01480 211 0 729 0 940 1017.9 1510.3 gi|183979392|dbj|BAG30748.1| hypothetical protein [Papilio xuthus] 
01601 60 1 79 0 140 289.5 163.7 
gi|270005801|gb|EFA02249.1| hypothetical protein TcasGA2_TC007912 
[Triboliumcastaneum] 
01742 65 0 75 0 140 313.6 155.4 gi|283100192|gb|ADB08386.1| sugar transporter 4 [Bombyx mori] 
01743 27 0 112 0 139 130.3 232.0 gi|134252572|gb|ABO65045.1| beta-hexosaminidase [Ostrinia furnacalis] 
01870 184 0 323 0 507 887.7 669.2 
gi|242010783|ref|XP_002426138.1| conserved hypothetical protein [Pediculushumanus 
corporis] 
01892 82 0 108 0 190 395.6 223.7 gi|158289807|ref|XP_311448.4| AGAP010734-PA [Anopheles gambiae str. PEST] 
01915 85 2 275 0 362 205.0 569.7 gi|110757936|ref|XP_623940.2| Peroxidase precursor (DmPO)[Apis mellifera] 
01956 127 0 99 0 226 612.7 205.1 gi|156551746|ref|XP_001602035.1| ENSANGP00000015052[Nasonia vitripennis] 
01972 etc. 383 0 3327 0 3710 1847.7 6892.5 
gi|136206|sp|P22297.1|transferrin (01972 10382 11027 14937 17193 17206 17395 16606 
18234 18308) 
02101 51 0 75 0 126 246.0 155.4 gi|186909546|gb|ACC94296.1| glucose oxidase-like enzyme [Helicoverpa armigera] 
02104 59 1 67 1 128 284.6 138.8 
gi|91079628|ref|XP_967731.1| PREDICTED: similar to AGAP002355-PA 
[Triboliumcastaneum] 
02137 101 0 24 0 125 487.2 49.7 
gi|91084191|ref|XP_967340.1| PREDICTED: similar to AGAP002557-PA 
[Triboliumcastaneum] 
02144 82 0 132 3 217 395.6 91.2 gi|62002223|gb|AAX58711.1| pheromone-degrading enzyme 1 [Antheraea polyphemus] 
02166 60 0 57 0 117 289.5 118.1 gi|193876254|gb|ACF24761.1| lipid storage droplet protein 1 [Manduca sexta] 
02184 53 2 111 1 167 127.8 230.0 gi|226342886|ref|NP_001139705.1| serpin 13 [Bombyx mori] 
02219 454 3 971 3 1431 730.1 670.5 gi|219815604|gb|ACL36977.1| putative ecdysone oxidase [Helicoverpa zea] 
02329 143 0 411 0 554 689.9 851.5 gi|112984054|ref|NP_001037422.1| yellow1 [Bombyx mori] 
02337 & 107 2 170 7 286 258.1 50.3 gi|91079867|ref|XP_967070.1| AGAP005945-PB [Triboliumcastaneum] (02337, 15796) 
02361 7 4 70 1 82 8.4 145.0 gi|56418425|gb|AAV91020.1| hemolymph proteinase 22 [Manduca sexta] 
02393 45 0 77 5 127 217.1 31.9 
gi|156545523|ref|XP_001607196.1| Dihydroxyacetone kinase2 homolog (yeast) [Nasonia 
vitripennis] 
02394 28 1 23 0 52 135.1 47.6 gi|91077746|ref|XP_966706.1| conserved hypotheticalprotein [Tribolium castaneum] 
02409 113 0 187 0 300 545.1 387.4 gi|109502352|gb|ABE01157.2| carboxylesterase [Spodoptera litura] 
02482 63 0 85 1 149 303.9 176.1 gi|66519258|ref|XP_625210.1| PREDICTED: similar to CG6188-PA [Apis mellifera] 
02609 97 0 146 2 245 468.0 151.2 gi|156968285|gb|ABU98614.1| alpha-amylase [Helicoverpa armigera] 
02638 & 241 0 206 0 447 1162.6 426.8 gi|41016826|sp|Q27772.3|C1TC_SPOFR C-1-THF synthase, cytoplasmic (02638, 07658) 
02651 24 0 124 0 148 115.8 256.9 
gi|5326830|gb|AAD42058.1|AF122899_1 plasmatocyte-spreading peptide precursor [Manduca 
sexta] 
02800 28 0 97 0 125 135.1 201.0 gi|260765449|gb|ACX49762.1| beta-fructofuranosidase 1 [Manduca sexta] 
02847 33 0 103 0 136 159.2 213.4 gi|114051702|ref|NP_001040423.1| zinc-containing alcohol dehydrogenase [Bombyxmori] 
02931 & 187 0 429 0 616 902.1 888.8 gi|1658003|gb|AAB18243.1| microsomal epoxide hydrolase [Trichoplusia ni] (02931, 04388) 
02947 518 21 981 56 1576 119.0 36.3 
gi|259493819|gb|ACW82749.1| hemocyte aggregation inhibitor protein precursor [Manduca 
sexta] 
02979 49 0 92 4 145 236.4 47.6 gi|52782757|sp|Q9NJ98.1|BGRP1_MANSE Beta-1,3-glucan recognitionprotein 1; BetaGRP-1 
02985 3 0 158 0 161 14.5 327.3 gi|56418466|gb|AAV91027.1| serine proteinase-like protein 4 [Manduca sexta] 
03185 106 0 234 10 350 511.4 48.5 gi|157117489|ref|XP_001658792.1| 3-hydroxyacyl-CoA dehyrogenase [Aedesaegypti] 
03224 98 0 477 0 575 472.8 988.2 gi|226342906|ref|NP_001139715.1| serpin 22 [Bombyx mori] 
03226 222 0 663 0 885 1071.0 1373.5 gi|153791757|ref|NP_001093275.1| myo-inositol oxygenase [Bombyx mori] 
03395 22 1 24 0 47 106.1 49.7 gi|157908523|dbj|BAF81491.1| juvenile hormone epoxide hydrolase [Bombyx mori] 
03415 190 0 216 1 407 916.6 447.5 gi|2708688|gb|AAB92583.1| acyl-CoA delta-9 desaturase [Trichoplusia ni] 
03434 1 0 387 0 388 4.8 801.7 gi|189234566|ref|XP_001815977.1| Kaz1-ORFB CG1220-PE [Tribolium castaneum] 
03454 28 0 102 0 130 135.1 211.3 gi|6560669|gb|AAF16712.1|AF117590_1 unknown [Manduca sexta] 
03483 280 0 374 0 654 1350.8 774.8 gi|283558277|gb|ADB27116.1| aliphatic nitrilase [Bombyx mori] 
03712 49 2 157 5 213 118.2 65.1 gi|170779021|gb|ACB36909.1| glutathione S-transferase theta [Antheraea pernyi] 
03737 167 1 197 0 365 805.6 408.1 gi|56462300|gb|AAV91433.1| putative serine protease-like protein 2 [Lonomiaobliqua] 
03776 etc. 204 8 960 51 1223 123.0 39.0 
gi|112983872|ref|NP_001036857.1| Serpin-like protein [Bombyx mori] (03776, 06215, 06531, 
17814) 
04012 & 167 3 727 11 908 268.5 136.9 gi|27733411|gb|AAO21503.1|AF413062_1 leureptin [Manduca sexta] (04012, 08453) 
04413 69 1 133 1 204 332.9 275.5 gi|194743582|ref|XP_001954279.1| GF18195 [Drosophila ananassae] 
04424 72 0 64 0 136 347.3 132.6 gi|114052020|ref|NP_001040445.1| tropomyosin 1 [Bombyx mori] 
04430 74 0 68 0 142 357.0 140.9 gi|114052573|ref|NP_001040481.1| phosphoribosyl pyrophosphate synthetase[Bombyx mori] 
04498 46 0 115 0 161 221.9 238.2 gi|90025232|gb|ABD85119.1| juvenile hormone epoxide hydrolase [Spodopteraexigua] 
04504 53 0 135 0 188 255.7 279.7 gi|7239259|gb|AAF43151.1|AF226857_1 hemolymph JHBP precursor [Manduca sexta] 
04722 & 578 0 861 0 1439 2788.4 1783.7 gi|116791778|gb|ABK26104.1| unknown [Picea sitchensis] (04722, 04994) 
04781 56 0 237 0 293 270.2 491.0 gi|118359591|ref|XP_001013035.1| PHD-finger family protein [Tetrahymenathermophila] 
04786 61 0 62 0 123 294.3 128.4 gi|219686082|emb|CAW30924.1| putative aldo-ketose reductase 1 [Papiliodardanus] 
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04791 144 0 200 0 344 694.7 414.3 gi|116788175|gb|ABK24783.1| unknown [Picea sitchensis] 
04806 518 1 372 0 891 2499.0 770.7 gi|157122933|ref|XP_001659963.1| actin [Aedes aegypti] 
04808 0 0 426 2 428 0.0 441.3 gi|237861314|gb|AAV41237.2| immulectin-4 [Manduca sexta] 
04830 etc. 59 2 755 6 822 142.3 260.7 
gi|169646838|ref|NP_001112375.1| heat shock protein 25.4 [Bombyx mori] (04830, 04887, 
05717) 
05038 & 101 0 175 1 277 487.2 362.5 gi|110759694|ref|XP_394781.3| rTS beta protein [Apismellifera] (05038, 05832) 
05136 1074 11 1041 37 2163 471.0 58.3 gi|114051966|ref|NP_001040198.1| mitochondrial aldehyde dehydrogenase [Bombyxmori] 
05324 68 0 88 0 156 328.0 182.3 gi|225346695|gb|AcCN86370.1| troponin I transcript variant C [Bombyx mandarina] 
05348 50 0 67 0 117 241.2 138.8 gi|189234391|ref|XP_974849.2| GA16498-PA [Triboliumcastaneum] 
05417 etc. 273 0 917 0 1190 1317.0 1899.7 
gi|260907784|gb|ACX53694.1| alcohol DH [Heliothis virescens] (05417, 05461, 07389, 
07432) 
05984 89 0 97 0 186 429.4 201.0 gi|56462260|gb|AAV91413.1| myosin 3 light chain [Lonomia obliqua] 
06175 11 0 52 1 64 53.1 107.7 gi|170070451|ref|XP_001869584.1| conserved hypothetical protein [Culexquinquefasciatus] 
06227 251 1 715 0 967 1210.9 1481.3 gi|124527|sp|Q00630.1|ICYB_MANSE insecticyanin-B (INS-b), blue biliprotein 
06251 66 2 57 7 132 159.2 16.9 gi|158289206|ref|XP_310956.4| AGAP000179-PA [Anopheles gambiae str. PEST] 
06394 51 0 228 0 279 246.0 472.3 
gi|110611262|gb|ABG77980.1| alanine-glyoxylate transaminase 1 [Glossinamorsitans 
morsitans] 
06588 60 0 75 0 135 289.5 155.4 gi|56462256|gb|AAV91411.1| myosin 1 light chain [Lonomia obliqua] 
06597 60 0 200 0 260 289.5 414.3 gi|56462320|gb|AAV91443.1| putative secreted peptide 30 [Lonomia obliqua] 
06732 115 1 244 0 360 554.8 505.5 gi|25090512|sp|Q25513.1|HGLY_MANSE 27 kDa hemolymph glycoprotein; 
06789 & 159 0 460 0 619 767.1 953.0 gi|156968291|gb|ABU98617.1| unknown [Helicoverpa armigera] (06789, 06876) 
06975 & 106 2 212 2 322 255.7 219.6 
gi|189237651|ref|XP_001813448.1| N-acetyl neuraminatelyase [Tribolium castaneum] (06975, 
14637) 
07116 & 1 4 1015 4 1024 1.2 525.7 gi|171262319|gb|ACB45566.1| lebocin-like protein [Antheraea pernyi] (07116, 10853) 
07565 24 1 14 0 39 115.8 29.0 
gi|7862150|gb|AAF70499.1|AF255341_1 3-dehydroecdysone 3alpha-reductase[Spodoptera 
littoralis] 
07608 etc. 353 3 3931 0 4287 567.7 8143.9 gi|159526|gb|AAA29320.1| methionine-rich storage protein 1 (07608, 07975, 08141, 14688) 
07629 65 0 82 0 147 313.6 169.9 gi|77415676|emb|CAJ01507.1| hypothetical protein [Manduca sexta] 
07639 & 811 0 1616 18 2445 3912.5 186.0 gi|134436|sp|P14754.1|Alaserpin; serpin-1 (07639, 15891) 
07671 227 3 450 3 683 365.0 310.8 gi|195164814|ref|XP_002023241.1| GL21066 [Drosophila persimilis] 
08076 & 47 3 115 2 167 75.6 119.1 gi|226342878|ref|NP_001139701.1| serpin 7 [Bombyx mori] (08076, 14528) 
08224 etc. 7528 8 10093 0 17629 4539.6 20909.2 
gi|1168527|sp|P14297.2|arylphorin β subunit (08224, 16474, 16501, 16664, 16715, 16764, 
18695) 
08467 0 0 113 0 113 0.0 234.1 gi|112983866|ref|NP_001036858.1| T7 lysozyme-like protein 1(BTL-LP1) [Bombyx mori] 
08500 138 0 407 0 545 665.7 843.2 gi|156406857|ref|XP_001641261.1| predicted protein [Nematostella vectensis] 
08821 246 0 436 2 684 1186.8 451.6 gi|112983550|ref|NP_001036879.1| fibrillin-like protein [Bombyx mori] 
08845 27 0 130 0 157 130.3 269.3 gi|195029763|ref|XP_001987741.1| GH19797 [Drosophila grimshawi] 
08854 & 302 5 5234 0 5541 291.4 10843.3 
gi|5869985|emb|CAB55603.1| moderately Met-rich storage protein [Spodoptera litura] (08854, 
15324) 
09928 30 0 106 0 136 144.7 219.6 
gi|242090851|ref|XP_002441258.1| hypothetical protein SORBIDRAFT_09g023310[Sorghum 
bicolor] 
10071 & 15 1 1243 0 1259 72.4 2575.1 gi|228382|prf||1803340A Met-rich storage protein SP1A (10071, 17516) 
10326 284 4 299 11 598 342.5 56.3 gi|56462160|gb|AAV91363.1| hypothetical protein 10 [Lonomia obliqua] 
10791 etc. 2 0 2756 2 2760 9.6 2854.8 
gi|4262357|gb|AAD14591.1| scolexin A [Manduca sexta] (10791, 10792, 16520, 18669, 
18670, 18963) 
11039 etc. 13962 11 19836 0 33809 6123.3 41094.2 
gi|114240|sp|P14296.1|arylphorin α subunit (11039 16171 16537 16814 17492 18240 18257 
18556) 
11830 26 1 33 0 60 125.4 68.4 gi|260780799|ref|XP_002585527.1| hypothetical protein BRAFLDRAFT_89257 [B. floridae] 
11922 & 901 12 1052 3 1968 362.2 726.5 gi|114058|sp|P13276.1|ApoLp-III; (11922, 13093) 
12005 154 0 2177 0 2331 742.9 4510.1 
gi|2625150|gb|AAB86646.1| moderately methionine rich hexamerin precursor[Hyalophora 
cecropia] 
12151 0 0 153 0 153 0.0 317.0 gi|116084|sp|P14665.1|Bactericidin B-5P; Cecropin-like peptide B-5; precursor 
12749 135 0 1462 0 1597 651.3 3028.8 gi|159530|gb|AAA29322.1| methionine-rich storage protein 3 [Manduca sexta] 
13563 0 0 657 0 657 0.0 1361.1 gi|110347786|gb|ABG72695.1| attacin-like protein [Antheraea mylitta] 
13916 etc. 3 0 1327 0 1330 14.5 2749.1 
gi|219958086|gb|ACL68097.1| lebocin-related protein precursor [M. sexta] (13916, 17301, 
17434) 
13994 57 0 62 0 119 275.0 128.4 gi|112983654|ref|NP_001036872.1| Bombyrin [Bombyx mori] 
14173 45 0 32 0 77 217.1 66.3 gi|153792114|ref|NP_001093267.1| phosphatidylethanolamine binding protein[Bombyx mori] 
14375 etc. 400 0 681 0 1081 1929.7 1410.8 
gi|400673|sp|P31420|OMBP Ommochrome-binding protein precursor (14375, 14659, 17494, 
17813) 
14380 etc. 0 1 408 3 412 0.0 281.8 gi|67906420|gb|AAY82587.1| attacin-1 [Manduca sexta] (14380, 14641, 16150) 
14700 & 0 0 301 4 305 0.0 155.9 
gi|260765453|gb|ACX49764.1| peptidoglycan recognition protein 2 [Manduca sexta] (14700, 
14752) 
15089 271 0 194 0 465 1307.4 401.9 gi|158293921|ref|XP_315269.4| AGAP011516-PA [Anopheles gambiae str. PEST] 
15639 10 0 109 0 119 48.2 225.8 gi|148298818|ref|NP_001091784.1| multi-binding protein [Bombyx mori] 
16000 61 0 138 0 199 294.3 285.9 gi|109458629|ref|XP_001073545.1| hypothetical protein [Rattusnorvegicus] 
16223 22 1 47 2 72 106.1 48.7 
gi|242003442|ref|XP_002422733.1| bifunctional purine biosynthesis protein [Pediculus 
corporis] 
16281 & 358 0 541 0 899 1727.1 1120.8 
gi|134103857|gb|ABO60878.1| cationic peptide CP8 precursor [Manduca sexta] (16281, 
17312) 
16849 134 0 541 0 675 646.4 1120.8 gi|114051738|ref|NP_001040426.1| alcohol dehydrogenase [Bombyx mori] 
17199 42 2 33 4 81 101.3 17.1 gi|3108073|gb|AAC15763.1| putative multifunctional protein ADE2 [Manducasexta] 
17350 0 0 205 0 205 0.0 424.7 gi|29469969|gb|AAO74640.1| antimicrobial protein attacin 2 [Manduca sexta] 
18797 9 0 549 0 558 43.4 1137.4 gi|39843367|gb|AAR32136.1| VHDL receptor [Helicoverpa zea] 
* RA and ARN are calculated using original read numbers as described in Section 2.3.  Listed here are contigs with RAIF/IH >100, 
RACF/CH >100, ARNIF >200 when RNIH =0, or ARNCF >200 when RNCH =0.  RAIF/IH and RACF/CH values are shown in red if they are 
greater than 100, whereas ARNIF and ARNCF values are shown in blue if they are higher than 200.  In the columns of RA or ARN, 
cells shaded green and orange represent down- and up-regulated gene expression, respectively.  Contigs with identical BLAST results 
are combined, with their average RAs or ARNs calculated based on the sums of original reads in CF, CH, IF, and IH for each group.  
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Table 10.  Summary statistics for mass spectra and protein IDs 
 
a Gel 1~9: protein samples from gel slices 1~9; b AcCN: acetonitrile-treated plasma samples; c matching spectra: number of spectra 
that match certain protein in the database; d FDR: false discovery rate. 
 
 
 
 
Table 11.  Pearson pairwise correlation among biological replicates 
 
 AcCN-treated or “peptide” samples  
CH1 CH2 CH3 IH1 IH2 IH3 
Gel-extracted or 
“protein” 
samples 
CH1 1 0.9490 0.9381 0.5990 0.5463 0.5536  
AcCN-
treated or 
“peptide” 
samples  
CH2 0.9760 1 0.9647 0.6425 0.5766 0.5918 
CH3 0.9884 0.9714 1 0.6541 0.5807 0.5907 
IH1 0.9334 0.9448 0.9360 1 0.9362 0.9629 
IH2 0.9405 0.9415 0.9504 0.9901 1 0.9416 
IH3 0.9385 0.9453 0.9454 0.9881 0.9896 1 
 Gel extracted or “protein” samples  
 
 
 
 
 
 
Table 12.  T-test results of 157 overlapping proteins* 
 
 “protein” samples 
“peptide” samples 
 significant insignificant total 
significant 
 
51 46 97 
insignificant 
 
14 46 60 
total 
 
65 92 157 
 
 
 
 
 gel 1a gel 2 gel 3 gel 4 gel 5 gel 6 gel 7 gel 8 gel 9 gel 1-9 AcCNb 
apparent Mr range (kDa)  201-350 121-200 81-120 71-80 51-70 46-50 25-45 20-24 10-19 10-350 n.c. 
total spectra 144,558 165,475 188,699 184,148 210,706 177,400 231,982 119,325 172,220 1,594,513 202,077 
matching spectra c 20,004 33,885 41,226 31,484 56,536 31,476 50,820 14,478 27,265 314,866 41,706 
# of protein IDs 59 121 171 111 271 167 319 123 255 785 270 
Protein FDRd 1.7% 0.8% 0.6% 0.9% 0.4% 0.6% 0.0% 0.0% 0.4% 0.5% 0.4% 
Peptide FDR 0.1% 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.0% 0.0% 
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Table 13.  A list of 115 up-regulated proteins after immune challenge* 
 
ID Function p-value IH/CH Source 
gi|29469965 antimicrobial peptide cecropin 6  0.0008 17.31 AcCN, Gel 
gi|29469969 antimicrobial protein attacin 2  0.0000 106.97 AcCN, Gel 
CUFF.24771.1 apyrase  0.0170 2.70 Gel 
CUFF.19825.1 attacin II  0.0000 98.84 Gel 
c25131 attacin-1  0.0000 40.86 AcCN, Gel 
c2978 attacin-1  0.0001 130.79 AcCN, Gel 
CUFF.19826.2 attacin-1  0.0003 72.41 AcCN 
CUFF.19826.3 attacin-1  0.0000 13.05 Gel 
CUFF.19826.4 attacin-1  0.0000 508.58 AcCN, Gel 
CUFF.19826.5 attacin-1  0.0000 176.15 AcCN 
CUFF.19828.1 attacin-1  0.0000 162.75 AcCN, Gel 
CUFF.19828.3 attacin-1  0.1200 98.55 AcCN 
gi|67906420 attacin-1  0.0000 143.86 AcCN, Gel 
lrc6486 attacin-1  0.3700 29.21 AcCN, Gel 
contig12105 bactericidin  0.0005 25.83 AcCN 
CUFF.10471.3 Cadherin-23 precursor, putative  0.2500 5.52 Gel 
contig01648 CALNUC  0.0450 10.60 Gel 
CUFF.17912.1 carboxylesterase CarE-7  0.0140 4.05 Gel 
gi|115654 Casocidin-I 0.4700 5.12 Gel 
contig13987 cecropin 3  0.0029 2.18 AcCN 
CUFF.24081.1 cold-related protein  0.3000 8.15 Gel 
CUFF.21538.1 cuticle protein 1  0.0180 6.53 Gel 
contig11699 cuticle protein 4  0.1800 5.19 Gel 
lrc23 dorsal  0.0069 2.08 Gel 
CUFF.25705.2 esterase  0.0022 15.67 AcCN, Gel 
CUFF.25705.3 esterase  0.0013 2.50 Gel 
contig03139 FK506-binding protein precursor  0.0370 2.86 Gel 
contig10194 gallerimycin  0.0000 21.00 AcCN, Gel 
contig02032 gloverin  0.0014 3.53 Gel 
gi|110649240 gloverin  0.0002 3.60 AcCN 
contig04865 heat shock protein 25.4  0.0120 10.87 Gel 
contig04960 heat shock protein 25.4  0.0012 3.75 Gel 
contig05548 heat shock protein 25.4  0.0790 12.90 AcCN, Gel 
contig05861 heat shock protein 25.4  0.1200 27.94 Gel 
contig08771 heat shock protein 25.4  0.1200 5.77 Gel 
CUFF.23729.1 hemolin  0.0001 12.54 Gel 
gi|511297 hemolin  0.0000 5.44 AcCN 
CUFF.14527.1 hemolymph proteinase 17  0.0720 12.93 Gel 
contig04271 hemolymph proteinase 20  0.0069 4.16 AcCN 
CUFF.25442.1 hemolymph proteinase 20  0.0004 2.75 Gel 
contig02033 hemolymph proteinase 22, partial  0.0490 15.83 Gel 
CUFF.31629.1 hemolymph proteinase 5  0.0370 5.76 Gel 
lrc512 hypothetical protein CHLNCDRAFT_55808  0.0250 9.28 AcCN, Gel 
contig04364 hypothetical protein KGM_01134  0.0490 4.96 Gel 
contig08449 hypothetical protein KGM_06199  0.0092 18.32 AcCN, Gel 
CUFF.31784.1 hypothetical protein KGM_16225  0.0006 9.17 Gel 
CUFF.1806.1 hypothetical protein KGM_20797  0.0170 7.39 Gel 
CUFF.19650.2 hypothetical protein KGM_21511  0.0090 2.15 Gel 
contig01508 IML1  0.0170 4.95 Gel 
contig04357 immulectin-4  0.0890 7.98 Gel 
gi|27733419 immune-induced protein 1  0.0100 23.09 AcCN, Gel 
contig02384 immune-related Hdd1  0.0000 10.85 AcCN, Gel 
CUFF.19800.1 integument esterase 2 0.0570 9.32 Gel 
c707 integument esterase 2 precursor  0.0000 4.71 AcCN, Gel 
CUFF.17913.2 integument esterase 2 precursor  0.0000 106.93 AcCN, Gel 
c2567 juvenile hormone binding protein  0.0110 7.30 Gel 
contig05216 Kazal-type inhibitor  0.0001 10.42 AcCN, Gel 
CUFF.7975.1 Kazal-type serine proteinase inhibitor  0.0037 8.79 Gel 
contig06672 lacunin  0.0260 5.11 Gel 
gi|291603839 lebocin-like protein 1  0.0005 9.28 AcCN 
gi|291603841 lebocin-like protein 2  0.0000 47.87 AcCN 
contig10931 lebocin-like protein B  0.0000 48.61 AcCN 
contig04845 lebocin-like protein C  0.0000 29.87 AcCN 
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c2002 legumaturain  0.2600 11.49 Gel 
CUFF.18786.1 legumaturain  0.2100 24.58 Gel 
CUFF.18788.1 legumaturain  0.0006 18.43 Gel 
contig00798 MBF2  0.0460 8.07 Gel 
contig00953 methylenetetrahydrofolate dehydrogenase  0.3700 19.67 Gel 
contig02555 mitochondrial aldehyde dehydrogenase  0.0170 4.51 Gel 
contig02897 molting fluid carboxypeptidase A precursor  0.0011 9.41 Gel 
contig09790 Multiple coagulation factor deficiency protein 2  0.0280 2.66 Gel 
CUFF.22549.1 neutral lipase  0.0430 2.52 AcCN 
contig06828 New attacin  0.0000 94.66 AcCN, Gel 
CUFF.32773.2 New attacin II  0.0017 109.37 AcCN 
CUFF.32773.5 New attacin II  0.0000 356.15 Gel 
contig14322 New attacin-1  0.0004 93.02 AcCN, Gel 
CUFF.3622.1 New lebocin-like protein B  0.0000 40.08 AcCN 
gi|28070937 non-muscle actin  0.3700 28.04 Gel 
CUFF.18570.1 ORF 0.0041 33.27 Gel 
gi|260765453 peptidoglycan recognition protein 2  0.0500 18.41 Gel 
contig00589 peptidoglycan recognition protein-D  0.0055 4.72 Gel 
CUFF.23390.3 peptidoglycan recognition protein-like protein 0.0002 3.68 AcCN, Gel 
contig01410 peptidyl-glycine alpha-amidating monooxygenase 1  0.0022 3.11 Gel 
contig00080 phosphoribosylformylglycinamidine synthase-like  0.1500 5.49 Gel 
CUFF.18564.1 phytosulfokine receptor kinase  0.0280 12.82 AcCN 
CUFF.21811.1 neuroendocrine convertase 1-like  0.0380 6.41 Gel 
CUFF.19272.1 similar to ubiquitin-activating enzyme E1  0.0470 8.26 Gel 
gi|219958088 pro-lebocin  0.0026 2.84 AcCN, Gel 
contig01664 prophenoloxidase-activating proteinase-2  0.0059 39.33 Gel 
gi|26006435 prophenoloxidase-activating proteinase-2  0.0330 15.82 AcCN 
CUFF.24908.2 prophenoloxidase-activating proteinase-3  0.0024 9.36 Gel 
gi|35277829 prophenoloxidase-activating proteinase-3 precursor  0.0001 6.50 AcCN 
contig07412 protease inhibitor 6  0.0000 33.03 AcCN, Gel 
contig03465 protease inhibitor-like protein  0.0009 18.51 AcCN, Gel 
CUFF.35951.1 psychimicin                       0.0170 13.91 AcCN, Gel 
contig00143 putative hemicentin 1  0.0140 5.57 Gel 
CUFF.19083.1 putative nidogen  0.0100 3.02 Gel 
contig00965 putative odd Oz protein  0.0150 13.17 Gel 
contig01992 putative Zn carboxypeptidase family protein  0.1300 9.79 Gel 
CUFF.24674.1 Pv-fam-d protein  0.0200 5.55 Gel 
contig04199 salivary cysteine-rich peptide precursor  0.0330 41.11 Gel 
lrc474 scolexin A  0.0002 54.40 AcCN, Gel 
CUFF.28292.2 serine protease inhibitor 11 precursor  0.0035 8.68 Gel 
CUFF.16810.10 serine protease inhibitor 28  0.0450 28.84 AcCN 
CUFF.16810.8 serine protease inhibitor 28  0.0000 89.43 AcCN, Gel 
gi|27733421 serine protease-like protein  0.3700 13.51 Gel 
contig03020 serine proteinase-like protein 4  0.0027 2.78 Gel 
gi|27733415 serpin 3a  0.0430 13.78 AcCN, Gel 
gi|2149091 serpin-2  0.0080 7.08 Gel 
gi|45594232 serpin-5A  0.0000 37.67 Gel 
CUFF.19298.1 triacylglycerol lipase  0.0006 24.38 Gel 
contig01723 Vanin-like protein 1  0.0001 6.12 Gel 
CUFF.30901.2 Vanin-like protein 1  0.0004 6.05 Gel 
CUFF.29762.1 Xaa-Pro dipeptidase  0.4500 6.28 Gel 
CUFF.9332.4 yellow-d  0.0054 3.16 Gel 
 
*T-test was conducted using normalized spectral counts of proteins from induced samples and control samples. Those with 
significant changes after immune challenge were marked red (p-value < 0.05). IH/CH was calculated using the average 
normalized spectral counts of induced and control samples. If the number for control sample was zero, we used one for the 
calculation.  
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Table 14.  A list of 155 down-regulated proteins after immune challenge* 
 
ID Function P-Value IH/CH Source 
contig01651 26S proteasome non-ATPase regulatory subunit 1  0.2000 0.00 Gel 
CUFF.14802.2 3-dehydroecdysone 3beta-reductase  0.2100 0.04 Gel 
gi|1350990 40S ribosomal protein S3                     0.0260 0.25 Gel 
gi|1351005 40S ribosomal protein S7                     0.2800 0.10 Gel 
gi|28207648 ADP/ATP translocase  0.0083 0.12 Gel 
CUFF.20827.1 alcohol dehydrogenase  0.3300 0.13 Gel 
contig03267 aldo-keto reductase  0.0080 0.18 AcCN 
CUFF.22393.1 aldo-keto reductase  0.0240 0.00 AcCN 
CUFF.12719.1 aldo-keto reductase 2E  0.0009 0.37 AcCN 
contig03322 aldose-1-epimerase  0.0005 0.06 AcCN 
CUFF.696.1 alpha-amylase 3  0.0110 0.42 AcCN 
CUFF.909.1 alpha-esterase 45  0.2100 0.00 Gel 
CUFF.23067.1 apolipophorin-III  0.0069 0.48 AcCN 
gi|159491 arylphorin beta subunit precursor  0.1600 0.13 AcCN 
CUFF.30159.1 Arylsulfatase B  0.0056 0.06 AcCN 
CUFF.4487.2 
basement membrane-specific heparan sulfate 
proteoglycan core pr.  0.0370 0.14 Gel 
contig05808 BCP inhibitor precursor  0.0087 0.31 Gel 
contig05808 BCP inhibitor precursor  0.0400 0.50 AcCN 
contig04133 β-1,3-glucanase  0.0100 0.32 AcCN 
contig00514 β-N-acetylglucosaminidase 1  0.0045 0.36 AcCN 
CUFF.18887.2 Bombyrin  0.4500 0.15 AcCN 
contig06322 Bombyrin precursor  0.0027 0.48 AcCN 
CUFF.13061.1 calcium-dependent protein 2  0.0240 0.00 Gel 
contig02851 Calmodulin  0.1900 0.00 AcCN 
gi|62738877 Insecticyanin 0.0390 0.42 Gel 
contig02044 chitin deacetylase 1  0.0370 0.18 Gel 
F5KO9GJ01A5X4X collagen, type IV  0.1600 0.00 Gel 
contig11118 cuticle protein 4  0.0001 0.04 AcCN 
CUFF.21137.1 cuticular protein analogous to peritrophins 3-A1  0.0097 0.33 AcCN 
CUFF.657.1 cuticular protein RR-1 motif 3 precursor  0.0043 0.41 Gel 
contig03131 cytosolic malate dehydrogenase  0.1100 0.08 Gel 
CUFF.27792.1 deoxyribonuclease I  0.0920 0.19 AcCN 
CUFF.32682.1 diapausin precursor  0.0010 0.00 AcCN 
gi|159499 diazepam binding inhibitor-like peptide  0.0009 0.34 AcCN 
contig03386 DNA supercoiling factor  0.0160 0.16 Gel 
contig05586 elongation factor 1-beta'  0.0004 0.18 Gel 
CUFF.11497.2 endoprotease FURIN  0.0260 0.21 AcCN 
contig01115 eukaryotic initiation factor 5A  0.0750 0.00 AcCN 
contig02840 eukaryotic translation initiation factor 4A  0.0690 0.17 Gel 
contig00923 FK506-binding protein FKBP59 homologue  0.0140 0.13 Gel 
CUFF.15602.1 flavin-dependent monooxygenase FMO2 precursor  0.0050 0.00 AcCN 
gi|113608 fructose-bisphosphate aldolase A 0.3700 0.00 Gel 
contig09929 
gamma-glutamyl cyclotransferase-like venom 
protein isoform 1  0.0015 0.46 Gel 
contig03063 glutaminyl-peptide cyclotransferase-like  0.0050 0.28 AcCN 
contig08432 glutaredoxin  0.2600 0.09 AcCN 
gi|121746 glutathione S-transferase P 0.3700 0.00 Gel 
CUFF.9633.1 glutathione S-transferase sigma 1  0.0240 0.39 Gel 
contig03213 glycerophosphoryl diester phosphodiesterase 0.0130 0.37 AcCN 
CUFF.15250.1 glycosyl hydrolase family 31 protein  0.0550 0.00 Gel 
contig12629 Hdd1-like protein 0.0430 0.39 AcCN 
lrc245 heat shock protein 25.4  0.1800 0.00 Gel 
contig00548 hemolymph proteinase 6  0.0340 0.00 AcCN 
CUFF.31628.6 hemolymph proteinase 8  0.0007 0.49 AcCN 
CUFF.6831.1 hemolymph trypsin inhibitor A;                     0.0000 0.48 Gel 
gi|123725 hemolymph trypsin inhibitor B 0.0170 0.44 Gel 
gi|505621 high affinity nuclear JH binding protein  0.1900 0.00 Gel 
contig06072 histone H2A-like protein 2  0.0180 0.33 Gel 
contig02045 hydroxypyruvate isomerase  0.0034 0.36 AcCN 
contig15813 hypothetical protein KGM_01763  0.0130 0.08 AcCN 
contig13712 hypothetical protein KGM_06638  0.0033 0.50 AcCN 
contig03958 hypothetical protein KGM_08730  0.3100 0.00 Gel 
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contig04595 hypothetical protein KGM_10974  0.0560 0.10 AcCN 
contig05943 hypothetical protein KGM_16230  0.0370 0.28 AcCN 
CUFF.22336.1 hypothetical protein KGM_21980  0.1300 0.00 Gel 
gi|9716 insecticyanin a form  0.0440 0.43 Gel 
CUFF.17913.1 integument esterase 2 precursor  0.0190 0.23 Gel 
gi|73921301 juvenile hormone esterase precursor  0.0027 0.11 Gel 
contig00254 juvenile hormone esterase precursor  0.0260 0.00 Gel 
CUFF.27967.12 kynurenine formamidase  0.0610 0.12 Gel 
gi|48428995 lysozyme C 0.3700 0.00 Gel 
contig06389 mating type protein MAT1-1-1  0.0260 0.00 Gel 
CUFF.23390.1 microvitellogenin  0.0500 0.16 AcCN 
lrc75 moderately methionine rich storage protein  0.1200 0.00 Gel 
CUFF.13545.2 multiplexin, isoform M  0.0820 0.08 Gel 
contig00808 N-acetylglucosaminidase  0.0770 0.10 Gel 
contig05820 nascent polypeptide associated complex α subunit  0.0340 0.32 Gel 
gi|1708635 neuroglian  0.2300 0.00 AcCN 
CUFF.9504.1 new antennal binding protein 7  0.0026 0.16 AcCN 
CUFF.17954.6 new sensory appendage protein 1  0.0038 0.50 AcCN 
CUFF.17957.2 new sensory appendage protein 1  0.0097 0.10 AcCN 
CUFF.5287.1 nonclathrin coat protein gamma2-COP  0.3700 0.00 Gel 
contig13241 odorant binding protein  0.3700 0.00 AcCN, Gel 
lrc1777 ommochrome-binding protein  0.0011 0.38 AcCN 
CUFF.8839.1 p270  0.2300 0.00 Gel 
CUFF.18772.10 paralytic peptide binding protein 1  0.3700 0.00 Gel 
CUFF.20588.18 peroxisomal N1-acetyl-spermine oxidase  0.0008 0.19 AcCN 
CUFF.20588.11 peroxisomal N1-acetyl-spermine oxidase  0.0014 0.20 AcCN 
contig14653 phosphoglucomutase  0.0460 0.49 Gel 
CUFF.38214.1 phosphoglucomutase  0.0870 0.16 Gel 
CUFF.32110.3 plasmatocyte-spreading peptide precursor  0.0330 0.45 Gel 
CUFF.12385.1 plasminogen activator inhibitor 1 RNA-binding pr.  0.3700 0.00 Gel 
CUFF.31619.1 apolipophorins-like, partial  0.0730 0.07 Gel 
CUFF.17519.2 collagen alpha-1(IV) chain-like  0.0016 0.37 Gel 
contig00668 lamin Dm0-like isoform 1  0.3700 0.00 Gel 
contig07975 proteasome subunit β type-2-like  0.3700 0.00 Gel 
CUFF.21412.1 similar to GA14337-PA  0.1500 0.00 AcCN 
CUFF.32240.1 protein disulfide isomerase  0.0026 0.09 Gel 
gi|58864722 putative annexin IX-B  0.0360 0.27 Gel 
gi|254746340 putative C1A cysteine protease precursor  0.0065 0.39 AcCN 
gi|254746338 putative C1A cysteine protease precursor  0.0450 0.41 AcCN 
CUFF.17517.1 putative collagen alpha-2IV chain protein  0.0220 0.42 Gel 
CUFF.21813.1 putative collagen and Ca2+-binding EGF domains 1  0.0003 0.49 AcCN 
CUFF.21813.1 putative collagen and Ca2+-binding EGF domains 1  0.0003 0.26 Gel 
contig02362 putative enolase protein  0.4500 0.15 AcCN 
CUFF.10253.3 inosine-uridine preferring nucleoside hydrolase  0.0005 0.00 AcCN 
CUFF.10254.1 inosine-uridine preferring nucleoside hydrolase  0.1600 0.00 AcCN 
CUFF.19054.1 putative mannosidase, βA, lysosomal  0.0048 0.04 AcCN 
CUFF.7410.1 putative protease inhibitor 4  0.0200 0.43 AcCN 
CUFF.16862.1 putative rab GDP-dissociation inhibitor  0.0350 0.18 Gel 
contig04965 putative ribophorin II  0.3700 0.00 Gel 
contig01389 ras-related GTP-binding protein Rab11  0.0004 0.31 Gel 
CUFF.31934.2 regulator of chromosome condensation  0.3700 0.00 Gel 
CUFF.24819.1 reticulon/nogo receptor  0.0300 0.08 Gel 
gi|268306444 ribosomal protein L10  0.3300 0.15 Gel 
gi|268306376 ribosomal protein L11  0.1300 0.03 Gel 
gi|268306382 ribosomal protein L12  0.2500 0.11 Gel 
gi|268306480 ribosomal protein L13  0.0680 0.05 Gel 
gi|268306366 ribosomal protein L13A  0.0170 0.18 Gel 
CUFF.2904.1 ribosomal protein L14  0.0040 0.48 Gel 
gi|268306486 ribosomal protein L15  0.0200 0.00 Gel 
gi|268306468 ribosomal protein L18  0.1400 0.05 Gel 
contig08946 ribosomal protein L18A  0.2700 0.00 Gel 
gi|268306370 ribosomal protein L26  0.1100 0.10 Gel 
gi|268306352 ribosomal protein L3  0.1800 0.19 Gel 
gi|268306418 ribosomal protein L31  0.0400 0.36 Gel 
gi|268306428 ribosomal protein L35A  0.0046 0.11 Gel 
gi|268306434 ribosomal protein L5  0.0001 0.04 Gel 
60 
 
gi|268306462 ribosomal protein L7  0.0370 0.33 Gel 
gi|268306466 ribosomal protein L7A  0.0046 0.14 Gel 
gi|268306420 ribosomal protein L8  0.1900 0.00 Gel 
gi|268306396 ribosomal protein L9  0.0660 0.14 Gel 
contig11395 ribosomal protein S12  0.0560 0.06 Gel 
gi|268306426 ribosomal protein S13  0.0610 0.00 Gel 
contig13755 ribosomal protein S15A  0.0042 0.14 Gel 
gi|268306384 ribosomal protein S18  0.0180 0.27 Gel 
gi|268306498 ribosomal protein S2  0.2100 0.13 Gel 
gi|268306374 ribosomal protein S20  0.0340 0.32 Gel 
gi|268306364 ribosomal protein S27  0.0032 0.00 Gel 
contig06573 ribosomal protein S3A  0.0017 0.09 Gel 
gi|268306408 ribosomal protein S4  0.0450 0.48 Gel 
CUFF.1918.1 ribosomal protein S6  0.0012 0.00 Gel 
gi|268306412 ribosomal protein S8  0.2700 0.00 Gel 
gi|268306404 ribosomal protein S9  0.0056 0.23 Gel 
contig01488 S-adenosyl-L-homocysteine hydrolase  0.0300 0.32 Gel 
CUFF.10507.1 secreted protein acidic and rich in cysteine  0.0017 0.30 Gel 
CUFF.2529.2 seminal fluid protein CSSFP028  0.2700 0.00 Gel 
gi|1378132 serpin 1  0.0019 0.49 AcCN 
CUFF.22827.1 serpin 7  0.0710 0.05 Gel 
contig02334 small GTP-binding protein  0.0440 0.30 Gel 
CUFF.10507.1 sparc  0.0006 0.10 AcCN 
contig05971 superoxide dismutase  0.0480 0.15 AcCN 
gi|6560635 thioredoxin-like protein  0.0180 0.13 AcCN 
CUFF.7756.1 Tolloid-like protein 2  0.0043 0.36 AcCN 
gi|136429 trypsin 0.0069 0.40 AcCN 
CUFF.10235.1 twelve cysteine protein 1  0.0180 0.00 AcCN 
CUFF.19786.1 unknown  0.0087 0.43 AcCN 
CUFF.19786.1 unknown  0.0099 0.40 Gel 
CUFF.5575.1 unknown                       0.0200 0.24 AcCN 
contig01080 venom acid phosphatase  0.0024 0.20 AcCN 
CUFF.10876.1 venom acid phosphatase  0.0040 0.50 Gel 
contig02578 vitellogenic carboxypeptidase  0.0440 0.07 Gel 
*See Table 13 
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Table 15.  A list of 211 immunity-related proteins* 
 
ID Function P-Value IH/CH Source Type 
contig03013 β-1,3-glucan recognition protein  0.0100 0.83 Gel 1 
gi|52782757 β -1,3-glucan recognition protein 1   0.8400 0.90 AcCN, Gel 1 
contig01306 β-1,3-glucan recognition protein 2  0.0660 1.82 Gel 1 
contig14217 β-1,3-glucan recognition protein 3  0.3200 0.76 Gel 1 
contig13657 β-1,3-glucan recognition protein 3  0.5600 0.34 Gel 1 
CUFF.37621.1 β-1,3-glucan recognition protein 3  0.6600 1.12 Gel 1 
CUFF.32840.1 β-1,3-glucan recognition protein 3  0.9500 1.01 Gel 1 
contig04133 β-1,3-glucanase  0.0100 0.32 AcCN 1 
contig04133 β-1,3-glucanase  0.2700 0.72 Gel 1 
contig01513 β-galactosidase  0.9600 0.99 AcCN, Gel 1 
CUFF.3641.4 C-type lectin 10 precursor  0.0530 0.24 Gel 1 
CUFF.3641.1 C-type lectin 10 precursor  0.2800 0.50 Gel 1 
CUFF.3645.2 C-type lectin 10 precursor  0.3100 0.25 AcCN, Gel 1 
CUFF.1879.2 draper  0.3800 1.43 Gel 1 
CUFF.29563.2 galectin-4  0.4500 0.71 Gel 1 
GNBP GNBP 0.6100 1.15 AcCN, Gel 1 
CUFF.15846.1 GNBP-like protein  0.2600 1.16 Gel 1 
contig15094 hemicentin-like protein  0.2500 1.39 Gel 1 
CUFF.4030.1 hemicentin-like protein 1  0.5700 1.17 Gel 1 
contig04393 hemicentin-like protein 2  0.2600 1.29 Gel 1 
gi|259493819 hemocyte aggregation inhibitor protein precursor  0.0250 0.75 AcCN 1 
CUFF.8487.3 hemocyte aggregation inhibitor protein precursor  0.0300 0.86 Gel 1 
CUFF.27533.1 hemocytin  0.1100 0.62 Gel 1 
CUFF.27538.1 hemocytin  0.3300 0.82 Gel 1 
gi|511297 hemolin  0.0000 5.44 AcCN 1 
CUFF.23729.1 hemolin  0.0001 12.54 Gel 1 
contig01508 Immulectin-1  0.0170 4.95 Gel 1 
gi|237869126 immulectin-2  0.6800 0.76 AcCN, Gel 1 
CUFF.5601.4 immulectin-3  0.1000 0.74 AcCN, Gel 1 
contig04357 immulectin-4  0.0890 7.98 Gel 1 
CUFF.32498.1 lectin 0.9100 1.07 Gel 1 
CUFF.11764.1 leureptin  0.0710 0.92 Gel 1 
CUFF.11766.1 leureptin  0.0940 0.66 Gel 1 
gi|27733411 leureptin  0.2400 0.78 Gel 1 
CUFF.3007.14 New immulectin  0.0390 1.70 Gel 1 
CUFF.3007.22 New immulectin  0.7700 1.07 Gel 1 
CUFF.5601.1 New immulectin-3 0.0014 0.64 Gel 1 
CUFF.5595.1 New immulectin-3  0.5000 4.24 AcCN, Gel 1 
CUFF.18040.1 nimrod B precursor  0.0280 0.69 AcCN, Gel 1 
c2114 nimrod B precursor  0.2000 0.79 Gel 1 
gi|27733423 peptidoglycan recognition protein 1A  0.9800 1.00 Gel 1 
gi|27733409 peptidoglycan recognition protein 1B  0.4500 0.93 AcCN 1 
gi|260765453 peptidoglycan recognition protein 2  0.0500 18.41 Gel 1 
contig00589 peptidoglycan recognition protein-D  0.0055 4.72 Gel 1 
CUFF.23390.3 peptidoglycan recognition protein-like protein 0.0002 3.68 AcCN, Gel 1 
CUFF.28117.2 hemocytin-like  0.0700 0.72 Gel 1 
contig00143 putative hemicentin 1  0.0140 5.57 Gel 1 
contig00476 putative hemicentin 1  0.0150 0.64 AcCN, Gel 1 
CUFF.237.1 putative hemicentin 1  0.1600 1.32 Gel 1 
CUFF.239.1 putative hemicentin 1  0.3500 2.06 AcCN, Gel 1 
contig08927 putative hemicentin 1  0.4700 1.24 Gel 1 
contig00583 putative hemicentin 1  0.5200 1.27 Gel 1 
CUFF.19863.5 putative hemicentin-1  0.0740 0.44 Gel 1 
contig15247 putative hemicentin-1  0.8200 1.11 Gel 1 
contig05808 BCP inhibitor precursor  0.0400 0.50 AcCN, Gel 2 
CUFF.26093.1 cysteine proteinase inhibitor precursor  0.0170 0.76 AcCN, Gel 2 
CUFF.26093.2 cysteine proteinase inhibitor precursor  0.3100 1.23 Gel 2 
CUFF.26093.3 cysteine proteinase inhibitor precursor  0.0720 0.77 AcCN, Gel 2 
gi|260234113 cysteine proteinase inhibitor precursor  0.3100 0.86 AcCN, Gel 2 
contig00585 cysteine-rich/pacifastin venom protein 2  0.7200 1.20 AcCN, Gel 2 
CUFF.18357.1 dorsal  0.6300 1.37 AcCN, Gel 2 
lrc23 dorsal  0.0230 1.77 AcCN, Gel 2 
contig12629 Hdd1-like protein  0.0430 0.39 AcCN, Gel 2 
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CUFF.10416.1 hemocyte protease-1  0.0074 0.51 AcCN, Gel 2 
contig06406 hemocyte protease-2  0.8500 1.09 Gel 2 
gi|56418409 hemolymph proteinase 15  0.2700 1.82 Gel 2 
CUFF.29694.1 hemolymph proteinase 16  0.2000 1.66 Gel 2 
CUFF.14527.1 hemolymph proteinase 17  0.0720 12.93 Gel 2 
gi|56418419 hemolymph proteinase 19  0.1100 1.56 Gel 2 
contig04271 hemolymph proteinase 20  0.0069 4.16 AcCN 2 
CUFF.25442.1 hemolymph proteinase 20  0.0004 2.75 Gel 2 
contig02445 hemolymph proteinase 21  0.0580 0.48 AcCN, Gel 2 
contig02033 hemolymph proteinase 22, partial  0.0490 15.83 Gel 2 
CUFF.31629.1 hemolymph proteinase 5  0.0370 5.76 Gel 2 
contig00548 hemolymph proteinase 6  0.0340 0.00 AcCN, Gel 2 
CUFF.31628.4 hemolymph proteinase 8  0.7000 0.93 Gel 2 
CUFF.31628.6 hemolymph proteinase 8  0.0007 0.49 AcCN 2 
gi|56418399 hemolymph proteinase 9  0.2300 1.77 Gel 2 
CUFF.6831.1 hemolymph trypsin inhibitor A                    0.0017 0.53 AcCN, Gel 2 
gi|123725 hemolymph trypsin inhibitor B        0.0170 0.44 Gel 2 
contig05216 Kazal-type inhibitor  0.0001 10.42 AcCN, Gel 2 
gi|6560641 Kazal-type proteinase inhibitor  0.0067 0.66 AcCN, Gel 2 
CUFF.7975.1 Kazal-type serine proteinase inhibitor  0.0037 8.79 Gel 2 
contig11836 Kunitz-type protease inhibitor precursor  0.0250 0.58 AcCN 2 
lrc464 Kunitz-type protease inhibitor precursor  0.0026 0.68 Gel 2 
contig03315 New hemolymph proteinase  0.1800 1.32 Gel 2 
CUFF.25432.2 New hemolymph proteinase 20  0.2600 2.55 Gel 2 
CUFF.29541.2 pattern recognition serine proteinase precursor  0.0600 1.62 Gel 2 
gi|39655053 pattern recognition serine proteinase precursor  0.4700 1.17 Gel 2 
CUFF.23027.1 prophenoloxidase subunit 1  0.0930 3.40 AcCN, Gel 2 
CUFF.26961.2 prophenoloxidase  0.0720 0.82 Gel 2 
contig03105 prophenoloxidase-activating proteinase-1  0.0320 0.84 AcCN, Gel 2 
contig01664 prophenoloxidase-activating proteinase-2  0.0059 39.33 Gel 2 
gi|26006435 prophenoloxidase-activating proteinase-2  0.0330 15.82 AcCN 2 
CUFF.24908.2 prophenoloxidase-activating proteinase-3  0.0024 9.36 Gel 2 
gi|35277829 prophenoloxidase-activating proteinase-3  0.0001 6.50 AcCN 2 
CUFF.7977.1 protease inhibitor 1  0.5700 1.10 AcCN 2 
contig07412 protease inhibitor 6 0.0000 33.03 AcCN, Gel 2 
contig03465 protease inhibitor-like protein  0.0009 18.51 AcCN, Gel 2 
contig02101 putative C1A Cys protease precursor  0.6200 0.74 Gel 2 
CUFF.14914.4 putative C1A Cys protease precursor  0.8900 1.15 Gel 2 
gi|254746338 putative C1A Cys protease precursor  0.0450 0.41 AcCN, Gel 2 
gi|254746340 putative C1A Cys protease precursor  0.0065 0.39 AcCN, Gel 2 
contig00474 putative f-spondin  0.0022 0.62 AcCN, Gel 2 
CUFF.7410.1 putative protease inhibitor 4  0.0200 0.43 AcCN, Gel 2 
contig03750 putative serine protease-like protein 2  0.0054 0.58 AcCN 2 
CUFF.23176.4 putative serine protease-like protein 2  0.0100 0.66 Gel 2 
gi|136429 trypsin precursor                     0.0069 0.40 AcCN, Gel 2 
CUFF.21587.1 REPAT31  0.0052 0.65 AcCN, Gel 2 
contig00315 REPAT32  0.2300 0.75 AcCN, Gel 2 
lrc474 scolexin A  0.0002 54.40 AcCN, Gel 2 
contig04027 scolexin B  0.0680 0.74 AcCN, Gel 2 
lrc45 serine protease 17  0.2900 0.64 Gel 2 
lrc477 serine protease 17  0.4400 1.89 Gel 2 
contig06430 serpin 11 precursor  0.0830 4.15 Gel 2 
CUFF.28292.2 serpin 11 precursor  0.0035 8.68 Gel 2 
CUFF.16311.1 serpin 13 precursor  0.1200 0.79 Gel 2 
CUFF.25074.1 serpin 23 precursor  0.1300 0.66 Gel 2 
CUFF.16810.1 serpin 28  0.0230 0.50 AcCN, Gel 2 
CUFF.16810.10 serpin 28  0.0450 28.84 AcCN 2 
CUFF.16810.8 seripn 28  0.0000 89.43 AcCN, Gel 2 
CUFF.25446.2 serine protease-like protein  0.2900 2.22 Gel 2 
CUFF.25446.3 serine protease-like protein  0.1600 1.34 Gel 2 
CUFF.25446.4 serine protease-like protein  0.0390 1.92 Gel 2 
gi|27733421 serine protease-like protein  0.3700 2.23 AcCN, Gel 2 
contig02838 serine proteinase-like protein 1b  0.0004 0.54 AcCN, Gel 2 
CUFF.33286.1 serine proteinase-like protein 1b  0.5700 0.90 Gel 2 
gi|21630233 serine proteinase-like protein 2  0.3400 0.76 AcCN, Gel 2 
contig03020 serine proteinase-like protein 4  0.0027 2.78 Gel 2 
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CUFF.30294.14 serpin 1  0.0120 0.73 Gel 2 
CUFF.30294.20 serpin 1  0.0720 0.85 Gel 2 
CUFF.30294.6 serpin 1  0.0039 0.82 Gel 2 
gi|1378127 serpin 1  0.0044 0.74 Gel 2 
gi|1378132 serpin 1  0.0019 0.49 AcCN 2 
gi|27733415 serpin 3a  0.0430 13.78 AcCN, Gel 2 
contig05880 serpin 2  0.3700 1.82 Gel 2 
contig15945 serpin 2  0.3700 2.06 Gel 2 
CUFF.16959.12 serpin 2  0.8100 1.31 Gel 2 
gi|2149091 serpin 2  0.0080 7.08 Gel 2 
gi|45594224 serpin 4A  0.2700 1.74 Gel 2 
gi|45594226 serpin 4B  0.0180 1.35 Gel 2 
gi|45594232 serpin 5A  0.0000 37.67 Gel 2 
CUFF.16998.1 serpin 6  0.0570 1.29 Gel 2 
CUFF.22827.1 serpin 7  0.0710 0.05 Gel 2 
serpin8 serpin 8 0.0380 1.89 Gel 2 
contig13837 silk protease inhibitor 1 precursor  0.0400 0.72 AcCN, Gel 2 
contig14017 silk protease inhibitor 1 precursor  0.2500 0.68 AcCN 2 
CUFF.6839.1 silk protease inhibitor 1 precursor  1.0000 1.00 AcCN, Gel 2 
CUFF.10507.1 sparc  0.0006 0.10 AcCN, Gel 2 
SPH6 SPH6 0.5600 3.05 Gel 2 
contig05893 Spz1B  0.1400 0.63 AcCN, Gel 2 
contig07592 Spz1B  0.1700 0.37 AcCN, Gel 2 
contig15228 antileukoproteinase precursor  0.1200 4.07 AcCN 3 
gi|29469965 antimicrobial peptide cecropin 6  0.0008 17.31 AcCN, Gel 3 
CUFF.21534.1 antimicrobial peptide MGD2b precursor  0.3800 0.61 AcCN, Gel 3 
CUFF.26341.2 antimicrobial protein 6Tox  0.2000 4.70 AcCN 3 
gi|29469969 antimicrobial protein attacin 2  0.0000 106.97 AcCN, Gel 3 
CUFF.19826.5 attacin-1  0.0000 176.15 AcCN 3 
CUFF.19828.1 attacin-1  0.0000 162.75 AcCN, Gel 3 
CUFF.19826.3 attacin-1  0.0000 13.05 Gel 3 
c25131 attacin-1  0.0000 40.86 AcCN, Gel 3 
gi|67906420 attacin-1  0.0000 143.86 AcCN, Gel 3 
CUFF.19826.4 attacin-1  0.0000 508.58 AcCN, Gel 3 
c2978 attacin-1  0.0001 130.79 AcCN, Gel 3 
CUFF.19826.2 attacin-1  0.0003 72.41 AcCN 3 
CUFF.19828.3 attacin-1  0.1200 98.55 AcCN 3 
lrc6486 attacin-1  0.3700 29.21 AcCN, Gel 3 
contig12105 bactericidin  0.0005 25.83 AcCN 3 
contig13987 cecropin 3  0.0029 2.18 AcCN 3 
CUFF.32682.1 diapausin precursor  0.0010 0.00 AcCN 3 
contig15549 diapausin precursor  0.0220 1.75 AcCN, Gel 3 
contig10194 gallerimycin  0.0000 21.00 AcCN, Gel 3 
gi|110649240 gloverin  0.0002 3.60 AcCN 3 
contig02032 gloverin  0.0014 3.53 Gel 3 
lrc512 hypothetical protein CHLNCDRAFT_55808  0.0250 9.28 AcCN, Gel 3 
contig08449 hypothetical protein KGM_06199  0.0092 18.32 AcCN, Gel 3 
gi|291603839 lebocin-like protein 1  0.0005 9.28 AcCN 3 
gi|291603841 lebocin-like protein 2  0.0000 47.87 AcCN 3 
contig10931 lebocin-like protein B  0.0000 48.61 AcCN 3 
contig04845 lebocin-like protein C  0.0000 29.87 AcCN 3 
CUFF.12293.1 lysozyme  0.0001 1.81 AcCN, Gel 3 
gi|48428995 lysozyme C 0.3700 0.00 Gel 3 
gi|260765455 lysozyme-like protein 1  0.2100 0.60 AcCN, Gel 3 
contig06828 new attacin  0.0000 94.66 AcCN, Gel 3 
CUFF.32773.5 new attacin II  0.0000 356.15 Gel 3 
CUFF.32773.2 new attacin II  0.0017 109.37 AcCN 3 
contig14322 new attacin-1  0.0004 93.02 AcCN, Gel 3 
CUFF.3622.1 new lebocin-like protein B  0.0000 40.08 AcCN 3 
gi|219958088 pro-lebocin  0.0026 2.84 AcCN, Gel 3 
CUFF.35951.1 psychimicin                       0.0170 13.91 AcCN, Gel 3 
CUFF.13075.1 WAP four-disulfide core domain 2 isoform 1  0.9700 1.02 AcCN 3 
contig04199 salivary cysteine-rich peptide precursor  0.6000 0.87 AcCN, Gel 3 
gi|136206 transferrin 0.9100 1.02 AcCN 3 
CUFF.7001.1 transferrin  0.0069 1.35 Gel 3 
c4856 transferrin  0.6800 0.87 Gel 3 
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c6909 transferrin  0.6900 0.94 Gel 3 
contig12389 transferrin  0.8800 1.26 AcCN, Gel 3 
contig06672 lacunin  0.0260 5.11 Gel 4 
gi|6164595 lacunin  0.2000 1.39 Gel 4 
CUFF.17122.1 laminin β-2 chain  0.7500 0.93 Gel 4 
gi|1708635 neuroglian  0.2300 0.00 AcCN, Gel 4 
CUFF.18772.10 paralytic peptide binding protein 1  0.3700 0.00 Gel 4 
CUFF.18772.6 paralytic peptide binding protein 2  0.3800 0.41 Gel 4 
CUFF.32110.3 plasmatocyte-spreading peptide precursor  0.0013 0.57 AcCN, Gel 4 
contig00030 putative laminin A chain  0.2500 1.11 Gel 4 
contig00004 putative laminin A chain  0.7600 1.12 Gel 4 
contig01397 45 kDa immunophilin FKBP45  0.4300 0.50 Gel 5 
gi|27733419 immune-induced protein 1  0.0100 23.09 AcCN, Gel 5 
contig02384 immune-related Hdd1  0.0000 10.85 AcCN, Gel 5 
contig04966 peroxiredoxin  0.4500 0.54 Gel 5 
CUFF.4124.1 thioredoxin peroxidase  0.4300 0.76 AcCN 5 
*T-test was conducted using normalized spectral counts of proteins from induced samples and control samples. 
Those with significant changes after immune challenge were marked red (p-value < 0.05). IH/CH was calculated 
using the average normalized spectral counts of induced and control samples. If the number for control sample 
was zero, we used one for the calculation. Type means different types of immunity related proteins (1: PRR; 2: 
signaling proteins; 3: AMPs; 4: proteins involved in hemocyte adhesion; 5: Others). 
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Fig. 1. Scheme of library sequencing, dataset assembling, read normalization, contig 
categorization, and function prediction. Five cDNA libraries (CF, CH, IF, IH, and 2006) were 
assembled into seven datasets, one of which (#5: CIFH) was further analyzed by extracting 
numbers of CF, CH, IF and IH reads assembled into each contig. As described in Section 2.3, 
read numbers were calibrated using library normalization factors (LNFs) for the calculation of 
relative abundances (RAs) or adjusted read numbers (ARNs). Based on thresholds set arbitrarily, 
contigs were categorized into four groups: UP and DN for up- and down-regulated; HC and FB 
for hemocyte- or fat body-specific. 
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Fig. 2. Experimental workflow for the proteome analysis. Plasma collected from pathogen- 
and buffer-injected insects was treated using two methods – gel electrophoresis and acetonitrile 
treatment. Both protein samples were digested by trypsin and loaded on LTQ-Orbitrap mass 
spectrometer. Proteins were identified using Mascot and X! Tandem. Spectral counts for each 
protein were used for quantitative analysis. 
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Fig. 3. Numbers of proteins identified using both methods. 785 proteins were identified from 
the gel-extracted samples and 270 proteins were identified from the ACN treated samples. 157 
proteins were identified from both samples.  
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Fig. 4. Numbers of proteins identified using different sequence sources.  
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Fig. 5. Differential expression of immunity-related proteins after immune challenge.  
Proteins from gel slices (A) or AcCN-treated samples (B).  Pattern recognition proteins 
(♦), signal mediators/modulators (■), effectors (▲), and others (●). 
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Fig. 6. Comparison of the abundances of proteins and mRNAs. Figure A-H showed 
the correlation of abundances of plasma proteins (SCs) and fat body /hemocyte mRNAs 
(RNs) from both induced and control M. sexta. Proteins from gel-extracted samples were 
marked blue and those from AcCN-treated samples were marked red.  
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Fig. 7. Comparison of protein- and mRNA-level changes. Figure A and B showed the 
relative protein and fat body mRNA level changes after immune challenge for proteins 
with significant differences between C and I (p <0.05), I/C >5, or C/I >5.  
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APPENDIX 
 
 
ABBREVIATION LIST 
AMP: antimicrobial peptide 
NGS: next generation sequencing 
MS: mass spectrometry/mass spectrometer 
PRR: pattern recognition receptor 
PAMP: pathogen-associated molecular pattern 
LPS: lipopolysaccharide 
LTA: lipoteichoic acid 
βGRP: β-1, 3-glucan recognition protein 
GNBP: Gram-negative bacteria binding protein 
PGRP: peptidoglycan recognition protein 
CTL: C-type lectin 
HP: hemolymph protease 
proPO/PPO: pro-phenoloxidase 
PO: phenoloxidase 
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SPH: serine protease homologue 
serpin: serine protease inhibitor 
DIF: dorsal-related immune factor 
EST: expressed sequence tag 
MALDI: matrix assisted laser desorption/ionization 
ESI: electrospray ionization 
QIT: quadrupole ion trap 
LIT: linear ion trap 
TOF: time of flight 
FTICR: Fourier transform ion cyclotron resonance 
LC: liquid chromatography 
MudPIT: multidimensional protein identification 
DiGE: difference gel electrophoresis 
SILAC: stable isotope-labeling with amino acids in cell culture 
ICAT: isotope coded affinity tag 
iTRAQ: isobaric tagging technology 
CF, IF, CH, IH: fat body (F) or hemocyte (H) mRNA samples/sequences from immune induced (I) 
or control (C) insects 
CIFH: contigs generated using reads from CF, CH, IF, and IH samples 
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06CIFH: contigs generated using reads from CF, CH, IF, IH samples and cDNA sequences 
obtained in 2006 
LNF: library normalization factor 
RA: relative abundance 
ARN: adjusted read number 
UP: up-regulated genes 
DN: down-regulated genes 
HC: genes preferentially expressed in hemocyte 
FB: genes preferentially expressed in fat body 
FDR: false discovery rate 
PAP: pro-phenol oxidase activating proteinase 
HAIP: hemocyte aggregation inhibitor protein 
SC: spectral count 
PSP: plasmatocyte spreading peptide 
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Scope and Method of Study:  
 
This study explores immunity-related molecules in Manduca sexta larvae by 
studying the quantitative change of mRNAs and proteins after immune challenge. To 
investigate the mRNA level changes, we isolated mRNA samples from fat body and 
hemocytes of both pathogen- and buffer-injected insects. The cDNA samples were 
separately sequenced on 454 pyrosequencer. Short reads from different samples were 
assembled to contigs and read numbers from each sample were retrieved for all the 
contigs. These numbers were used to calculate relative abundances of the corresponding 
genes in each sample. Thus we compared the read numbers from different samples and 
found immune induced/suppressed genes and tissue preferentially expressed genes. In the 
proteome study, we collected plasma from both pathogen- and buffer-injected insects. 
After gel electrophoresis or acetonitrile precipitation, plasma samples were digested by 
trypsin and subsequently analyzed on mass analyzer. A manually constructed protein 
database was used for protein identification and spectral counts for each protein were 
used for semi-quantitative analysis. 
 
Findings and Conclusions: 
 
In the transcriptome study, we obtained two millions of reads which were assembled 
to 19,020 contigs. By comparing read numbers from different samples we found 528 up-
regulated genes including different immune factors. We also found hundreds of down-
regulated genes and fat body/hemocyte preferentially expressed genes. The set of genes 
enlarged our knowledge about immune factors in M. sexta. They also contributed to the 
M. sexta genome annotation. In the proteome study, we identified 785 proteins from the 
gel-extracted samples and 270 samples from the acetonitrile treated samples. Of them, 
115 and 155 proteins were found to be increased and decreased after immune challenge, 
respectively. A total of 211 immunity-related proteins were discovered in this study. The 
transcriptome study showed the efficiency and accuracy of pyrosequencing in 
quantitative transcriptomic analyses. The proteome study proved the robustness of 
spectral counting method. These two studies showed that many immune factors did not 
show drastic change except that antimicrobial peptides were highly induce at both mRNA 
and protein levels. 
